10-Q
Table of Contents

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

 

 

FORM 10-Q

 

 

 

þ  QUARTERLY

REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended September 30, 2011

OR

 

¨  TRANSITION

REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from            to            .

Commission file number: 001-14057

 

 

KINDRED HEALTHCARE, INC.

(Exact name of registrant as specified in its charter)

 

 

 

Delaware   61-1323993

(State or other jurisdiction of

incorporation or organization)

 

(I.R.S. Employer

Identification No.)

680 South Fourth Street

Louisville, KY

  40202-2412
(Address of principal executive offices)   (Zip Code)

(502) 596-7300

(Registrant’s telephone number, including area code)

 

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.     Yes   þ     No   ¨

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).     Yes   þ     No   ¨

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer,” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer   ¨    Accelerated filer   þ
Non-accelerated filer   ¨      Smaller reporting company   ¨

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).     Yes   ¨     No   þ

Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date.

 

Class of Common Stock

  

Outstanding at October 31, 2011

Common stock, $0.25 par value    52,121,641 shares

 

 

 

1 of 73


Table of Contents

KINDRED HEALTHCARE, INC.

FORM 10-Q

INDEX

 

          Page  

PART I.

   FINANCIAL INFORMATION   

Item 1.

  

Financial Statements (Unaudited):

  
  

Condensed Consolidated Statement of Operations—for the three months ended September 30,  2011 and 2010 and for the nine months ended September 30, 2011
and 2010

     3   
  

Condensed Consolidated Balance Sheet—September 30, 2011 and December 31, 2010

     4   
  

Condensed Consolidated Statement of Cash Flows—for the three months ended September  30, 2011 and 2010 and for the nine months ended September 30, 2011
and 2010

     5   
  

Notes to Condensed Consolidated Financial Statements

     6   

Item 2.

  

Management’s Discussion and Analysis of Financial Condition and Results of Operations

     39   

Item 3.

  

Quantitative and Qualitative Disclosures About Market Risk

     69   

Item 4.

  

Controls and Procedures

     70   

PART II.

   OTHER INFORMATION   

Item 1.

  

Legal Proceedings

     71   

Item 6.

  

Exhibits

     72   

 

2


Table of Contents

KINDRED HEALTHCARE, INC.

CONDENSED CONSOLIDATED STATEMENT OF OPERATIONS

(Unaudited)

(In thousands, except per share amounts)

 

     Three months ended
September 30,
    Nine months ended
September 30,
 
     2011     2010     2011     2010  

Revenues

   $ 1,514,062      $ 1,053,012      $ 3,999,075      $ 3,224,213   
  

 

 

   

 

 

   

 

 

   

 

 

 

Salaries, wages and benefits

     900,570        613,607        2,344,398        1,852,987   

Supplies

     107,514        83,753        294,254        255,094   

Rent

     105,511        89,295        292,641        266,595   

Other operating expenses

     332,017        234,968        878,518        707,859   

Other income

     (2,815     (2,794     (8,480     (8,735

Depreciation and amortization

     46,947        29,167        117,367        90,140   

Interest expense

     25,790        1,642        54,675        4,247   

Investment income

     (37     (403     (789     (903
  

 

 

   

 

 

   

 

 

   

 

 

 
     1,515,497        1,049,235        3,972,584        3,167,284   
  

 

 

   

 

 

   

 

 

   

 

 

 

Income (loss) from continuing operations before income taxes

     (1,435     3,777        26,491        56,929   

Provision (benefit) for income taxes

     (2,342     (1,323     9,848        20,538   
  

 

 

   

 

 

   

 

 

   

 

 

 

Income from continuing operations

     907        5,100        16,643        36,391   

Discontinued operations, net of income taxes:

        

Income (loss) from operations

     1,119        (260     1,527        (327

Gain on divestiture of operations

     —          86        —          3   
  

 

 

   

 

 

   

 

 

   

 

 

 

Income (loss) from discontinued operations

     1,119        (174     1,527        (324
  

 

 

   

 

 

   

 

 

   

 

 

 

Net income

     2,026        4,926        18,170        36,067   

(Earnings) loss attributable to noncontrolling interests

     (241     —          180        —     
  

 

 

   

 

 

   

 

 

   

 

 

 

Income attributable to Kindred

   $ 1,785      $ 4,926      $ 18,350      $ 36,067   
  

 

 

   

 

 

   

 

 

   

 

 

 

Amounts attributable to Kindred stockholders:

        

Income from continuing operations

   $ 666      $ 5,100      $ 16,823      $ 36,391   

Income (loss) from discontinued operations

     1,119        (174     1,527        (324
  

 

 

   

 

 

   

 

 

   

 

 

 

Net income

   $ 1,785      $ 4,926      $ 18,350      $ 36,067   
  

 

 

   

 

 

   

 

 

   

 

 

 

Earnings per common share:

        

Basic:

        

Income from continuing operations

   $ 0.01      $ 0.13      $ 0.37      $ 0.92   

Discontinued operations:

        

Income (loss) from operations

     0.02        (0.01     0.03        (0.01

Gain on divestiture of operations

     —          —          —          —     
  

 

 

   

 

 

   

 

 

   

 

 

 

Net income

   $ 0.03      $ 0.12      $ 0.40      $ 0.91   
  

 

 

   

 

 

   

 

 

   

 

 

 

Diluted:

        

Income from continuing operations

   $ 0.01      $ 0.13      $ 0.37      $ 0.92   

Discontinued operations:

        

Income (loss) from operations

     0.02        (0.01     0.03        (0.01

Gain on divestiture of operations

     —          —          —          —     
  

 

 

   

 

 

   

 

 

   

 

 

 

Net income

   $ 0.03      $ 0.12      $ 0.40      $ 0.91   
  

 

 

   

 

 

   

 

 

   

 

 

 

Shares used in computing earnings per common share:

        

Basic

     51,329        38,778        44,577        38,720   

Diluted

     51,406        38,838        44,934        38,855   

See accompanying notes.

 

3


Table of Contents

KINDRED HEALTHCARE, INC.

CONDENSED CONSOLIDATED BALANCE SHEET

(Unaudited)

(In thousands, except per share amounts)

 

     September 30,
2011
    December 31,
2010
 
ASSETS     

Current assets:

    

Cash and cash equivalents

   $ 34,095      $ 17,168   

Cash—restricted

     5,402        5,494   

Insurance subsidiary investments

     64,846        76,753   

Accounts receivable less allowance for loss of $22,631—September 30, 2011 and $13,584—December 31, 2010

     972,340        631,877   

Inventories

     30,821        24,327   

Deferred tax assets

     28,799        13,439   

Income taxes

     18,039        42,118   

Other

     30,796        24,862   
  

 

 

   

 

 

 
     1,185,138        836,038   

Property and equipment

     1,926,726        1,754,170   

Accumulated depreciation

     (875,885     (857,623
  

 

 

   

 

 

 
     1,050,841        896,547   

Goodwill

     1,123,699        242,420   

Intangible assets less accumulated amortization of $11,169—September 30, 2011 and $3,731—December 31, 2010

     506,066        92,883   

Assets held for sale

     7,094        7,167   

Insurance subsidiary investments

     104,298        101,210   

Deferred tax assets

     —          88,816   

Other

     198,441        72,334   
  

 

 

   

 

 

 

Total assets

   $ 4,175,577      $ 2,337,415   
  

 

 

   

 

 

 
LIABILITIES AND EQUITY     

Current liabilities:

    

Accounts payable

   $ 218,523      $ 174,495   

Salaries, wages and other compensation

     392,297        291,116   

Due to third party payors

     41,436        27,115   

Professional liability risks

     41,728        41,555   

Other accrued liabilities

     140,840        87,012   

Long-term debt due within one year

     10,539        91   
  

 

 

   

 

 

 
     845,363        621,384   

Long-term debt

     1,489,359        365,556   

Professional liability risks

     224,903        207,669   

Deferred tax liabilities

     26,678        —     

Deferred credits and other liabilities

     189,814        111,047   

Noncontrolling interests-redeemable

     9,626        —     

Commitments and contingencies

    

Equity:

    

Stockholders’ equity:

    

Common stock, $0.25 par value; authorized 175,000 shares; issued 52,112 shares—September 30, 2011 and 39,495 shares—December 31, 2010

     13,028        9,874   

Capital in excess of par value

     1,135,032        828,593   

Accumulated other comprehensive income (loss)

     (1,000     135   

Retained earnings

     211,003        193,157   
  

 

 

   

 

 

 
     1,358,063        1,031,759   

Noncontrolling interests-nonredeemable

     31,771        —     
  

 

 

   

 

 

 

Total equity

     1,389,834        1,031,759   
  

 

 

   

 

 

 

Total liabilities and equity

   $ 4,175,577      $ 2,337,415   
  

 

 

   

 

 

 

See accompanying notes.

 

4


Table of Contents

KINDRED HEALTHCARE, INC.

CONDENSED CONSOLIDATED STATEMENT OF CASH FLOWS

(Unaudited)

(In thousands)

 

    Three months ended
September 30,
    Nine months ended
September 30,
 
    2011     2010     2011     2010  

Cash flows from operating activities:

       

Net income

  $ 2,026      $ 4,926      $ 18,170      $ 36,067   

Adjustments to reconcile net income to net cash provided by operating activities:

       

Depreciation and amortization

    46,947        29,167        117,367        90,140   

Amortization of stock-based compensation costs

    3,505        2,593        9,611        8,114   

Payment of lender fees related to debt issuance

    —          —          (46,232     —     

Provision for doubtful accounts

    7,793        6,110        22,049        18,387   

Deferred income taxes

    (2,286     (3,017     (4,975     (13,744

Impairment charges

    26,712        —          26,712        —     

Gain on divestiture of discontinued operations

    —          (86     —          (3

Other

    (922     (2,792     1,465        (1,866

Change in operating assets and liabilities:

       

Accounts receivable

    (27,497     8,146        (108,072     (21,379

Inventories and other assets

    6,304        (1,088     3,649        (7,574

Accounts payable

    (831     (7,515     386        (15,693

Income taxes

    (6,881     3,981        20,792        25,734   

Due to third party payors

    1,143        12,123        4,698        10,099   

Other accrued liabilities

    10,505        15,361        52,186        22,573   
 

 

 

   

 

 

   

 

 

   

 

 

 

Net cash provided by operating activities

    66,518        67,909        117,806        150,855   
 

 

 

   

 

 

   

 

 

   

 

 

 

Cash flows from investing activities:

       

Routine capital expenditures

    (36,595     (28,623     (95,263     (69,108

Development capital expenditures

    (44,152     (20,364     (69,570     (40,219

Acquisitions, net of cash acquired

    (50,928     (38,379     (710,907     (87,869

Sale of assets

    —          —          1,714        —     

Purchase of insurance subsidiary investments

    (8,867     (10,566     (25,904     (34,684

Sale of insurance subsidiary investments

    10,398        11,138        37,587        72,971   

Net change in insurance subsidiary cash and cash equivalents

    (826     (3,111     (4,870     (10,612

Change in other investments

    —          —          1,000        2   

Other

    (663     698        (692     1,279   
 

 

 

   

 

 

   

 

 

   

 

 

 

Net cash used in investing activities

    (131,633     (89,207     (866,905     (168,240
 

 

 

   

 

 

   

 

 

   

 

 

 

Cash flows from financing activities:

       

Proceeds from borrowings under revolving credit

    533,200        457,900        1,633,300        1,109,900   

Repayment of borrowings under revolving credit

    (474,700     (432,800     (1,749,800     (1,092,400

Proceeds from issuance of senior unsecured notes

    —          —          550,000        —     

Proceeds from issuance of term loan, net of discount

    —          —          693,000        —     

Repayment of other long-term debt

    (2,545     (22     (348,233     (64

Payment of deferred financing costs

    (1,855     (1,361     (8,715     (1,414

Issuance of common stock

    —          —          3,019        35   

Purchase of noncontrolling interests in subsidiaries

    (7,292     —          (7,292     —     

Other

    3        —          747        346   
 

 

 

   

 

 

   

 

 

   

 

 

 

Net cash provided by financing activities

    46,811        23,717        766,026        16,403   
 

 

 

   

 

 

   

 

 

   

 

 

 

Change in cash and cash equivalents

    (18,304     2,419        16,927        (982

Cash and cash equivalents at beginning of period

    52,399        12,902        17,168        16,303   
 

 

 

   

 

 

   

 

 

   

 

 

 

Cash and cash equivalents at end of period

  $ 34,095      $ 15,321      $ 34,095      $ 15,321   
 

 

 

   

 

 

   

 

 

   

 

 

 

Supplemental information:

       

Issuance of common stock in RehabCare acquisition

  $ —        $ —        $ 300,426      $ —     

Financing costs paid in connection with RehabCare acquisition

    —          —          13,074        —     

Interest payments

    5,839        1,110        12,783        3,376   

Income tax payments (refunds)

    10,848        468        (2,435     11,021   

See accompanying notes.

 

5


Table of Contents

KINDRED HEALTHCARE, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

NOTE 1—BASIS OF PRESENTATION

Business

Kindred Healthcare, Inc. is a healthcare services company that through its subsidiaries operates long-term acute care (“LTAC”) hospitals, inpatient rehabilitation hospitals, nursing and rehabilitation centers, assisted living facilities and a contract rehabilitation services business across the United States (collectively, the “Company” or “Kindred”). At September 30, 2011, the Company’s hospital division operated 120 LTAC hospitals and five inpatient rehabilitation hospitals in 26 states. The Company’s nursing center division operated 224 nursing and rehabilitation centers and six assisted living facilities in 27 states. The Company’s rehabilitation division provides rehabilitative services primarily in hospital and long-term care settings in 46 states.

In recent years, the Company has completed several transactions related to the divestiture of unprofitable hospitals and nursing and rehabilitation centers to improve its future operating results. For accounting purposes, the operating results of these businesses and the gains associated with these transactions have been classified as discontinued operations in the accompanying unaudited condensed consolidated statement of operations for all periods presented. Assets not sold at September 30, 2011 have been measured at the lower of carrying value or estimated fair value less costs of disposal and have been classified as held for sale in the accompanying unaudited condensed consolidated balance sheet. See Note 5 for a summary of discontinued operations.

Recently issued accounting requirements

In September 2011, the Financial Accounting Standards Board (the “FASB”) issued authoritative guidance related to testing goodwill for impairment. The main provisions of the guidance state that an entity has the option to first assess qualitative factors to determine whether the existence of events or circumstances leads to a determination that it is more likely than not that the fair value of a reporting unit is less than its carrying amount. If an entity determines it is not more likely than not that the fair value of a reporting unit is less than its carrying amount, then performing the two-step goodwill impairment test is unnecessary. However, if an entity concludes otherwise, then it is required to perform Step 1 of the goodwill impairment test. The guidance is effective for all interim and annual reporting periods beginning after December 15, 2011. Early adoption is permitted. The adoption of the guidance is not expected to have a material impact on the Company’s business, financial position, results of operations or liquidity.

In July 2011, the FASB issued authoritative guidance related to the presentation and disclosure of patient service revenue, provision for bad debts, and the allowance for doubtful accounts for certain healthcare entities. The provisions of the guidance require healthcare entities that recognize significant amounts of patient service revenue at the time services are rendered, even though they do not assess a patient’s ability to pay, to present the provision for bad debts related to those revenues as a deduction from patient service revenue (net of contractual allowances and discounts), as opposed to an operating expense. All other entities would continue to present the provision for bad debts as an operating expense. The guidance is effective for all interim and annual reporting periods beginning after December 15, 2011. Early adoption is permitted, but full retrospective application is required. The adoption of the guidance is not expected to have a material impact on the Company’s business, financial position, results of operations or liquidity.

In June 2011, the FASB issued authoritative guidance related to the presentation of other comprehensive income. The provisions of the guidance state that an entity has the option to present the total of comprehensive income either in a single continuous statement of comprehensive income or in two separate but consecutive statements. The statement(s) should be presented with equal prominence to the other primary financial

 

6


Table of Contents

KINDRED HEALTHCARE, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)

(Unaudited)

 

NOTE 1—BASIS OF PRESENTATION (Continued)

 

Recently issued accounting requirements (Continued)

 

statements. The guidance is effective for all interim and annual reporting periods beginning after December 15, 2011. Early adoption is permitted, but full retrospective application is required. The adoption of the guidance will not have a material impact on the Company’s business, financial position, results of operations or liquidity.

In May 2011, the FASB issued authoritative guidance related to fair value measurements. The provisions of the guidance result in applying common fair value measurement and disclosure requirements in both United States generally accepted accounting principles and International Financial Reporting Standards. The amendments primarily change the wording used to describe many of the requirements in generally accepted accounting principles for measuring and disclosing information about fair value measurements. The guidance is effective for all interim and annual reporting periods beginning after December 15, 2011. The adoption of the guidance is not expected to have a material impact on the Company’s business, financial position, results of operations or liquidity.

In December 2010, the FASB issued authoritative guidance related to goodwill and other intangibles. The provisions of the guidance modify Step 1 of the goodwill impairment test for reporting units with zero or negative carrying amounts. For those reporting units, an entity is required to perform Step 2 of the goodwill impairment test if it is more likely than not that a goodwill impairment exists. In determining if it is more likely than not that a goodwill impairment exists, an entity should consider whether there are any adverse qualitative factors indicating that an impairment may exist. The guidance is effective for all interim and annual reporting periods beginning after December 15, 2010. The adoption of the guidance did not, and is not expected to, have a material impact on the Company’s business, financial position, results of operations or liquidity.

In December 2010, the FASB issued authoritative guidance related to business combinations. The provisions of the guidance specify that if a public entity presents comparative financial statements, the entity should disclose revenue and earnings of the combined entity as though the business combination(s) that occurred during a particular year had occurred as of the beginning of the comparable prior year annual reporting period. Supplemental pro forma disclosures also have been expanded to include a description of the nature and amount of material, non-recurring pro forma adjustments included in the pro forma financial statements. The guidance is effective prospectively for business combinations with an acquisition date on or after the beginning of the first annual reporting period beginning on or after December 15, 2010. The adoption of the guidance did not have a material impact on the Company’s business, financial position, results of operations or liquidity.

In August 2010, the FASB issued authoritative guidance related to the presentation of insurance claims and related insurance recoveries, which addresses the diversity in practice related to the accounting by healthcare entities for medical malpractice claims and similar liabilities and their related anticipated insurance recoveries. The provisions clarify that a healthcare entity should not net insurance recoveries against the related claim liability and the amount of the claim liability should be determined without consideration of insurance recoveries. The guidance is effective for all interim periods beginning after December 15, 2010. The adoption of the guidance did not have a material impact on the Company’s business, financial position, results of operations or liquidity.

In January 2010, the FASB issued authoritative guidance related to fair value measurements and disclosures. The provisions of the guidance require new disclosures related to transfers in and out of Levels 1 and 2 classifications (as described in Note 14). The provisions also require a reconciliation of the activity in Level 3 recurring fair value measurements (as described in Note 14). Existing disclosures also were expanded to include Level 2 fair value measurement valuation techniques and inputs. The guidance is effective for all interim and

 

7


Table of Contents

KINDRED HEALTHCARE, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)

(Unaudited)

 

NOTE 1—BASIS OF PRESENTATION (Continued)

 

Recently issued accounting requirements (Continued)

 

annual reporting periods beginning after December 15, 2009, except for the disclosures for Level 3 activity which is effective for fiscal years beginning after December 15, 2010. The adoption of the guidance did not, and is not expected to, have a material impact on the Company’s business, financial position, results of operations or liquidity.

Comprehensive income

The following table sets forth the computation of comprehensive income (in thousands):

 

     Three months ended
September 30,
     Nine months ended
September 30,
 
        2011           2010         2011     2010  

Net income

   $ 2,026      $ 4,926       $ 18,170      $ 36,067   

Net unrealized investment gains (losses), net of income taxes

     (1,317     786         (1,135     585   
  

 

 

   

 

 

    

 

 

   

 

 

 

Comprehensive income

     709        5,712         17,035        36,652   

Earnings attributable to noncontrolling interests—redeemable

     (374     —           (346     —     

Loss attributable to noncontrolling interests—nonredeemable

     133        —           526        —     
  

 

 

   

 

 

    

 

 

   

 

 

 

Comprehensive income attributable to Kindred

   $ 468      $ 5,712       $ 17,215      $ 36,652   
  

 

 

   

 

 

    

 

 

   

 

 

 

Equity

The following table sets forth a reconciliation of the carrying amount of equity attributable to Kindred, equity attributable to nonredeemable noncontrolling interests and total equity (in thousands):

 

     Amounts
attributable to
Kindred
stockholders
    Nonredeemable
noncontrolling
interests
    Total
equity
 

Balance at December 31, 2010

   $ 1,031,759      $ —        $ 1,031,759   

Acquired noncontrolling interests—nonredeemable

     —          23,990        23,990   

Comprehensive income:

      

Net income (loss)

     18,350        (526     17,824   

Net unrealized investment losses, net of income taxes

     (1,135     —          (1,135
  

 

 

   

 

 

   

 

 

 

Comprehensive income (loss)

     17,215        (526     16,689   

Issuance of common stock in connection with employee benefit plans

     3,019        —          3,019   

Shares tendered by employees for statutory tax withholdings upon issuance of common stock

     (3,360     —          (3,360

Income tax benefit in connection with the issuance of common stock under employee benefit plans

     403        —          403   

Stock-based compensation amortization

     9,611        —          9,611   

Equity consideration for acquisition (See Note 2)

     300,426        —          300,426   

Purchase of noncontrolling interests in subsidiaries

     (1,010     (6,282     (7,292

Reclassification from noncontrolling interests-redeemable

     —          14,589        14,589   
  

 

 

   

 

 

   

 

 

 

Balance at September 30, 2011

   $ 1,358,063      $ 31,771      $ 1,389,834   
  

 

 

   

 

 

   

 

 

 

 

8


Table of Contents

KINDRED HEALTHCARE, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)

(Unaudited)

 

NOTE 1—BASIS OF PRESENTATION (Continued)

 

Equity (Continued)

 

The reclassification from noncontrolling interests-redeemable resulted from minority ownership interests containing put rights in connection with the Merger (as defined) that expired by September 30, 2011.

Other information

The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with the instructions for Form 10-Q of Regulation S-X and do not include all of the disclosures normally required by generally accepted accounting principles or those normally required in annual reports on Form 10-K. Accordingly, these financial statements should be read in conjunction with the audited consolidated financial statements of the Company for the year ended December 31, 2010 filed with the Securities and Exchange Commission (the “SEC”) on Form 10-K. The accompanying condensed consolidated balance sheet at December 31, 2010 was derived from audited consolidated financial statements, but does not include all disclosures required by generally accepted accounting principles.

The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with the Company’s customary accounting practices. Management believes that financial information included herein reflects all adjustments necessary for a fair presentation of interim results and, except as otherwise disclosed, all such adjustments are of a normal and recurring nature.

The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with generally accepted accounting principles and include amounts based upon the estimates and judgments of management. Actual amounts may differ from those estimates.

Reclassifications

Certain prior period amounts have been reclassified to conform with the current period presentation.

NOTE 2—REHABCARE ACQUISITION

On June 1, 2011, the Company completed the acquisition of RehabCare Group, Inc. (“RehabCare”) (the “Merger”). Upon consummation of the Merger, each issued and outstanding share of RehabCare common stock was converted into the right to receive 0.471 of a share of Kindred common stock and $26 per share in cash, without interest (the “Merger Consideration”). Kindred issued approximately 12 million shares of its common stock in connection with the Merger. The purchase price totaled $963 million and was comprised of $662 million in cash and $301 million of Kindred common stock at fair value. The Company also assumed $356 million of long-term debt in the Merger, of which $345 million was refinanced on June 1, 2011. The operating results of RehabCare have been included in the accompanying unaudited condensed consolidated financial statements of the Company since June 1, 2011.

At the Merger date, the Company acquired 32 LTAC hospitals, five inpatient rehabilitation hospitals, approximately 1,200 rehabilitation therapy sites of service and 102 hospital-based inpatient rehabilitation units. The Merger expanded the Company’s service offerings, positioned the Company for future growth and should provide for significant operating synergies. RehabCare reported consolidated revenues of approximately $1.3 billion and net income from continuing operations of approximately $65 million in fiscal 2010.

 

9


Table of Contents

KINDRED HEALTHCARE, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)

(Unaudited)

 

NOTE 2—REHABCARE ACQUISITION (Continued)

 

Operating results for the third quarter of 2011 included transaction costs totaling $4.0 million and severance costs totaling $1.3 million related to the Merger. Operating results for the nine months ended September 30, 2011 included transaction costs totaling $27.0 million, financing costs totaling $13.8 million and severance costs totaling $16.2 million related to the Merger. In the accompanying unaudited condensed consolidated statement of operations, transaction costs were included in other operating expenses, financing costs were included in interest expense and severance costs were included in salaries, wages and benefits.

New credit facilities and notes

In connection with the Merger, the Company entered into a new $650 million senior secured asset-based revolving credit facility (the “ABL Facility”), a new $700 million senior secured term loan facility (the “Term Loan Facility”) and successfully completed the private placement of $550 million of senior notes due 2019 (the “Notes”). The Company used proceeds from the ABL Facility, the Term Loan Facility and the Notes to pay the Merger Consideration, repay all amounts outstanding under Kindred’s and RehabCare’s previous credit facilities and to pay transaction costs. The amounts outstanding under Kindred’s and RehabCare’s former credit facilities that were repaid at the Merger closing were $390 million and $345 million, respectively. The ABL Facility and the Term Loan Facility have incremental facility capacity in an aggregate amount between the two facilities of $200 million, subject to meeting certain conditions, including a specified senior secured leverage ratio. In connection with these new credit arrangements, the Company paid $46 million of lender fees related to debt issuance that were capitalized as deferred financing costs and paid $13 million of other financing costs that were charged to interest expense.

All obligations under the ABL Facility and the Term Loan Facility are fully and unconditionally guaranteed, subject to certain exceptions, by substantially all of the Company’s existing and future direct and indirect domestic 100% owned subsidiaries, as well as certain non-100% owned domestic subsidiaries as the Company may determine from time to time in its sole discretion. The Notes are guaranteed by substantially all of the Company’s domestic 100% owned subsidiaries.

The agreements governing the ABL Facility, the Term Loan Facility and the Notes include a number of restrictive covenants that, among other things and subject to certain exceptions and baskets, impose operating and financial restrictions on the Company and certain of its subsidiaries. In addition, the Company is required to comply with a minimum fixed charge coverage ratio and a maximum total leverage ratio. These financing agreements also contain customary affirmative covenants and events of default.

ABL Facility

The ABL Facility has a five-year tenor and is secured by a first priority lien on eligible accounts receivable, cash, deposit accounts, and certain other assets and property and proceeds from the foregoing (the “First Priority ABL Collateral”). The ABL Facility has a second priority lien on substantially all of the other assets and properties of the Company. As of September 30, 2011, the Company had $248.5 million outstanding under the ABL Facility. In addition, approximately $13 million of letters of credit were issued under the ABL Facility to backstop outstanding letters of credit previously issued by RehabCare under its terminated credit facility.

Borrowings under the ABL Facility bear interest at a rate per annum equal to the applicable margin plus, at the Company’s option, either (1) the London Interbank Offered Rate (“LIBOR”) determined by reference to the costs of funds for eurodollar deposits for the interest period relevant to such borrowing adjusted for certain additional costs, or (2) a base rate determined by reference to the highest of (a) the prime rate of JPMorgan Chase

 

10


Table of Contents

KINDRED HEALTHCARE, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)

(Unaudited)

 

NOTE 2—REHABCARE ACQUISITION (Continued)

 

ABL Facility (Continued)

 

Bank, N.A., (b) the federal funds effective rate plus one-half of 1.00% and (c) LIBOR as described in subclause (1) plus 1.00%. The initial applicable margin for borrowings under the ABL Facility was 2.75% with respect to LIBOR borrowings and 1.75% with respect to base rate borrowings. The applicable margin is subject to adjustment each fiscal quarter, based upon average historical excess availability during the preceding quarter.

Term Loan Facility

The Term Loan Facility has a tenor of seven years and is secured by a first priority lien on substantially all of the Company’s assets and properties other than the First Priority ABL Collateral and a second priority lien on the First Priority ABL Collateral. The Term Loan Facility net proceeds totaled $693 million, net of a $7 million original issue discount that will be amortized over the tenor of the Term Loan Facility.

Borrowings under the Term Loan Facility bear interest at a rate per annum equal to an applicable margin plus, at the Company’s option, either (1) LIBOR determined by reference to the costs of funds for eurodollar deposits for the interest period relevant to such borrowing adjusted for certain additional costs, or (2) a base rate determined by reference to the highest of (a) the prime rate of JPMorgan Chase Bank, N.A., (b) the federal funds effective rate plus one-half of 1.00% and (c) LIBOR described in subclause (1) plus 1.00%. LIBOR is subject to an interest rate floor of 1.50%. The initial applicable margin for borrowings under the Term Loan Facility was 3.75% with respect to LIBOR borrowings and 2.75% with respect to base rate borrowings.

Notes

In connection with the Merger, the Company completed a private placement of the Notes.

The Notes bear interest at an annual rate equal to 8.25% and are senior unsecured obligations of the Company and the subsidiary guarantors, ranking pari passu with all of their respective existing and future senior unsubordinated indebtedness. The indenture contains certain restrictive covenants that will, among other things, limit the Company and certain of its subsidiaries’ ability to incur, assume or guarantee additional indebtedness; pay dividends; make distributions or redeem or repurchase stock; restrict dividends, loans or asset transfers from its subsidiaries; sell or otherwise dispose of assets; and enter into transactions with affiliates. These covenants are subject to a number of limitations and exceptions. The indenture also contains customary events of default.

Pursuant to a registration rights agreement, the Company filed with the SEC a registration statement relating to an offer to exchange the Notes for an issue of SEC-registered notes with substantially identical terms. The exchange offer commenced on October 13, 2011 and is currently scheduled to expire on November 10, 2011.

Purchase price allocation

The Merger purchase price of $963 million was allocated on a preliminary basis to the estimated fair value of the tangible and intangible assets, and goodwill.

 

11


Table of Contents

KINDRED HEALTHCARE, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)

(Unaudited)

 

NOTE 2—REHABCARE ACQUISITION (Continued)

 

Purchase price allocation (Continued)

 

The following is the preliminary Merger purchase price allocation (in thousands):

 

Cash and cash equivalents

   $ 19,932   

Accounts receivable

     244,642   

Deferred income taxes and other current assets

     48,253   

Property and equipment

     114,079   

Identifiable intangible assets:

  

Customer relationships

     188,900   

Trade names (indefinite life)

     115,400   

Medicare certifications (indefinite life)

     75,900   

Trade name

     16,600   

Certificates of need (indefinite life)

     7,900   

Non-compete agreements

     2,800   
  

 

 

 

Total identifiable intangible assets

     407,500   

Other assets

     11,023   

Accounts payable and other current liabilities

     (169,512

Long-term debt, including amounts due within one year

     (355,650

Deferred income taxes and other liabilities

     (155,575

Noncontrolling interests—redeemable

     (23,869

Noncontrolling interests—nonredeemable

     (23,990
  

 

 

 

Total identifiable net assets

     116,833   

Goodwill

     845,975   
  

 

 

 

Net assets

   $ 962,808   
  

 

 

 

The fair value allocation was measured primarily using a discounted cash flows methodology, which is considered a Level 3 input (as described in Note 14).

The value of gross contractual accounts receivable before determining uncollectable amounts totaled $261 million. Accounts estimated to be uncollectable totaled $16 million.

The weighted average life of the definite lived intangible assets consisting primarily of customer relationships is 13 years.

The aggregate goodwill arising from the Merger is based upon the expected future cash flows of the RehabCare operations, which reflect both growth expectations and cost savings from combining the operations of the Company and RehabCare. Goodwill is not amortized and is not deductible for income tax purposes. Goodwill was preliminarily assigned to the Company’s hospital reporting unit ($587 million), skilled nursing rehabilitation services reporting unit ($121 million) and hospital rehabilitation services reporting unit ($138 million).

The valuation technique used to measure the value of the noncontrolling interests was an average of the implied equity value of the noncontrolling interests based upon the Merger Consideration and market multiple methodologies. Redeemable noncontrolling interests as of September 30, 2011 represent the minority ownership interests containing put rights in connection with the Merger.

 

12


Table of Contents

KINDRED HEALTHCARE, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)

(Unaudited)

 

NOTE 2—REHABCARE ACQUISITION (Continued)

 

Purchase price allocation (Continued)

 

The unaudited pro forma net effect of the Merger assuming the acquisition occurred as of January 1, 2010 is as follows (in thousands, except per share amounts):

 

     Three months ended
September 30,
     Nine months ended
September 30,
 
     2011      2010      2011      2010  

Revenues

   $ 1,514,062       $ 1,390,493       $ 4,604,597       $ 4,214,312   

Income (loss) from continuing operations attributable to Kindred

     4,509         5,951         66,536         (1,294

Income (loss) attributable to Kindred

     5,628         6,318         71,106         (1,054

Earnings (loss) per common share:

           

Basic:

           

Income (loss) from continuing operations

   $ 0.09       $ 0.12       $ 1.28       $ (0.02

Net income (loss)

   $ 0.11       $ 0.12       $ 1.37       $ (0.02

Diluted:

           

Income (loss) from continuing operations

   $ 0.09       $ 0.12       $ 1.27       $ (0.02

Net income (loss)

   $ 0.11       $ 0.12       $ 1.36       $ (0.02

The unaudited pro forma financial data has been derived by combining the historical financial results of the Company and the operations acquired in the Merger for the periods presented. The unaudited pro forma financial data includes transaction, financing and severance costs totaling $79.8 million incurred by both the Company and RehabCare related to the Merger. These costs have been eliminated from the results of operations for 2011 and have been reflected as expenses incurred as of January 1, 2010 for purposes of the pro forma financial presentation. Revenues and operating income associated with RehabCare aggregated $343 million and $56 million, respectively, for the three months ended September 30, 2011. Revenues and operating income associated with RehabCare aggregated $457 million and $73 million, respectively, since the date of the Merger.

NOTE 3—OTHER ACQUISITIONS

The following is a summary of the Company’s other significant acquisition activities. The operating results of the acquired businesses have been included in the accompanying unaudited condensed consolidated financial statements of the Company from the respective acquisition dates. The purchase price of the acquired businesses and acquired leased facilities resulted from negotiations with each of the sellers that were based upon both the historical and expected future cash flows of the respective businesses and real estate values. All of these acquisitions were financed through operating cash flows or borrowings under the Company’s revolving credit facility. Unaudited pro forma financial data related to the acquired businesses have not been presented because the acquisitions are not material, either individually or in the aggregate, to the Company’s consolidated financial statements.

In September 2011, the Company acquired a home health and hospice company for $50.9 million, including $9.8 million of accounts receivable, $1.4 million of other assets, $0.9 million of property and equipment, $33.9 million of goodwill, $11.2 million of identifiable intangible assets and $6.3 million of deferred income taxes and other liabilities.

In April 2011, the Company acquired a home health company for $9.5 million, including $0.1 million of property and equipment, $7.5 million of goodwill and $1.9 million of identifiable intangible assets.

 

13


Table of Contents

KINDRED HEALTHCARE, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)

(Unaudited)

 

NOTE 3—OTHER ACQUISITIONS (Continued)

 

In March 2011, the Company acquired the real estate of a previously leased hospital for $8.0 million. Annual rent associated with the hospital aggregated $0.9 million.

In September 2010, the Company acquired three nursing and rehabilitation centers for $37.7 million, including $30.4 million of property and equipment, $5.0 million of goodwill, $2.5 million of identifiable intangible assets and $0.2 million of other assets.

In March 2010, the Company acquired a combined nursing and rehabilitation center and assisted living facility for $16.6 million, including $0.2 million of goodwill, $2.2 million of identifiable intangible assets and $14.2 million of property and equipment and other assets.

In January 2010, the Company acquired the real estate of two previously leased hospitals and two previously leased nursing and rehabilitation centers for $31.1 million in cash and $2.4 million in unamortized prepaid rent. Annual rents associated with these four facilities aggregated $2.9 million.

The fair value of each of the acquisitions noted above was measured primarily using discounted cash flow methodologies which are considered Level 3 inputs (as described in Note 14).

NOTE 4—IMPAIRMENT CHARGES

On July 29, 2011, the Centers for Medicare and Medicaid Services (“CMS”) issued final rules which, among other things, significantly reduced Medicare payments to nursing centers and changed the reimbursement for the provision of group rehabilitation therapy services to Medicare beneficiaries beginning October 1, 2011 (the “2011 CMS Rules”). As a result of these rules, the Company tested the recoverability of its nursing and rehabilitation centers reporting unit goodwill and intangible assets and property and equipment within asset groups impacted by the reduced payments. The Company determined that pretax impairment charges aggregating $26.7 million were necessary. The charges included $6.1 million of goodwill (which represented the entire nursing and rehabilitation centers reporting unit goodwill) and $20.6 million of property and equipment. These charges reflected the amount by which the carrying value of certain assets exceeded their estimated fair value. The impairment charges did not impact the Company’s cash flows or liquidity.

The impairment charges are recorded in other operating expenses in the accompanying unaudited condensed consolidated statement of operations.

NOTE 5—DISCONTINUED OPERATIONS

In accordance with the authoritative guidance for the impairment or disposal of long-lived assets, the divestitures of unprofitable businesses discussed in Note 1 have been accounted for as discontinued operations. Accordingly, the results of operations of these businesses for all periods presented and the gains related to these divestitures have been classified as discontinued operations, net of income taxes, in the accompanying unaudited condensed consolidated statement of operations. At September 30, 2011, the Company held for sale two hospitals reported as discontinued operations.

 

14


Table of Contents

KINDRED HEALTHCARE, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)

(Unaudited)

 

NOTE 5—DISCONTINUED OPERATIONS (Continued)

 

A summary of discontinued operations follows (in thousands):

 

     Three months ended
September 30,
    Nine months ended
September 30,
 
         2011             2010             2011             2010      

Revenues

   $ 848      $ 2,508      $ 1,025      $ 9,956   
  

 

 

   

 

 

   

 

 

   

 

 

 

Salaries, wages and benefits

     (77     2,348        (393     7,359   

Supplies

     2        161        (1     556   

Rent

     28        31        86        103   

Other operating expenses (income)

     (924     390        (1,149     2,495   

Depreciation

     —          —          —          —     

Interest expense

     —          1       —          1   

Investment income

     —          (1     —          (27
  

 

 

   

 

 

   

 

 

   

 

 

 
     (971     2,930        (1,457     10,487   
  

 

 

   

 

 

   

 

 

   

 

 

 

Income (loss) from operations before income taxes

     1,819        (422     2,482        (531

Provision (benefit) for income taxes

     700        (162     955        (204
  

 

 

   

 

 

   

 

 

   

 

 

 

Income (loss) from operations

     1,119        (260     1,527        (327

Gain on divestiture of operations, net of income taxes

     —          86        —          3   
  

 

 

   

 

 

   

 

 

   

 

 

 
   $ 1,119      $ (174   $ 1,527      $ (324
  

 

 

   

 

 

   

 

 

   

 

 

 

The following table sets forth certain discontinued operating data by business segment (in thousands):

 

     Three months ended
September 30,
    Nine months ended
September 30,
 
     2011      2010     2011     2010  

Revenues:

         

Hospital division

   $ 846       $ (196   $ 822      $ (89

Nursing center division

     2         2,704        203        10,045   
  

 

 

    

 

 

   

 

 

   

 

 

 
   $ 848       $ 2,508      $ 1,025      $ 9,956   
  

 

 

    

 

 

   

 

 

   

 

 

 

Operating income (loss):

         

Hospital division

   $ 633       $ (348   $ (65   $ (1,185

Nursing center division

     1,214         (43     2,633        731   
  

 

 

    

 

 

   

 

 

   

 

 

 
   $ 1,847       $ (391   $ 2,568      $ (454
  

 

 

    

 

 

   

 

 

   

 

 

 

Rent:

         

Hospital division

   $ 28       $ 29      $ 86      $ 93   

Nursing center division

     —           2        —          10   
  

 

 

    

 

 

   

 

 

   

 

 

 
   $ 28       $ 31      $ 86      $ 103   
  

 

 

    

 

 

   

 

 

   

 

 

 

 

15


Table of Contents

KINDRED HEALTHCARE, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)

(Unaudited)

 

NOTE 5—DISCONTINUED OPERATIONS (Continued)

 

A summary of the net assets held for sale, including certain assets included in continuing operations, follows (in thousands):

 

     September 30,
2011
    December 31,
2010
 

Long-term assets:

    

Property and equipment, net

   $ 7,086      $ 7,062   

Other

     8        105   
  

 

 

   

 

 

 
     7,094        7,167   

Current liabilities (included in other accrued liabilities)

     (127     (72
  

 

 

   

 

 

 
   $ 6,967      $ 7,095   
  

 

 

   

 

 

 

NOTE 6—REVENUES

Revenues are recorded based upon estimated amounts due from patients and third party payors for healthcare services provided, including anticipated settlements under reimbursement agreements with Medicare, Medicaid, Medicare Advantage and other third party payors.

A summary of revenues by payor type follows (in thousands):

 

     Three months ended
September 30,
    Nine months ended
September 30,
 
     2011     2010     2011     2010  

Medicare

   $ 629,279      $ 438,931      $ 1,761,847      $ 1,382,368   

Medicaid

     269,804        265,143        791,933        794,967   

Medicare Advantage

     111,322        82,116        304,777        255,939   

Other

     583,406        343,165        1,378,835        1,020,285   
  

 

 

   

 

 

   

 

 

   

 

 

 
     1,593,811        1,129,355        4,237,392        3,453,559   

Eliminations

     (79,749     (76,343     (238,317     (229,346
  

 

 

   

 

 

   

 

 

   

 

 

 
   $ 1,514,062      $ 1,053,012      $ 3,999,075      $ 3,224,213   
  

 

 

   

 

 

   

 

 

   

 

 

 

NOTE 7—EARNINGS PER SHARE

Earnings per common share are based upon the weighted average number of common shares outstanding during the respective periods. The diluted calculation of earnings per common share includes the dilutive effect of stock options. The Company follows the provisions of the authoritative guidance for determining whether instruments granted in share-based payment transactions are participating securities, which requires that unvested restricted stock that entitles the holder to receive nonforfeitable dividends before vesting be included as a participating security in the basic and diluted earnings per common share calculation pursuant to the two-class method.

 

16


Table of Contents

KINDRED HEALTHCARE, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)

(Unaudited)

 

NOTE 7—EARNINGS PER SHARE (Continued)

 

A computation of earnings per common share follows (in thousands, except per share amounts):

 

    Three months ended September 30,     Nine months ended September 30,  
    2011     2010     2011     2010  
    Basic     Diluted     Basic     Diluted     Basic     Diluted     Basic     Diluted  

Earnings:

               

Amounts attributable to Kindred stockholders:

               

Income from continuing operations:

               

As reported in Statement of Operations

  $ 666      $ 666      $ 5,100      $ 5,100      $ 16,823      $ 16,823      $ 36,391      $ 36,391   

Allocation to participating unvested restricted stockholders

    (10     (10     (91     (91     (287     (284     (664     (662
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Available to common stockholders

  $ 656      $ 656      $ 5,009      $ 5,009      $ 16,536      $ 16,539      $ 35,727      $ 35,729   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Discontinued operations, net of income taxes:

               

Income (loss) from operations:

               

As reported in Statement of Operations

  $ 1,119      $ 1,119      $ (260   $ (260   $ 1,527      $ 1,527      $ (327   $ (327

Allocation to participating unvested restricted stockholders

    (17     (17     5        5        (26     (26     6        6   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Available to common stockholders

  $ 1,102      $ 1,102      $ (255   $ (255   $ 1,501      $ 1,501      $ (321   $ (321
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Gain on divestiture of operations:

               

As reported in Statement of Operations

  $ —        $ —        $ 86      $ 86      $ —        $ —        $ 3      $ 3   

Allocation to participating unvested restricted stockholders

    —          —          (2     (2     —          —          —          —     
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Available to common stockholders

  $ —        $ —        $ 84      $ 84      $ —        $ —        $ 3      $ 3   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net income:

               

As reported in Statement of Operations

  $ 1,785      $ 1,785      $ 4,926      $ 4,926      $ 18,350      $ 18,350      $ 36,067      $ 36,067   

Allocation to participating unvested restricted stockholders

    (27     (27     (88     (88     (313     (310     (658     (656
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Available to common stockholders

  $ 1,758      $ 1,758      $ 4,838      $ 4,838      $ 18,037      $ 18,040      $ 35,409      $ 35,411   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Shares used in the computation:

               

Weighted average shares outstanding—basic computation

    51,329        51,329        38,778        38,778        44,577        44,577        38,720        38,720   
 

 

 

     

 

 

     

 

 

     

 

 

   

Dilutive effect of employee stock options

      77         60          357          135   
   

 

 

     

 

 

     

 

 

     

 

 

 

Adjusted weighted average shares outstanding—diluted computation

      51,406          38,838          44,934          38,855   
   

 

 

     

 

 

     

 

 

     

 

 

 

Earnings per common share:

               

Income from continuing operations

  $ 0.01      $ 0.01      $ 0.13      $ 0.13      $ 0.37      $ 0.37      $ 0.92      $ 0.92   

Discontinued operations:

               

Income (loss) from operations

    0.02        0.02        (0.01     (0.01     0.03        0.03        (0.01     (0.01

Gain on divestiture of operations

    —          —          —          —          —          —          —          —     
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net income

  $ 0.03      $ 0.03      $ 0.12      $ 0.12      $ 0.40      $ 0.40      $ 0.91      $ 0.91   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Number of antidilutive stock options excluded from shares used in the diluted earnings per common share computation

      2,769          2,959          1,226          2,496   

 

17


Table of Contents

KINDRED HEALTHCARE, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)

(Unaudited)

 

NOTE 8—BUSINESS SEGMENT DATA

At September 30, 2011, the Company operated three divisions consisting of hospitals, nursing centers and rehabilitation services. Based upon the authoritative guidance for business segments and after giving consideration to the Company’s business segments after the Merger, the divisions represent four reportable operating segments, which consist of (i) LTAC hospitals, (ii) skilled nursing and rehabilitation centers, (iii) skilled nursing-based rehabilitation contract therapy services, and (iv) hospital-based rehabilitation contract therapy services. The Company includes operating data for its home health and hospice businesses in the skilled nursing-based rehabilitation contract therapy services segment. These segments are consistent with information used by the Company’s Chief Executive Officer and Chief Operating Officer to assess performance and allocate resources. The accounting policies of the segments are the same as those described in the summary of significant accounting policies. Prior period segment information has been conformed to the current period presentation.

For segment purposes, the Company defines operating income as earnings before interest, income taxes, depreciation, amortization and rent. Operating income reported for each of the Company’s business segments excludes the allocation of corporate overhead.

Operating income for the three and nine months ended September 30, 2011 included impairment charges approximating $3.1 million for the hospital division and $23.6 million for the nursing center division.

Operating income for the nine months ended September 30, 2010 included severance and retirement costs approximating $1.1 million for the hospital division, $0.5 million for the nursing center division and $1.3 million for corporate.

Transaction costs for the three and nine months ended September 30, 2010 have been reclassified to conform with the current period presentation and are excluded from business segment operating income (loss).

 

18


Table of Contents

KINDRED HEALTHCARE, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)

(Unaudited)

 

NOTE 8—BUSINESS SEGMENT DATA (Continued)

 

The following table sets forth certain data by business segment (in thousands):

 

     Three months ended
September 30,
    Nine months ended
September 30,
 
     2011     2010     2011     2010  

Revenues:

        

Hospital division

   $ 684,781      $ 465,198      $ 1,837,180      $ 1,465,661   

Nursing center division

     571,226        539,914        1,706,897        1,621,450   

Rehabilitation division:

        

Skilled nursing rehabilitation services

     267,993        103,807        562,723        303,952   

Hospital rehabilitation services

     69,811        20,436        130,592        62,496   
  

 

 

   

 

 

   

 

 

   

 

 

 
     337,804        124,243        693,315        366,448   
  

 

 

   

 

 

   

 

 

   

 

 

 
     1,593,811        1,129,355        4,237,392        3,453,559   

Eliminations:

        

Skilled nursing rehabilitation services

     (59,221     (56,841     (175,858     (169,584

Hospital rehabilitation services

     (20,528     (19,502     (62,459     (59,762
  

 

 

   

 

 

   

 

 

   

 

 

 
     (79,749     (76,343     (238,317     (229,346
  

 

 

   

 

 

   

 

 

   

 

 

 
   $ 1,514,062      $ 1,053,012      $ 3,999,075      $ 3,224,213   
  

 

 

   

 

 

   

 

 

   

 

 

 

Income from continuing operations:

        

Operating income (loss):

        

Hospital division

   $ 122,599      $ 75,784      $ 339,449      $ 263,014   

Nursing center division

     65,982        69,363        246,864        216,506   

Rehabilitation division:

        

Skilled nursing rehabilitation services

     28,682        9,486        53,362        28,330   

Hospital rehabilitation services

     15,606        4,728        28,971        14,667   
  

 

 

   

 

 

   

 

 

   

 

 

 
     44,288        14,214        82,333        42,997   

Corporate:

        

Overhead

     (48,806     (34,329     (130,922     (100,959

Insurance subsidiary

     (750     (783     (1,772     (2,054
  

 

 

   

 

 

   

 

 

   

 

 

 
     (49,556     (35,112     (132,694     (103,013

Transaction costs

     (6,537     (771     (45,567     (2,496
  

 

 

   

 

 

   

 

 

   

 

 

 

Operating income

     176,776        123,478        490,385        417,008   

Rent

     (105,511     (89,295     (292,641     (266,595

Depreciation and amortization

     (46,947     (29,167     (117,367     (90,140

Interest, net

     (25,753     (1,239     (53,886     (3,344
  

 

 

   

 

 

   

 

 

   

 

 

 

Income (loss) from continuing operations before income taxes

     (1,435     3,777        26,491        56,929   

Provision (benefit) for income taxes

     (2,342     (1,323     9,848        20,538   
  

 

 

   

 

 

   

 

 

   

 

 

 
   $ 907      $ 5,100      $ 16,643      $ 36,391   
  

 

 

   

 

 

   

 

 

   

 

 

 

 

19


Table of Contents

KINDRED HEALTHCARE, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)

(Unaudited)

 

NOTE 8—BUSINESS SEGMENT DATA (Continued)

 

     Three months ended
September 30,
     Nine months ended
September 30,
 
     2011      2010      2011      2010  

Rent:

           

Hospital division

   $ 52,737       $ 38,122       $ 137,033       $ 113,580   

Nursing center division

     49,862         49,627         148,808         148,458   

Rehabilitation division:

           

Skilled nursing rehabilitation services

     2,169         1,474         5,658         4,368   

Hospital rehabilitation services

     95         28         156         79   
  

 

 

    

 

 

    

 

 

    

 

 

 
     2,264         1,502         5,814         4,447   

Corporate

     648         44         986         110   
  

 

 

    

 

 

    

 

 

    

 

 

 
   $ 105,511       $ 89,295       $ 292,641       $ 266,595   
  

 

 

    

 

 

    

 

 

    

 

 

 

Depreciation and amortization:

           

Hospital division

   $ 21,612       $ 12,655       $ 52,462       $ 38,218   

Nursing center division

     12,655         10,527         37,486         33,825   

Rehabilitation division:

           

Skilled nursing rehabilitation services

     3,023         591         5,121         1,672   

Hospital rehabilitation services

     2,372         77         3,288         207   
  

 

 

    

 

 

    

 

 

    

 

 

 
     5,395         668         8,409         1,879   

Corporate

     7,285         5,317         19,010         16,218   
  

 

 

    

 

 

    

 

 

    

 

 

 
   $ 46,947       $ 29,167       $ 117,367       $ 90,140   
  

 

 

    

 

 

    

 

 

    

 

 

 

Capital expenditures, excluding acquisitions (including discontinued operations):

           

Hospital division:

           

Routine

   $ 12,919       $ 9,113       $ 36,872       $ 23,132   

Development

     39,964         12,900         54,164         28,883   
  

 

 

    

 

 

    

 

 

    

 

 

 
     52,883         22,013         91,036         52,015   

Nursing center division:

           

Routine

     10,572         11,548         26,727         24,732   

Development

     4,113         7,464         15,140         11,336   
  

 

 

    

 

 

    

 

 

    

 

 

 
     14,685         19,012         41,867         36,068   

Rehabilitation division:

           

Skilled nursing rehabilitation services:

           

Routine

     296         328         768         814   

Development

     75         —           266         —     
  

 

 

    

 

 

    

 

 

    

 

 

 
     371         328         1,034         814   

Hospital rehabilitation services:

           

Routine

     81         23         178         85   

Development

     —           —           —           —     
  

 

 

    

 

 

    

 

 

    

 

 

 
     81         23         178         85   

Corporate:

           

Information systems

     11,516         6,625         29,089         18,624   

Other

     1,211         986         1,629         1,721   
  

 

 

    

 

 

    

 

 

    

 

 

 
   $ 80,747       $ 48,987       $ 164,833       $ 109,327   
  

 

 

    

 

 

    

 

 

    

 

 

 

 

20


Table of Contents

KINDRED HEALTHCARE, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)

(Unaudited)

 

NOTE 8—BUSINESS SEGMENT DATA (Continued)

 

     September 30,
2011
     December 31,
2010
 

Assets at end of period:

     

Hospital division

   $ 2,151,650       $ 1,100,138   

Nursing center division

     629,734         647,355   

Rehabilitation division:

     

Skilled nursing rehabilitation services

     546,388         87,055   

Hospital rehabilitation services

     319,995         798   
  

 

 

    

 

 

 
     866,383         87,853   

Corporate

     527,810         502,069   
  

 

 

    

 

 

 
   $ 4,175,577       $ 2,337,415   
  

 

 

    

 

 

 

Goodwill:

     

Hospital division

   $ 800,053       $ 213,200   

Nursing center division

     —           6,080   

Rehabilitation division:

     

Skilled nursing rehabilitation services

     185,668         23,140   

Hospital rehabilitation services

     137,978         —     
  

 

 

    

 

 

 
     323,646         23,140   
  

 

 

    

 

 

 
   $ 1,123,699       $ 242,420   
  

 

 

    

 

 

 

NOTE 9—INSURANCE RISKS

The Company insures a substantial portion of its professional liability risks and workers compensation risks through its wholly owned limited purpose insurance subsidiary. Provisions for loss for these risks are based upon management’s best available information including actuarially determined estimates.

The allowance for professional liability risks includes an estimate of the expected cost to settle reported claims and an amount, based upon past experiences, for losses incurred but not reported. These liabilities are necessarily based upon estimates and, while management believes that the provision for loss is adequate, the ultimate liability may be in excess of, or less than, the amounts recorded. To the extent that expected ultimate claims costs vary from historical provisions for loss, future earnings will be charged or credited.

The provision for loss for insurance risks, including the cost of coverage maintained with unaffiliated commercial insurance carriers, follows (in thousands):

 

     Three months ended
September 30,
    Nine months ended
September 30,
 
     2011     2010     2011     2010  

Professional liability:

        

Continuing operations

   $ 15,953      $ 13,123      $ 50,584      $ 45,961   

Discontinued operations

     (897     (934     (1,718     (1,763

Workers compensation:

        

Continuing operations

   $ 15,908      $ 10,049      $ 43,057      $ 31,763   

Discontinued operations

     (120     (103     (640     (1,104

 

21


Table of Contents

KINDRED HEALTHCARE, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)

(Unaudited)

 

NOTE 9—INSURANCE RISKS (Continued)

 

A summary of the assets and liabilities related to insurance risks included in the accompanying unaudited condensed consolidated balance sheet follows (in thousands):

 

     September 30, 2011      December 31, 2010  
     Professional
liability
     Workers
compensation
     Total      Professional
liability
     Workers
compensation
     Total  

Assets:

                 

Current:

                 

Insurance subsidiary investments

   $ 40,403       $ 24,443       $ 64,846       $ 54,162       $ 22,591       $ 76,753   

Reinsurance recoverables

     263         —           263         265         —           265   

Other

     —           319         319         —           319         319   
  

 

 

    

 

 

    

 

 

    

 

 

    

 

 

    

 

 

 
     40,666         24,762         65,428         54,427         22,910         77,337   

Non-current:

                 

Insurance subsidiary investments

     40,246         64,052         104,298         38,635         62,575         101,210   

Reinsurance and other recoverables

     43,778         63,775         107,553         41,752         3,222         44,974   

Deposits

     3,643         1,623         5,266         3,000         1,313         4,313   

Other

     —           43         43         —           44         44   
  

 

 

    

 

 

    

 

 

    

 

 

    

 

 

    

 

 

 
     87,667         129,493         217,160         83,387         67,154         150,541   
  

 

 

    

 

 

    

 

 

    

 

 

    

 

 

    

 

 

 
   $ 128,333       $ 154,255       $ 282,588       $ 137,814       $ 90,064       $ 227,878   
  

 

 

    

 

 

    

 

 

    

 

 

    

 

 

    

 

 

 

Liabilities:

                 

Allowance for insurance risks:

                 

Current

   $ 41,728       $ 30,063       $ 71,791       $ 41,555       $ 24,676       $ 66,231   

Non-current

     224,903         136,315         361,218         207,669         59,504         267,173   
  

 

 

    

 

 

    

 

 

    

 

 

    

 

 

    

 

 

 
   $ 266,631       $ 166,378       $ 433,009       $ 249,224       $ 84,180       $ 333,404   
  

 

 

    

 

 

    

 

 

    

 

 

    

 

 

    

 

 

 

Provisions for loss for professional liability risks retained by the Company’s limited purpose insurance subsidiary have been discounted based upon actuarial estimates of claim payment patterns using a discount rate of 1% to 5% depending upon the policy year. The discount rate was 1% for the 2011 and 2010 policy years. The discount rates are based upon the risk free interest rate for the respective year. Amounts equal to the discounted loss provision are funded annually. The Company does not fund the portion of professional liability risks related to estimated claims that have been incurred but not reported. Accordingly, these liabilities are not discounted. If the Company did not discount any of the allowances for professional liability risks, these balances would have approximated $269.5 million at September 30, 2011 and $252.6 million at December 31, 2010.

Provisions for loss for workers compensation risks retained by the Company’s limited purpose insurance subsidiary are not discounted and amounts equal to the loss provision are funded annually.

NOTE 10—INSURANCE SUBSIDIARY INVESTMENTS

The Company maintains investments, consisting principally of cash and cash equivalents, debt securities, equities and commercial paper for the payment of claims and expenses related to professional liability and workers compensation risks. These investments have been categorized as available-for-sale and are reported at fair value.

 

22


Table of Contents

KINDRED HEALTHCARE, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)

(Unaudited)

 

NOTE 10—INSURANCE SUBSIDIARY INVESTMENTS (Continued)

 

The amortized cost and estimated fair value of the Company’s insurance subsidiary investments follows (in thousands):

 

    September 30, 2011     December 31, 2010  
    Amortized
cost
    Unrealized
gains
    Unrealized
losses
    Fair
value
    Amortized
cost
    Unrealized
gains
    Unrealized
losses
    Fair
value
 

Cash and cash equivalents (a)

  $ 109,534      $ —        $ —        $ 109,534      $ 104,664      $ —        $ —        $ 104,664   

Debt securities:

               

Corporate bonds

    23,115        192        (55     23,252        32,174        542        (40     32,676   

Debt securities issued by U.S. government agencies

    17,380        128        (6     17,502        17,906        113        (27     17,992   

U.S. Treasury notes

    2,864        12        (2     2,874        2,482        11        —          2,493   

Debt securities issued by foreign governments

    874        10        —          884        2,081        15        —          2,096   

Commercial mortgage-backed securities

    206        11        —          217        307        19        —          326   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
    44,439        353        (63     44,729        54,950        700        (67     55,583   

Equities by industry:

               

Healthcare

    1,474        17        (148     1,343        1,572        20        (235     1,357   

Financial services

    1,150        42        (173     1,019        1,284        209        (66     1,427   

Oil and gas

    921        51        (165     807        921        142        (37     1,026   

Other

    7,594        453        (840     7,207        7,594        876        (269     8,201   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
    11,139        563        (1,326     10,376        11,371        1,247        (607     12,011   

Commercial paper

    4,505        1        (1     4,505        5,705        2        (2     5,705   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
  $ 169,617      $ 917      $ (1,390   $ 169,144      $ 176,690      $ 1,949      $ (676   $ 177,963   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

 

(a) Includes $2.9 million and $2.6 million of money market funds at September 30, 2011 and December 31, 2010, respectively.

The Company’s investment policy governing insurance subsidiary investments precludes the investment portfolio managers from selling any security at a loss without prior authorization from the Company. The investment managers also limit the exposure to any one issue, issuer or type of investment. The Company intends, and has the ability, to hold insurance subsidiary investments for a long duration without the necessity of selling securities to fund the underwriting needs of its insurance subsidiary. This ability to hold securities allows sufficient time for recovery of temporary declines in the market value of equity securities and the par value of debt securities as of their stated maturity date.

The Company considered the severity and duration of its unrealized losses at September 30, 2011 and recognized a $0.2 million pretax other-than-temporary impairment in the third quarter of 2011 for various investments held in its insurance subsidiary investment portfolio. The Company recognized a $0.7 million pretax other-than-temporary impairment for the nine months ended September 30, 2010 for various investments held in its insurance subsidiary investment portfolio.

As a result of improved professional liability underwriting results of the Company’s limited purpose insurance subsidiary, the Company received distributions of $3 million and $22 million during the nine months ended September 30, 2011 and 2010, respectively, from its limited purpose insurance subsidiary in accordance with applicable regulations. These distributions had no impact on earnings and the proceeds were used primarily to repay borrowings under the Company’s revolving credit facility.

 

23


Table of Contents

KINDRED HEALTHCARE, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)

(Unaudited)

 

NOTE 11—INCOME TAXES

The provision for income taxes for the third quarter and nine months ended September 30, 2011 included a favorable adjustment of $3.3 million related to the resolution of certain income tax contingencies from prior years. As a result, the Company reduced its unrecognized tax benefits and related accrued interest by $3.5 million. The deferred tax asset associated with unrecognized tax benefits also was reduced by $0.2 million. As of September 30, 2011, the Company’s unrecognized tax benefits totaled $1.1 million and accrued interest related to uncertain tax positions totaled $0.1 million.

The provision for income taxes for the third quarter and nine months ended September 30, 2010 included a favorable adjustment of $2.9 million related to the resolution of certain income tax contingencies from prior years.

The federal statute of limitations remains open for tax years 2008 through 2010. In July 2011, the Company resolved federal income tax audits for the 2007 through 2009 tax years. The Company has been notified by the Internal Revenue Service (the “IRS”) that an examination will be conducted for the 2010 tax year.

State jurisdictions generally have statutes of limitations ranging from three to five years. The state impact of federal income tax changes remains subject to examination by various states for a period of up to one year after formal notification to the states. Currently, the Company has various state income tax returns under examination.

During the nine months ended September 30, 2010, the Company received approval from the IRS for an accounting method change for income tax purposes that resulted in a non-recurring reduction in income tax payments of approximately $25 million during 2010. The Company’s earnings were not impacted by this transaction.

NOTE 12—CONTINGENCIES

Management continually evaluates contingencies based upon the best available information. In addition, allowances for losses are provided currently for disputed items that have continuing significance, such as certain third party reimbursements and deductions that continue to be claimed in current cost reports and tax returns.

Management believes that allowances for losses have been provided to the extent necessary and that its assessment of contingencies is reasonable.

Principal contingencies are described below:

Revenues—Certain third party payments are subject to examination by agencies administering the various reimbursement programs. The Company is contesting certain issues raised in audits of prior year cost reports.

Professional liability risks—The Company has provided for losses for professional liability risks based upon management’s best available information including actuarially determined estimates. Ultimate claims costs may differ from the provisions for loss. See Note 9.

Income taxes—The Company is subject to various federal and state income tax audits in the ordinary course of business. Such audits could result in increased tax payments, interest and penalties. In addition, the Company is a party to a tax matters agreement with PharMerica Corporation, which sets forth the Company’s rights and obligations related to taxes for periods before and after the Company’s spin-off of its former institutional pharmacy business in 2007 and the related merger transaction which created PharMerica Corporation.

 

24


Table of Contents

KINDRED HEALTHCARE, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)

(Unaudited)

 

NOTE 12—CONTINGENCIES (Continued)

 

Litigation—The Company is a party to various legal actions (some of which are not insured), and regulatory and other governmental audits and investigations in the ordinary course of business. The Company cannot predict the ultimate outcome of pending litigation and regulatory and other governmental audits and investigations. These matters could potentially subject the Company to sanctions, damages, recoupments, fines and other penalties. The U.S. Department of Justice (the “DOJ”), CMS or other federal and state enforcement and regulatory agencies may conduct additional investigations related to the Company’s businesses in the future which may, either individually or in the aggregate, have a material adverse effect on the Company’s business, financial position, results of operations and liquidity.

Other indemnifications—In the ordinary course of business, the Company enters into contracts containing standard indemnification provisions and indemnifications specific to a transaction, such as a disposal of an operating facility. These indemnifications may cover claims related to employment-related matters, governmental regulations, environmental issues and tax matters, as well as patient, third party payor, supplier and contractual relationships. Obligations under these indemnities generally are initiated by a breach of the terms of a contract or by a third party claim or event.

NOTE 13—CAPITAL STOCK

In May 2011, the shareholders of the Company approved an additional 3,000,000 shares of common stock that could be issued under the Company’s incentive compensation plans.

NOTE 14—FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS

The Company follows the provisions of the authoritative guidance for fair value measurements, which addresses how companies should measure fair value when they are required to use a fair value measure for recognition or disclosure purposes under generally accepted accounting principles.

Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. The guidance related to fair value measures establishes a fair value hierarchy that requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. The guidance describes three levels of inputs that may be used to measure fair value:

 

Level 1    Quoted prices in active markets for identical assets or liabilities. Level 1 assets and liabilities include debt and equity securities and derivative contracts that are traded in an active exchange market, as well as certain U.S. Treasury, other U.S. Government and agency asset-backed debt securities that are highly liquid and are actively traded in over-the-counter markets.
Level 2    Observable inputs other than Level 1 prices, such as quoted prices for similar assets or liabilities, quoted prices in markets that are not active, and other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.
Level 3    Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities. Level 3 assets and liabilities include financial instruments whose value is determined using pricing models, discounted cash flow methodologies, or similar techniques, as well as instruments for which the determination of fair value requires significant management judgment or estimation.

 

25


Table of Contents

KINDRED HEALTHCARE, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)

(Unaudited)

 

NOTE 14—FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS (Continued)

 

The Company’s assets and liabilities measured at fair value on a recurring and non-recurring basis and any associated losses are summarized below (in thousands):

 

     Fair value measurements      Assets/liabilities
at fair value
     Total
losses
 
     Level 1      Level 2      Level 3        

September 30, 2011:

              

Recurring:

              

Assets:

              

Available-for-sale debt securities:

              

Corporate bonds

   $ —         $ 23,252       $ —         $ 23,252       $ —     

Debt securities issued by U.S. government agencies

     —           17,502         —           17,502         —     

U.S. Treasury notes

     2,874         —           —           2,874         —     

Debt securities issued by foreign governments

     —           884         —           884         —     

Commercial mortgage-backed securities

     —           217         —           217         —     
  

 

 

    

 

 

    

 

 

    

 

 

    

 

 

 
     2,874         41,855         —           44,729         —     

Available-for-sale equity securities

     10,376         —           —           10,376         —     

Commercial paper

     —           4,505         —           4,505         —     

Money market funds

     6,787         —           —           6,787         —     
  

 

 

    

 

 

    

 

 

    

 

 

    

 

 

 

Total available-for-sale investments

     20,037         46,360         —           66,397         —     

Deposits held in money market funds

     562         3,645         —           4,207         —     
  

 

 

    

 

 

    

 

 

    

 

 

    

 

 

 
   $ 20,599       $ 50,005       $ —         $ 70,604       $ —     
  

 

 

    

 

 

    

 

 

    

 

 

    

 

 

 

Liabilities

   $ —         $ —         $ —         $ —         $ —     
  

 

 

    

 

 

    

 

 

    

 

 

    

 

 

 

Non-recurring:

              

Assets:

              

Goodwill—nursing and rehabilitation centers

   $ —         $ —         $ —         $ —         $ (6,080

Property and equipment

     —           —           6,372         6,372         (20,632
  

 

 

    

 

 

    

 

 

    

 

 

    

 

 

 
   $ —         $ —         $ 6,372       $ 6,372       $ (26,712
  

 

 

    

 

 

    

 

 

    

 

 

    

 

 

 

Liabilities

   $ —         $ —         $ —         $ —         $ —     
  

 

 

    

 

 

    

 

 

    

 

 

    

 

 

 

December 31, 2010:

              

Recurring:

              

Assets:

              

Available-for-sale debt securities:

              

Corporate bonds

   $ —         $ 32,676       $ —         $ 32,676       $ —     

Debt securities issued by U.S. government agencies

     —           17,992         —           17,992         —     

U.S. Treasury notes

     2,493         —           —           2,493         —     

Debt securities issued by foreign governments

     —           2,096         —           2,096         —     

Commercial mortgage-backed securities

     —           326         —           326         —     
  

 

 

    

 

 

    

 

 

    

 

 

    

 

 

 
     2,493         53,090         —           55,583         —     

Available-for-sale equity securities

     12,011         —           —           12,011         —     

Commercial paper

     —           5,705         —           5,705         —     

Money market funds

     2,581         —           —           2,581         —     
  

 

 

    

 

 

    

 

 

    

 

 

    

 

 

 

Total available-for-sale investments

     17,085         58,795         —           75,880         —     

Deposits held in money market funds

     7,238         3,001         —           10,239         —     
  

 

 

    

 

 

    

 

 

    

 

 

    

 

 

 
   $ 24,323       $ 61,796       $ —         $ 86,119       $ —     
  

 

 

    

 

 

    

 

 

    

 

 

    

 

 

 

Liabilities

   $ —         $ —         $ —         $ —         $ —     
  

 

 

    

 

 

    

 

 

    

 

 

    

 

 

 

Non-recurring:

              

Assets:

              

Hospitals available for sale

   $ —         $ —         $ 5,605       $ 5,605       $ (1,880
  

 

 

    

 

 

    

 

 

    

 

 

    

 

 

 

Liabilities

   $ —         $ —         $ —         $ —         $ —     
  

 

 

    

 

 

    

 

 

    

 

 

    

 

 

 

 

26


Table of Contents

KINDRED HEALTHCARE, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)

(Unaudited)

 

NOTE 14—FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS (Continued)

 

Recurring measurements

The Company’s available-for-sale investments are primarily held by its limited purpose insurance subsidiary and consist of debt securities, equities, commercial paper and money market funds. These available-for-sale investments and the insurance subsidiary’s cash and cash equivalents of $106.6 million as of September 30, 2011 and $102.1 million as of December 31, 2010, classified as insurance subsidiary investments, are maintained for the payment of claims and expenses related to professional liability and workers compensation risks.

The Company also has available-for-sale investments totaling $3.9 million related to a deferred compensation plan that is maintained for certain of the Company’s current and former employees.

The Company’s deposits held in money market funds consist primarily of cash and cash equivalents held for general corporate purposes.

The fair value of actively traded debt and equity securities and money market funds are based upon quoted market prices and are generally classified as Level 1. The fair value of inactively traded debt securities and commercial paper are based upon either quoted market prices of similar securities or observable inputs such as interest rates using either a market or income valuation approach and are generally classified as Level 2. The Company’s investment advisors obtain and review pricing for each security. The Company is responsible for the determination of fair value and as such the Company reviews the pricing information from its advisors in determining reasonable estimates of fair value. Based upon the Company’s internal review procedures, there were no adjustments to the prices during the three or nine months ended September 30, 2011 or September 30, 2010.

The following table presents the carrying amounts and estimated fair values of the Company’s financial instruments. The carrying value is equal to fair value for financial instruments that are based upon quoted market prices or current market rates.

 

     September 30, 2011      December 31, 2010  

(In thousands)

   Carrying
value
     Fair
value
     Carrying
value
     Fair
value
 

Cash and cash equivalents

   $ 34,095       $ 34,095       $ 17,168       $ 17,168   

Cash—restricted

     5,402         5,402         5,494         5,494   

Insurance subsidiary investments

     169,144         169,144         177,963         177,963   

Other marketable securities

     3,882         3,882         —           —     

Tax refund escrow investments

     214         214         213         213   

Long-term debt, including amounts due within one year (excluding capital lease obligations totaling $4.8 million at September 30, 2011)

     1,495,139         1,321,215         365,647         365,640   

Non-recurring measurements

On July 29, 2011, CMS issued the 2011 CMS Rules. As a result of these rules, the Company tested the recoverability of its nursing and rehabilitation centers reporting unit goodwill and intangible assets and property and equipment within asset groups impacted by the reduced payments. The Company determined that pretax impairment charges aggregating $26.7 million were necessary. The charges included $6.1 million of goodwill (which represented the entire nursing and rehabilitation centers reporting unit goodwill) and $20.6 million of property and equipment. These charges reflected the amount by which the carrying value of certain assets exceeded their estimated fair value. The fair value of goodwill was measured using both Level 2 and Level 3 inputs such as discounted cash flows, market multiple analysis, replacement costs and sales comparison methodologies. The fair value of property and equipment was measured using Level 3 inputs such as replacement costs factoring in depreciation, economic obsolesce and inflation trends.

 

27


Table of Contents

KINDRED HEALTHCARE, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)

(Unaudited)

 

NOTE 15—CONDENSED CONSOLIDATING FINANCIAL INFORMATION

The accompanying condensed consolidating financial information has been prepared and presented pursuant to SEC Regulation S-X, Rule 3-10, “Financial Statements of Guarantors and Issuers of Guaranteed Securities Registered or Being Registered.” The Company’s Notes issued on June 1, 2011, are fully and unconditionally guaranteed subject to certain customary release provisions on an unsecured, joint and severally liable basis by substantially all of the Company’s domestic 100% owned subsidiaries. The equity method has been used with respect to the parent company’s (Kindred) investment in subsidiaries.

The following unaudited condensed, consolidating financial data present the composition of the parent company/issuer, the guarantor subsidiaries and the non-guarantor subsidiaries as of September 30, 2011 and December 31, 2010 for the balance sheet, and the results of operations and cash flows for the three and nine months ended September 30, 2011 and September 30, 2010.

 

28


Table of Contents

KINDRED HEALTHCARE, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)

(Unaudited)

 

NOTE 15—CONDENSED CONSOLIDATING FINANCIAL INFORMATION (Continued)

 

Condensed Consolidating Statement of Operations

 

     Three months ended September 30, 2011  

(In thousands)

   Parent
company/
issuer
    Guarantor
subsidiaries
    Non-guarantor
subsidiaries
    Consolidating
and
eliminating
adjustments
    Consolidated  

Revenues

   $ —        $ 1,424,647      $ 111,847      $ (22,432   $ 1,514,062   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Salaries, wages and benefits

     130        860,448        39,992        —          900,570   

Supplies

     —          98,846        8,668        —          107,514   

Rent

     —          97,901        7,610        —          105,511   

Other operating expenses

     23        311,310        43,116        (22,432     332,017   

Other income

     —          (2,815     —          —          (2,815

Depreciation and amortization

     —          43,865        3,082        —          46,947   

Management fees

     —          (3,469     3,469        —          —     

Intercompany interest (income) expense from affiliates

     (26,379     22,409        3,970        —          —     

Interest expense

     25,454        123        213        —          25,790   

Investment (income) loss

     —          (4,621     4,584        —          (37

Equity in net income of consolidating affiliates

     (1,282     —          —          1,282        —     
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
     (2,054     1,423,997        114,704        (21,150     1,515,497   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Income (loss) from continuing operations before income taxes

     2,054        650        (2,857     (1,282     (1,435

Provision (benefit) for income taxes

     269        (2,621     10        —          (2,342
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Income (loss) from continuing operations

     1,785        3,271        (2,867     (1,282     907   

Income from discontinued operations, net of income taxes

     —          1,119        —          —          1,119   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net income (loss)

     1,785        4,390        (2,867     (1,282     2,026   

Earnings attributable to noncontrolling interest

     —          —          (241     —          (241
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Income (loss) attributable to Kindred

   $ 1,785      $ 4,390      $ (3,108   $ (1,282   $ 1,785   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

 

29


Table of Contents

KINDRED HEALTHCARE, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)

(Unaudited)

 

NOTE 15—CONDENSED CONSOLIDATING FINANCIAL INFORMATION (Continued)

 

Condensed Consolidating Statement of Operations (Continued)

 

    Three months ended September 30, 2010  

(In thousands)

  Parent
company/
issuer
    Guarantor
subsidiaries
    Non-guarantor
subsidiaries
    Consolidating
and
eliminating
adjustments
    Consolidated  

Revenues

  $ —        $ 1,052,459      $ 19,342      $ (18,789   $ 1,053,012   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Salaries, wages and benefits

    77        613,530        —          —          613,607   

Supplies

    —          83,753        —          —          83,753   

Rent

    —          89,295        —          —          89,295   

Other operating expenses

    600        233,585        19,572        (18,789     234,968   

Other income

    —          (2,794     —          —          (2,794

Depreciation and amortization

    —          29,167        —          —          29,167   

Management fees

    32        (32     —          —          —     

Intercompany interest (income) expense from affiliates

    (7,960     7,960        —          —          —     

Interest expense

    1,606        36        —          —          1,642   

Investment income

    —          (23     (380     —          (403

Equity in net income of consolidating affiliates

    (1,455     —          —          1,455        —     
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
    (7,100     1,054,477        19,192        (17,334     1,049,235   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Income (loss) from continuing operations before income taxes

    7,100        (2,018     150        (1,455     3,777   

Provision (benefit) for income taxes

    2,174        (3,570     73        —          (1,323
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Income from continuing operations

    4,926        1,552        77        (1,455     5,100   

Discontinued operations, net of income taxes:

         

Loss from operations

    —          (260     —          —          (260

Gain on divestiture of operations

    —          86        —          —          86   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Loss from discontinued operations

    —          (174     —          —          (174
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net income

  $ 4,926      $ 1,378      $ 77      $ (1,455   $ 4,926   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

 

30


Table of Contents

KINDRED HEALTHCARE, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)

(Unaudited)

 

NOTE 15—CONDENSED CONSOLIDATING FINANCIAL INFORMATION (Continued)

 

Condensed Consolidating Statement of Operations (Continued)

 

    Nine months ended September 30, 2011  

(In thousands)

  Parent
company/
issuer
    Guarantor
subsidiaries
    Non-guarantor
subsidiaries
    Consolidating
and
eliminating
adjustments
    Consolidated  

Revenues

  $ —        $ 3,879,843      $ 184,025      $ (64,793   $ 3,999,075   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Salaries, wages and benefits

    401        2,290,765        53,232        —          2,344,398   

Supplies

    —          282,713        11,541        —          294,254   

Rent

    3        282,524        10,114        —          292,641   

Other operating expenses

    70        850,080        93,161        (64,793     878,518   

Other income

    —          (8,480     —          —          (8,480

Depreciation and amortization

    —          112,897        4,470        —          117,367   

Management fees

    —          (4,627     4,627        —          —     

Intercompany interest (income) expense from affiliates

    (61,317     56,017        5,300        —          —     

Interest expense

    54,228        144        303        —          54,675   

Investment (income) loss

    —          (6,212     5,423        —          (789

Equity in net income of consolidating affiliates

    (14,225     —          —          14,225        —     
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
    (20,840     3,855,821        188,171        (50,568     3,972,584   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Income (loss) from continuing operations before income taxes

    20,840        24,022        (4,146     (14,225     26,491   

Provision for income taxes

    2,490        7,194        164        —          9,848   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Income (loss) from continuing operations

    18,350        16,828        (4,310     (14,225     16,643   

Income from discontinued operations, net of income taxes

    —          1,527        —          —          1,527   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net income (loss)

    18,350        18,355        (4,310     (14,225     18,170   

Loss attributable to noncontrolling interest

    —          —          180        —          180   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Income (loss) attributable to Kindred

  $ 18,350      $ 18,355      $ (4,130   $ (14,225   $ 18,350   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

 

31


Table of Contents

KINDRED HEALTHCARE, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)

(Unaudited)

 

NOTE 15—CONDENSED CONSOLIDATING FINANCIAL INFORMATION (Continued)

 

Condensed Consolidating Statement of Operations (Continued)

 

    Nine months ended September 30, 2010  

(In thousands)

  Parent
company/
issuer
    Guarantor
subsidiaries
    Non-guarantor
subsidiaries
    Consolidating
and
eliminating
adjustments
    Consolidated  

Revenues

  $ —        $ 3,222,587      $ 57,992      $ (56,366   $ 3,224,213   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Salaries, wages and benefits

    249        1,852,738        —          —          1,852,987   

Supplies

    —          255,094        —          —          255,094   

Rent

    3        266,592        —          —          266,595   

Other operating expenses

    641        705,163        58,421        (56,366     707,859   

Other income

    —          (8,735     —          —          (8,735

Depreciation and amortization

    —          90,140        —          —          90,140   

Management fees

    168        (168     —          —          —     

Intercompany interest (income) expense from affiliates

    (23,737     23,737        —          —          —     

Interest expense

    4,148        99        —          —          4,247   

Investment income

    —          (68     (835     —          (903

Equity in net income of consolidating affiliates

    (24,673     —          —          24,673        —     
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
    (43,201     3,184,592        57,586        (31,693     3,167,284   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Income from continuing operations before income taxes

    43,201        37,995        406        (24,673     56,929   

Provision for income taxes

    7,134        13,205        199        —          20,538   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Income from continuing operations

    36,067        24,790        207        (24,673     36,391   

Discontinued operations, net of income taxes:

         

Loss from operations

    —          (327     —          —          (327

Gain on divestiture of operations

    —          3        —          —          3   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Loss from discontinued operations

    —          (324     —          —          (324
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net income

  $ 36,067      $ 24,466      $ 207      $ (24,673   $ 36,067   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

 

32


Table of Contents

KINDRED HEALTHCARE, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)

(Unaudited)

 

NOTE 15—CONDENSED CONSOLIDATING FINANCIAL INFORMATION (Continued)

 

Condensed Consolidating Balance Sheet

 

    As of September 30, 2011  

(In thousands)

  Parent
company/
issuer
    Guarantor
subsidiaries
    Non-guarantor
subsidiaries
    Consolidating
and
eliminating
adjustments
    Consolidated  
ASSETS          

Current assets:

         

Cash and cash equivalents

  $ —        $ 8,967      $ 25,128      $ —        $ 34,095   

Cash—restricted

    —          5,402        —          —          5,402   

Insurance subsidiary investments

    —          —          64,846        —          64,846   

Accounts receivable, net

    —          880,145        92,195        —          972,340   

Inventories

    —          27,975        2,846        —          30,821   

Deferred tax assets

    —          28,799        —          —          28,799   

Income taxes

    —          18,039        —          —          18,039   

Other

    —          26,786        4,010        —          30,796   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
    —          996,113        189,025        —          1,185,138   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Property and equipment, net

    —          998,118        52,723        —          1,050,841   

Goodwill

    —          827,091        296,608        —          1,123,699   

Intangible assets, net

    —          479,472        26,594        —          506,066   

Assets held for sale

    —          7,094        —          —          7,094   

Insurance subsidiary investments

    —          —          104,298        —          104,298   

Investment in subsidiaries

    339,247        —          —          (339,247     —     

Other

    54,522        91,517        52,402        —          198,441   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
  $ 393,769      $ 3,399,405      $ 721,650      $ (339,247   $ 4,175,577   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
LIABILITIES AND EQUITY          

Current liabilities:

         

Accounts payable

  $ 102      $ 200,221      $ 18,200      $ —        $ 218,523   

Salaries, wages and other compensation

    77        347,627        44,593        —          392,297   

Due to third party payors

    —          41,436        —          —          41,436   

Professional liability risks

    —          (10,475     52,203        —          41,728   

Other accrued liabilities

    —          130,665        10,175        —          140,840   

Income taxes

    —          227        (227     —          —     

Long-term debt due within one year

    7,000        327        3,212        —          10,539   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
    7,179        710,028        128,156        —          845,363   

Long-term debt

    1,483,083        486        5,790        —          1,489,359   

Intercompany

    (2,454,556     2,099,244        355,312        —          —     

Professional liability risks

    —          118,078        106,825        —          224,903   

Deferred tax liabilities

    —          33,569        (6,891     —          26,678   

Deferred credits and other liabilities

    —          141,290        48,524        —          189,814   

Noncontrolling interests-redeemable

    —          —          9,626        —          9,626   

Commitments and contingencies

         

Equity:

         

Stockholders’ equity

    1,358,063        296,710        42,537        (339,247     1,358,063   

Noncontrolling interests-nonredeemable

    —          —          31,771        —          31,771   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
    1,358,063        296,710        74,308        (339,247     1,389,834   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
  $ 393,769      $ 3,399,405      $ 721,650      $ (339,247   $ 4,175,577   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

 

33


Table of Contents

KINDRED HEALTHCARE, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)

(Unaudited)

 

NOTE 15—CONDENSED CONSOLIDATING FINANCIAL INFORMATION (Continued)

 

Condensed Consolidating Balance Sheet (Continued)

 

    As of December 31, 2010  

(In thousands)

  Parent
company/
issuer
    Guarantor
subsidiaries
    Non-guarantor
subsidiaries
    Consolidating
and
eliminating
adjustments
    Consolidated  
ASSETS          

Current assets:

         

Cash and cash equivalents

  $ —        $ 17,168      $ —        $ —        $ 17,168   

Cash—restricted

    —          5,494        —          —          5,494   

Insurance subsidiary investments

    —          —          76,753        —          76,753   

Accounts receivable, net

    —          631,612        265        —          631,877   

Inventories

    —          24,327        —          —          24,327   

Deferred tax assets

    —          13,439        —          —          13,439   

Income taxes

    —          42,118        —          —          42,118   

Other

    —          24,850        12        —          24,862   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
    —          759,008        77,030        —          836,038   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Property and equipment, net

    —          896,547        —          —          896,547   

Goodwill

    —          242,420        —          —          242,420   

Intangible assets, net

    —          92,883        —          —          92,883   

Assets held for sale

    —          7,167        —          —          7,167   

Insurance subsidiary investments

    —          —          101,210        —          101,210   

Deferred tax assets

    —          82,536        6,280        —          88,816   

Investment in subsidiaries

    329,657        —          —          (329,657     —     

Other

    4,948        14,166        53,220        —          72,334   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
  $ 334,605      $ 2,094,727      $ 237,740      $ (329,657   $ 2,337,415   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
LIABILITIES AND STOCKHOLDERS’ EQUITY          

Current liabilities:

         

Accounts payable

  $ 81      $ 172,296      $ 2,118      $ —        $ 174,495   

Salaries, wages and other compensation

    44        268,481        22,591        —          291,116   

Due to third party payors

    —          27,115        —          —          27,115   

Professional liability risks

    —          2,385        39,170        —          41,555   

Other accrued liabilities

    —          87,012        —          —          87,012   

Long-term debt due within one year

    —          91        —          —          91   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
    125        557,380        63,879        —          621,384   

Long-term debt

    365,000        556        —          —          365,556   

Intercompany

    (1,062,279     1,071,029        (8,750     —          —     

Professional liability risks

    —          106,769        100,900        —          207,669   

Deferred credits and other liabilities

    —          64,712        46,335        —          111,047   

Commitments and contingencies

         

Stockholders’ equity

    1,031,759        294,281        35,376        (329,657     1,031,759   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
  $ 334,605      $ 2,094,727      $ 237,740      $ (329,657   $ 2,337,415   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

 

34


Table of Contents

KINDRED HEALTHCARE, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)

(Unaudited)

 

NOTE 15—CONDENSED CONSOLIDATING FINANCIAL INFORMATION (Continued)

 

Condensed Consolidating Statement of Cash Flows

 

     Three months ended September 30, 2011  

(In thousands)

   Parent
company/
issuer
    Guarantor
subsidiaries
    Non-guarantor
subsidiaries
    Consolidating
and
eliminating
adjustments
     Consolidated  

Net cash provided by operating activities

   $ 1,029      $ 58,112      $ 7,377      $ —         $ 66,518   
  

 

 

   

 

 

   

 

 

   

 

 

    

 

 

 

Cash flows from investing activities:

           

Routine capital expenditures

     —          (35,140     (1,455     —           (36,595

Development capital expenditures

     —          (44,152     —          —           (44,152

Acquisitions, net of cash acquired

     —          (50,928     —          —           (50,928

Purchase of insurance subsidiary investments

     —          —          (8,867     —           (8,867

Sale of insurance subsidiary investments

     —          —          10,398        —           10,398   

Net change in insurance subsidiary cash and cash equivalents

     —          —          (826     —           (826

Other

     —          (663     —          —           (663
  

 

 

   

 

 

   

 

 

   

 

 

    

 

 

 

Net cash used in investing activities

     —          (130,883     (750     —           (131,633
  

 

 

   

 

 

   

 

 

   

 

 

    

 

 

 

Cash flows from financing activities:

           

Proceeds from borrowings under revolving credit

     533,200        —          —          —           533,200   

Repayment of borrowings under revolving credit

     (474,700     —          —          —           (474,700

Repayment of other long-term debt

     —          (1,542     (1,003     —           (2,545

Payment of deferred financing costs

     (1,855     —          —          —           (1,855

Purchase of noncontrolling interests in subsidiaries

     —          —          (7,292     —           (7,292

Change in intercompany accounts

     (57,677     48,084        9,593        —           —     

Insurance subsidiary distribution

     —          —          —          —           —     

Other

     3        —          —          —           3   
  

 

 

   

 

 

   

 

 

   

 

 

    

 

 

 

Net cash provided by (used in) financing activities

     (1,029     46,542        1,298        —           46,811   
  

 

 

   

 

 

   

 

 

   

 

 

    

 

 

 

Change in cash and cash equivalents

     —          (26,229     7,925        —           (18,304

Cash and cash equivalents at beginning of period

     —          35,196        17,203        —           52,399   
  

 

 

   

 

 

   

 

 

   

 

 

    

 

 

 

Cash and cash equivalents at end of period

   $ —        $ 8,967      $ 25,128      $ —         $ 34,095   
  

 

 

   

 

 

   

 

 

   

 

 

    

 

 

 

 

35


Table of Contents

KINDRED HEALTHCARE, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)

(Unaudited)

 

NOTE 15—CONDENSED CONSOLIDATING FINANCIAL INFORMATION (Continued)

 

Condensed Consolidating Statement of Cash Flows (Continued)

 

     Three months ended September 30, 2010  

(In thousands)

   Parent
company/
issuer
    Guarantor
subsidiaries
    Non-guarantor
subsidiaries
    Consolidating
and
eliminating
adjustments
     Consolidated  

Net cash provided by operating activities

   $ 3,929      $ 61,562      $ 2,418      $ —         $ 67,909   
  

 

 

   

 

 

   

 

 

   

 

 

    

 

 

 

Cash flows from investing activities:

           

Routine capital expenditures

     —          (28,623     —          —           (28,623

Development capital expenditures

     —          (20,364     —          —           (20,364

Acquisitions

     —          (38,379     —          —           (38,379

Purchase of insurance subsidiary investments

     —          —          (10,566     —           (10,566

Sale of insurance subsidiary investments

     —          —          11,138        —           11,138   

Net change in insurance subsidiary cash and cash equivalents

     —          —          (3,111     —           (3,111

Other

     —          698        —          —           698   
  

 

 

   

 

 

   

 

 

   

 

 

    

 

 

 

Net cash used in investing activities

     —          (86,668     (2,539     —           (89,207
  

 

 

   

 

 

   

 

 

   

 

 

    

 

 

 

Cash flows from financing activities:

           

Proceeds from borrowings under revolving credit

     457,900        —          —          —           457,900   

Repayment of borrowings under revolving credit

     (432,800     —          —          —           (432,800

Repayment of long-term debt

     —          (22     —          —           (22

Payment of deferred financing costs

     (1,361     —          —          —           (1,361

Change in intercompany accounts

     (27,668     27,547        121        —           —     

Other

     —          —          —          —           —     
  

 

 

   

 

 

   

 

 

   

 

 

    

 

 

 

Net cash provided by (used in) financing activities

     (3,929     27,525        121        —           23,717   
  

 

 

   

 

 

   

 

 

   

 

 

    

 

 

 

Change in cash and cash equivalents

     —          2,419        —          —           2,419   

Cash and cash equivalents at beginning of period

     —          12,902        —          —           12,902   
  

 

 

   

 

 

   

 

 

   

 

 

    

 

 

 

Cash and cash equivalents at end of period

   $ —        $ 15,321      $ —        $ —         $ 15,321   
  

 

 

   

 

 

   

 

 

   

 

 

    

 

 

 

 

36


Table of Contents

KINDRED HEALTHCARE, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)

(Unaudited)

 

NOTE 15—CONDENSED CONSOLIDATING FINANCIAL INFORMATION (Continued)

 

Condensed Consolidating Statement of Cash Flows (Continued)

 

    Nine months ended September 30, 2011  

(In thousands)

  Parent
company/
issuer
    Guarantor
subsidiaries
    Non-guarantor
subsidiaries
    Consolidating
and
eliminating
adjustments
    Consolidated  

Net cash provided by (used in) operating activities

  $ (38,301   $ 143,202      $ 16,405      $ (3,500   $ 117,806   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Cash flows from investing activities:

         

Routine capital expenditures

    —          (93,734     (1,529     —          (95,263

Development capital expenditures

    —          (69,570     —          —          (69,570

Acquisitions, net of cash acquired

    —          (741,079     30,172        —          (710,907

Sale of assets

    —          1,714        —          —          1,714   

Purchase of insurance subsidiary investments

    —          —          (25,904     —          (25,904

Sale of insurance subsidiary investments

    —          —          37,587        —          37,587   

Net change in insurance subsidiary cash and cash equivalents

    —          —          (4,870     —          (4,870

Change in other investments

    —          1,000        —          —          1,000   

Other

    —          (692     —          —          (692
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net cash provided by (used in) investing activities

    —          (902,361     35,456        —          (866,905
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Cash flows from financing activities:

         

Proceeds from borrowings under revolving credit

    1,633,300        —          —          —          1,633,300   

Repayment of borrowings under revolving credit

    (1,749,800     —          —          —          (1,749,800

Proceeds from issuance of senior unsecured notes

    550,000        —          —          —          550,000   

Proceeds from issuance of term loan, net of discount

    693,000        —          —          —          693,000   

Repayment of other long-term debt

    —          (346,959     (1,274     —          (348,233

Payment of deferred financing costs

    (8,715     —          —          —          (8,715

Issuance of common stock

    3,019        —          —          —          3,019   

Purchase of noncontrolling interests in subsidiaries

    —          —          (7,292     —          (7,292

Change in intercompany accounts

    (1,083,250     1,097,917        (14,667     —          —     

Insurance subsidiary distribution

    —          —          (3,500     3,500        —     

Other

    747        —          —          —          747   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net cash provided by (used in) financing activities

    38,301        750,958        (26,733     3,500        766,026   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Change in cash and cash equivalents

    —          (8,201     25,128        —          16,927   

Cash and cash equivalents at beginning of period

    —          17,168        —          —          17,168   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Cash and cash equivalents at end of period

  $ —        $ 8,967      $ 25,128      $ —        $ 34,095   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

 

37


Table of Contents

KINDRED HEALTHCARE, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)

(Unaudited)

 

NOTE 15—CONDENSED CONSOLIDATING FINANCIAL INFORMATION (Continued)

 

Condensed Consolidating Statement of Cash Flows (Continued)

 

     Nine months ended September 30, 2010  

(In thousands)

   Parent
company/
issuer
    Guarantor
subsidiaries
    Non-guarantor
subsidiaries
    Consolidating
and
eliminating
adjustments
    Consolidated  

Net cash provided by operating activities

   $ 32,147      $ 135,367      $ 5,141      $ (21,800   $ 150,855   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Cash flows from investing activities:

          

Routine capital expenditures

     —          (69,108     —          —          (69,108

Development capital expenditures

     —          (40,219     —          —          (40,219

Acquisitions

     —          (87,869     —          —          (87,869

Purchase of insurance subsidiary investments

     —          —          (34,684     —          (34,684

Sale of insurance subsidiary investments

     —          —          72,971        —          72,971   

Net change in insurance subsidiary cash and cash equivalents

     —          —          (10,612     —          (10,612

Change in other investments

     —          2        —          —          2   

Other

     —          1,279        —          —          1,279   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net cash provided by (used in) investing activities

     —          (195,915     27,675        —          (168,240
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Cash flows from financing activities:

          

Proceeds from borrowings under revolving credit

     1,109,900        —          —          —          1,109,900   

Repayment of borrowings under revolving credit

     (1,092,400     —          —          —          (1,092,400

Repayment of long-term debt

     —          (64     —          —          (64

Payment of deferred financing costs

     (1,414     —          —          —          (1,414

Issuance of common stock

     35        —          —          —          35   

Change in intercompany accounts

     (48,268     59,284        (11,016     —          —     

Insurance subsidiary distribution

     —          —          (21,800     21,800        —     

Other

     —          346        —          —          346   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net cash provided by (used in) financing activities

     (32,147     59,566        (32,816     21,800        16,403   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Change in cash and cash equivalents

     —          (982     —          —          (982

Cash and cash equivalents at beginning of period

     —          16,303        —          —          16,303   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Cash and cash equivalents at end of period

   $ —        $ 15,321      $ —        $ —        $ 15,321   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

 

38


Table of Contents

ITEM 2.    MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

Cautionary Statement

This Form 10-Q includes forward-looking statements within the meaning of Section 27A of the Securities Act and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). All statements regarding the Company’s expected future financial position, results of operations, cash flows, financing plans, business strategy, budgets, capital expenditures, competitive positions, growth opportunities, plans and objectives of management and statements containing words such as “anticipate,” “approximate,” “believe,” “plan,” “estimate,” “expect,” “project,” “could,” “should,” “will,” “intend,” “may” and other similar expressions, are forward-looking statements.

Such forward-looking statements are inherently uncertain, and stockholders and other potential investors must recognize that actual results may differ materially from the Company’s expectations as a result of a variety of factors, including, without limitation, those discussed below. Such forward-looking statements are based upon management’s current expectations and include known and unknown risks, uncertainties and other factors, many of which the Company is unable to predict or control, that may cause the Company’s actual results or performance to differ materially from any future results or performance expressed or implied by such forward-looking statements. These statements involve risks, uncertainties and other factors discussed below and detailed from time to time in the Company’s filings with the SEC. Factors that may affect the Company’s plans or results include, without limitation:

 

   

the impact of a final rule issued by CMS on July 29, 2011 providing for a 11.1% reduction in Medicare reimbursement to nursing centers as well as changes in payments for the provision of group rehabilitation therapy services,

 

   

other potential reimbursement changes resulting from the Budget Control Act of 2011,

 

   

the Company’s ability to integrate the operations of the acquired hospitals and rehabilitation services operations and realize the anticipated revenues, economies of scale, cost synergies and productivity gains in connection with the RehabCare acquisition and any other acquisitions undertaken during 2011, as and when planned, including the potential for unanticipated issues, expenses and liabilities associated with those acquisitions,

 

   

the potential for diversion of management time and resources in seeking to integrate RehabCare’s operations,

 

   

the potential failure to retain key employees of RehabCare,

 

   

the impact of the Company’s significantly increased levels of indebtedness as a result of the RehabCare acquisition on the Company’s funding costs, operating flexibility and ability to fund ongoing operations, development capital expenditures or other strategic acquisitions with additional borrowings, particularly in light of ongoing volatility in the credit and capital markets,

 

   

the impact of healthcare reform, which will initiate significant reforms to the United States healthcare system, including potential material changes to the delivery of healthcare services and the reimbursement paid for such services by the government or other third party payors. Healthcare reform will impact each of the Company’s businesses in some manner. Due to the substantial regulatory changes that will need to be implemented by CMS and others, and the numerous processes required to implement these reforms, the Company cannot predict which healthcare initiatives will be implemented at the federal or state level, the timing of any such reforms, or the effect such reforms or any other future legislation or regulation will have on the Company’s business, financial position, results of operations and liquidity,

 

   

changes in the reimbursement rates or the methods or timing of payment from third party payors, including commercial payors and the Medicare and Medicaid programs, changes arising from and

 

39


Table of Contents

ITEM 2.    MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND

RESULTS OF OPERATIONS (Continued)

 

Cautionary Statement (Continued)

 

 

related to the Medicare prospective payment system for LTAC hospitals, including potential changes in the Medicare payment rules, the Medicare Prescription Drug, Improvement, and Modernization Act of 2003, and changes in Medicare and Medicaid reimbursements for nursing centers, and the expiration of the Medicare Part B therapy cap exception process,

 

   

the effects of additional legislative changes and government regulations, interpretation of regulations and changes in the nature and enforcement of regulations governing the healthcare industry,

 

   

the Company’s ability to successfully pursue its development activities, including through acquisitions, and successfully integrate new operations, including the realization of anticipated revenues, economies of scale, cost savings and productivity gains associated with such operations,

 

   

the impact of the Medicare, Medicaid and SCHIP Extension Act of 2007 (the “SCHIP Extension Act”), including the ability of the Company’s hospitals to adjust to potential LTAC certification, medical necessity reviews and the moratorium on future hospital development,

 

   

the impact of the expiration of several moratoriums under the SCHIP Extension Act which could impact the short stay rules, the budget neutrality adjustment as well as implement the policy known as the “25 Percent Rule,” which would limit certain patient admissions,

 

   

failure of the Company’s facilities to meet applicable licensure and certification requirements,

 

   

the further consolidation and cost containment efforts of managed care organizations and other third party payors,

 

   

the Company’s ability to meet its rental and debt service obligations,

 

   

the Company’s ability to operate pursuant to the terms of its debt obligations and its master lease agreements with Ventas, Inc.,

 

   

the condition of the financial markets, including volatility and weakness in the equity, capital and credit markets, which could limit the availability and terms of debt and equity financing sources to fund the requirements of the Company’s businesses, or which could negatively impact the Company’s investment portfolio,

 

   

national and regional economic, financial, business and political conditions, including their effect on the availability and cost of labor, credit, materials and other services,

 

   

the Company’s ability to control costs, particularly labor and employee benefit costs,

 

   

increased operating costs due to shortages in qualified nurses, therapists and other healthcare personnel,

 

   

the Company’s ability to attract and retain key executives and other healthcare personnel,

 

   

the increase in the costs of defending and insuring against alleged professional liability and other claims and the ability to predict the estimated costs related to such claims, including the impact of differences in actuarial assumptions and estimates compared to eventual outcomes,

 

   

the Company’s ability to successfully reduce (by divestiture of operations or otherwise) its exposure to professional liability and other claims,

 

   

the Company’s ability to successfully dispose of unprofitable facilities,

 

   

events or circumstances which could result in the impairment of an asset or other charges,

 

40


Table of Contents

ITEM 2.    MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND

RESULTS OF OPERATIONS (Continued)

 

Cautionary Statement (Continued)

 

   

changes in generally accepted accounting principles or practices, and changes in tax accounting or tax laws (or authoritative interpretations relating to any of these matters), and

 

   

the Company’s ability to maintain an effective system of internal control over financial reporting.

Many of these factors are beyond the Company’s control. The Company cautions investors that any forward-looking statements made by the Company are not guarantees of future performance. The Company disclaims any obligation to update any such factors or to announce publicly the results of any revisions to any of the forward-looking statements to reflect future events or developments.

General

The accompanying unaudited condensed consolidated financial statements, including the notes thereto, should be read in conjunction with the following discussion and analysis.

The Company is a healthcare services company that through its subsidiaries operates LTAC hospitals, inpatient rehabilitation hospitals, nursing and rehabilitation centers, assisted living facilities and a contract rehabilitation services business across the United States. At September 30, 2011, the Company’s hospital division operated 120 LTAC hospitals (8,597 licensed beds) and five inpatient rehabilitation hospitals (183 licensed beds) in 26 states. The Company’s nursing center division operated 224 nursing and rehabilitation centers (27,172 licensed beds) and six assisted living facilities (413 licensed beds) in 27 states. The Company’s rehabilitation division provided rehabilitative services primarily in hospital and long-term care settings in 46 states.

RehabCare acquisition

On June 1, 2011, the Company completed the Merger. Upon consummation of the Merger, each issued and outstanding share of RehabCare common stock was converted into the right to receive the Merger Consideration. Kindred issued approximately 12 million shares of its common stock in connection with the Merger. The purchase price totaled $963 million and was comprised of $662 million in cash and $301 million of Kindred common stock at fair value. The Company also assumed $356 million of long-term debt in the Merger, of which $345 million was refinanced on June 1, 2011. The operating results of RehabCare have been included in the accompanying unaudited condensed consolidated financial statements of the Company since June 1, 2011. RehabCare reported consolidated revenues of approximately $1.3 billion and net income from continuing operations of approximately $65 million in fiscal 2010.

Operating results for the third quarter of 2011 included transaction costs totaling $4 million and severance costs totaling $1 million related to the Merger. Operating results for the nine months ended September 30, 2011 included transaction costs totaling $27 million, financing costs totaling $14 million and severance costs totaling $16 million related to the Merger.

Vista acquisition

On November 1, 2010, the Company completed the acquisition of five LTAC hospitals from Vista Healthcare, LLC (“Vista”) for a purchase price of $179 million in cash (the “Vista Acquisition”). The Vista Acquisition was financed with proceeds from the Company’s revolving credit facility.

The Vista Acquisition included four freestanding hospitals and one hospital-in-hospital with a total of 250 beds, all of which are located in southern California. The Company did not acquire the working capital of Vista or assume any of its liabilities. All of the Vista hospitals are leased.

 

41


Table of Contents

ITEM 2.    MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND

RESULTS OF OPERATIONS (Continued)

 

General (Continued)

 

Discontinued operations

In recent years, the Company has completed several strategic divestitures to improve its future operating results. For accounting purposes, the operating results of these businesses and the gains associated with these transactions have been classified as discontinued operations in the accompanying unaudited condensed consolidated statement of operations for all periods presented. Assets not sold at September 30, 2011 have been measured at the lower of carrying value or estimated fair value less costs of disposal and have been classified as held for sale in the accompanying unaudited condensed consolidated balance sheet.

Critical Accounting Policies

Management’s discussion and analysis of financial condition and results of operations are based upon the Company’s consolidated financial statements which have been prepared in accordance with accounting principles generally accepted in the United States. The preparation of these financial statements requires the use of estimates and judgments that affect the reported amounts and related disclosures of commitments and contingencies. The Company relies on historical experience and various other assumptions that management believes to be reasonable under the circumstances to make judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results may differ materially from these estimates.

The Company believes the following critical accounting policies, among others, affect the more significant judgments and estimates used in the preparation of its consolidated financial statements.

Revenue recognition

The Company has agreements with third party payors that provide for payments to each of its operating divisions. These payment arrangements may be based upon prospective rates, reimbursable costs, established charges, discounted charges or per diem payments. Net patient service revenue is recorded at the estimated net realizable amounts from Medicare, Medicaid, Medicare Advantage, other third party payors and individual patients for services rendered. Retroactive adjustments that are likely to result from future examinations by third party payors are accrued on an estimated basis in the period the related services are rendered and adjusted as necessary in future periods based upon new information or final settlements.

Collectibility of accounts receivable

Accounts receivable consist primarily of amounts due from the Medicare and Medicaid programs, other government programs, managed care health plans, commercial insurance companies and individual patients and customers. Estimated provisions for doubtful accounts are recorded to the extent it is probable that a portion or all of a particular account will not be collected.

In evaluating the collectibility of accounts receivable, the Company considers a number of factors, including the age of the accounts, changes in collection patterns, the composition of patient accounts by payor type, the status of ongoing disputes with third party payors and general industry conditions. Actual collections of accounts receivable in subsequent periods may require changes in the estimated provision for loss. Changes in these estimates are charged or credited to the results of operations in the period of the change.

The provision for doubtful accounts totaled $8 million and $6 million for the third quarter of 2011 and 2010, respectively, and $22 million and $18 million for the nine months ended September 30, 2011 and 2010, respectively.

 

42


Table of Contents

ITEM 2.    MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND

RESULTS OF OPERATIONS (Continued)

 

Critical Accounting Policies (Continued)

 

Allowances for insurance risks

The Company insures a substantial portion of its professional liability risks and workers compensation risks through its limited purpose insurance subsidiary. Provisions for loss for these risks are based upon management’s best available information including actuarially determined estimates.

The allowance for professional liability risks includes an estimate of the expected cost to settle reported claims and an amount, based upon past experiences, for losses incurred but not reported. These liabilities are necessarily based upon estimates and, while management believes that the provision for loss is adequate, the ultimate liability may be in excess of, or less than, the amounts recorded. To the extent that expected ultimate claims costs vary from historical provisions for loss, future earnings will be charged or credited.

Provisions for loss for professional liability risks retained by the Company’s limited purpose insurance subsidiary have been discounted based upon actuarial estimates of claim payment patterns using a discount rate of 1% to 5% depending upon the policy year. The discount rate was 1% for the 2011 and 2010 policy years. The discount rates are based upon the risk free interest rate for the respective year. Amounts equal to the discounted loss provision are funded annually. The Company does not fund the portion of professional liability risks related to estimated claims that have been incurred but not reported. Accordingly, these liabilities are not discounted. The allowance for professional liability risks aggregated $267 million at September 30, 2011 and $249 million at December 31, 2010. If the Company did not discount any of the allowances for professional liability risks, these balances would have approximated $270 million at September 30, 2011 and $253 million at December 31, 2010.

As a result of improved professional liability underwriting results of the Company’s limited purpose insurance subsidiary, the Company received distributions of $3 million and $22 million during the nine months ended September 30, 2011 and 2010, respectively, from its limited purpose insurance subsidiary in accordance with applicable regulations. These distributions had no impact on earnings and the proceeds were used primarily to repay borrowings under the Company’s revolving credit facility.

Changes in the number of professional liability claims and the cost to settle these claims significantly impact the allowance for professional liability risks. A relatively small variance between the Company’s estimated and actual number of claims or average cost per claim could have a material impact, either favorable or unfavorable, on the adequacy of the allowance for professional liability risks. For example, a 1% variance in the allowance for professional liability risks at September 30, 2011 would impact the Company’s operating income by approximately $3 million.

The provision for professional liability risks (continuing operations), including the cost of coverage maintained with unaffiliated commercial insurance carriers, aggregated $16 million and $13 million for the third quarter of 2011 and 2010, respectively, and $51 million and $46 million for the nine months ended September 30, 2011 and 2010, respectively.

Provisions for loss for workers compensation risks retained by the Company’s limited purpose insurance subsidiary are not discounted and amounts equal to the loss provision are funded annually. The allowance for workers compensation risks aggregated $166 million at September 30, 2011 and $84 million December 31, 2010. The provision for workers compensation risks (continuing operations), including the cost of coverage maintained with unaffiliated commercial insurance carriers, aggregated $16 million and $10 million for the third quarter of 2011 and 2010, respectively, and $43 million and $32 million for the nine months ended September 30, 2011 and 2010, respectively.

 

43


Table of Contents

ITEM 2.    MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND

RESULTS OF OPERATIONS (Continued)

 

Critical Accounting Policies (Continued)

 

Accounting for income taxes

The provision for income taxes is based upon the Company’s estimate of annual taxable income or loss for each respective accounting period. The Company recognizes an asset or liability for the deferred tax consequences of temporary differences between the tax bases of assets and liabilities and their reported amounts in the financial statements. These temporary differences will result in taxable or deductible amounts in future years when the reported amounts of the assets are recovered or liabilities are settled. The Company also recognizes as deferred tax assets the future tax benefits from net operating and capital loss carryforwards. A valuation allowance is provided for these deferred tax assets if it is more likely than not that some portion or all of the net deferred tax assets will not be realized.

The Company’s effective income tax rate for the third quarter and nine months ended September 30, 2011 and 2010, respectively, were favorably impacted by approximately $3 million related to the resolution of certain prior year income tax contingencies.

There are significant uncertainties with respect to capital loss carryforwards that could affect materially the realization of certain deferred tax assets. Accordingly, the Company has recognized deferred tax assets to the extent it is more likely than not they will be realized and a valuation allowance is provided for deferred tax assets to the extent that it is uncertain that the deferred tax asset will be realized. The Company recognized net deferred tax assets totaling $2 million at September 30, 2011 and $102 million at December 31, 2010. The change in net deferred taxes at September 30, 2011 was primarily attributable to the Merger and related fair value adjustments recorded in purchase accounting.

During the nine months ended September 30, 2010, the Company received approval from the IRS for an accounting method change for income tax purposes that resulted in a non-recurring reduction in income tax payments of approximately $25 million during 2010. The Company’s earnings were not impacted by this transaction.

The Company is subject to various federal and state income tax audits in the ordinary course of business. Such audits could result in increased tax payments, interest and penalties. In July 2011, the Company resolved federal income tax audits for the 2007 through 2009 tax years. The Company has been notified by the IRS that an examination will be conducted for the 2010 tax year. While the Company believes its tax positions are appropriate, there can be no assurance that the various authorities engaged in the examination of its income tax returns will not challenge the Company’s positions.

Valuation of long-lived assets and goodwill

The Company regularly reviews the carrying value of certain long-lived assets and identifiable finite lived intangible assets with respect to any events or circumstances that indicate an impairment or an adjustment to the amortization period is necessary. If circumstances suggest that the recorded amounts cannot be recovered based upon estimated future undiscounted cash flows, the carrying values of such assets are reduced to fair value.

In assessing the carrying values of long-lived assets, the Company estimates future cash flows at the lowest level for which there are independent, identifiable cash flows. For this purpose, these cash flows are aggregated based upon the contractual agreements underlying the operation of the facility or group of facilities. Generally, an individual facility is considered the lowest level for which there are independent, identifiable cash flows. However, to the extent that groups of facilities are leased under a master lease agreement in which the operations of a facility and compliance with the lease terms are interdependent upon other facilities in the agreement

 

44


Table of Contents

ITEM 2.    MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND

RESULTS OF OPERATIONS (Continued)

 

Critical Accounting Policies (Continued)

 

Valuation of long-lived assets and goodwill (Continued)

 

(including the Company’s ability to renew the lease or divest a particular property), the Company defines the group of facilities under a master lease agreement as the lowest level for which there are independent, identifiable cash flows. Accordingly, the estimated cash flows of all facilities within a master lease agreement are aggregated for purposes of evaluating the carrying values of long-lived assets.

The Company’s other intangible assets with finite lives are amortized in accordance with the authoritative guidance for goodwill and other intangible assets using the straight-line method over their estimated useful lives ranging from one to 20 years.

As a result of the Merger, the Company acquired finite lived intangible assets consisting of customer relationships ($189 million), a trade name ($17 million) and non-compete agreements ($3 million) with estimated useful lives ranging from two to 15 years.

In accordance with the authoritative guidance for goodwill and other intangible assets, the Company is required to perform an impairment test for goodwill and indefinite lived intangible assets at least annually or more frequently if adverse events or changes in circumstances indicate that the asset may be impaired. The Company performs its annual goodwill impairment test at the end of each fiscal year for each of its reporting units. A reporting unit is either an operating segment or one level below the operating segment, referred to as a component.

On July 29, 2011, CMS issued the 2011 CMS Rules. Based upon the Company’s review of the 2011 CMS Rules, the Company believes that its nursing center Medicare rates could decline by as much as 15% in 2012. As a result of these rules, the Company tested the recoverability of its nursing and rehabilitation centers reporting unit goodwill and intangible assets and property and equipment within asset groups impacted by the reduced payments. The Company determined that pretax impairment charges aggregating $27 million ($16 million net of income taxes or $0.31 per diluted share) were necessary. The charges included $6 million of goodwill (which represented the entire nursing and rehabilitation centers reporting unit goodwill) and $21 million of property and equipment. These charges reflected the amount by which the carrying value of certain assets exceeded their estimated fair value. The impairment charges did not impact the Company’s cash flows or liquidity.

Although the Company has determined that there was no other goodwill or other indefinite lived intangible asset impairments as of September 30, 2011, adverse changes in the operating environment and related key assumptions used to determine the fair value of the Company’s reporting units and indefinite lived intangible assets or declines in the value of the Company’s common stock may result in future impairment charges for a portion or all of these assets. Specifically, if the rate of growth of government and commercial revenues earned by the Company’s reporting units were to be less than projected or if healthcare reforms were to negatively impact the Company’s business, an impairment charge of a portion or all of the assets may be required. An impairment charge could have a material adverse effect on the Company’s business, financial position and results of operations, but would not be expected to have an impact on the Company’s cash flows or liquidity.

When the components within the Company’s operating segments have similar economic characteristics, the Company aggregates the components of its operating segments into one reporting unit. Accordingly, the Company has determined that its reporting units are hospitals, nursing and rehabilitation centers, skilled nursing

 

45


Table of Contents

ITEM 2.    MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND

RESULTS OF OPERATIONS (Continued)

 

Critical Accounting Policies (Continued)

 

Valuation of long-lived assets and goodwill (Continued)

 

rehabilitation services, hospital rehabilitation services, home health and hospice. The carrying value of goodwill for each of the Company’s reporting units at September 30, 2011 and December 31, 2010 follows (in thousands):

 

     September 30,
2011
     December 31,
2010
 

Hospitals

   $ 800,053       $ 213,200   

Nursing and rehabilitation centers

     —           6,080   

Rehabilitation division:

     

Skilled nursing rehabilitation services

     124,507         3,363   

Hospital rehabilitation services

     137,978         —     

Home health

     45,848         11,383   

Hospice

     15,313         8,394   
  

 

 

    

 

 

 
   $ 1,123,699       $ 242,420   
  

 

 

    

 

 

 

As a result of the Merger, goodwill was preliminarily assigned to the Company’s hospital reporting unit ($587 million), skilled nursing rehabilitation services reporting unit ($121 million) and hospital rehabilitation services reporting unit ($138 million).

The goodwill impairment test involves a two-step process. The first step is a comparison of each reporting unit’s fair value to its carrying value. If the carrying value of the reporting unit is greater than its fair value, there is an indication that impairment may exist and the second step must be performed to measure the amount of impairment loss. Based upon the results of the step one impairment test for goodwill and the impairment test of indefinite lived intangible assets, no impairment charges were recorded in connection with the Company’s annual impairment tests at December 31, 2010. The Company did not believe that any of its reporting units were at risk of failing the step one impairment test at December 31, 2010.

Since quoted market prices for the Company’s reporting units are not available, the Company applies judgment in determining the fair value of these reporting units for purposes of performing the goodwill impairment test. The Company relies on widely accepted valuation techniques, including equally weighted discounted cash flow and market multiple analyses approaches, which capture both the future income potential of the reporting unit and the market behaviors and actions of market participants in the industry that includes the reporting unit. These types of analyses require management to make assumptions and estimates regarding future cash flows, industry-specific economic factors and the profitability of future business strategies. The discounted cash flow approach uses a projection of estimated operating results and cash flows that are discounted using a weighted average cost of capital. Under the discounted cash flow approach, the projection uses management’s best estimates of economic and market conditions over the projected period for each reporting unit including growth rates in the number of admissions, patient days, reimbursement rates, operating costs, rent expense and capital expenditures. Other significant estimates and assumptions include terminal value growth rates, changes in working capital requirements and weighted average cost of capital. The market multiple analysis estimates fair value by applying cash flow multiples to the reporting unit’s operating results. The multiples are derived from comparable publicly traded companies with similar operating and investment characteristics to the reporting units.

The Company’s indefinite lived intangible assets as of December 31, 2010 consist primarily of certificates of need, which are estimated primarily using an excess earnings method, a form of discounted cash flows, which is based upon the concept that net after-tax cash flows provide a return supporting all of the assets of a business enterprise. The carrying value of the Company’s certificates of need at December 31, 2010 was $66 million. The

 

46


Table of Contents

ITEM 2.    MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND

RESULTS OF OPERATIONS (Continued)

 

Critical Accounting Policies (Continued)

 

Valuation of long-lived assets and goodwill (Continued)

 

fair values of the Company’s indefinite lived intangible assets are derived from current market data and projections at a facility level which include management’s best estimates of economic and market conditions over the projected period including growth rates in the number of admissions, patient days, reimbursement rates, operating costs, rent expense and capital expenditures. Other significant estimates and assumptions include terminal value growth rates, changes in working capital requirements and weighted average cost of capital. At December 31, 2010, the fair value of the Company’s certificates of need intangible assets exceeded its carrying value.

As a result of the Merger, the Company acquired indefinite lived intangible assets consisting of trade names ($115 million), Medicare certifications ($76 million) and certificates of need ($8 million).

Recently Issued Accounting Requirements

In September 2011, the FASB issued authoritative guidance related to testing goodwill for impairment. The main provisions of the guidance state that an entity has the option to first assess qualitative factors to determine whether the existence of events or circumstances leads to a determination that it is more likely than not that the fair value of a reporting unit is less than its carrying amount. If an entity determines it is not more likely than not that the fair value of a reporting unit is less than its carrying amount, then performing the two-step goodwill impairment test is unnecessary. However, if an entity concludes otherwise, then it is required to perform Step 1 of the goodwill impairment test. The guidance is effective for all interim and annual reporting periods beginning after December 15, 2011. Early adoption is permitted. The adoption of the guidance is not expected to have a material impact on the Company’s business, financial position, results of operations or liquidity.

In July 2011, the FASB issued authoritative guidance related to the presentation and disclosure of patient service revenue, provision for bad debts, and the allowance for doubtful accounts for certain healthcare entities. The provisions of the guidance require healthcare entities that recognize significant amounts of patient service revenue at the time services are rendered, even though they do not assess a patient’s ability to pay, to present the provision for bad debts related to those revenues as a deduction from patient service revenue (net of contractual allowances and discounts), as opposed to an operating expense. All other entities would continue to present the provision for bad debts as an operating expense. The guidance is effective for all interim and annual reporting periods beginning after December 15, 2011. Early adoption is permitted, but full retrospective application is required. The adoption of the guidance is not expected to have a material impact on the Company’s business, financial position, results of operations or liquidity.

In June 2011, the FASB issued authoritative guidance related to the presentation of other comprehensive income. The provisions of the guidance state that an entity has the option to present the total of comprehensive income either in a single continuous statement of comprehensive income or in two separate but consecutive statements. The statement(s) should be presented with equal prominence to the other primary financial statements. The guidance is effective for all interim and annual reporting periods beginning after December 15, 2011. Early adoption is permitted, but full retrospective application is required. The adoption of the guidance will not have a material impact on the Company’s business, financial position, results of operations or liquidity.

In May 2011, the FASB issued authoritative guidance related to fair value measurements. The provisions of the guidance result in applying common fair value measurement and disclosure requirements in both United States generally accepted accounting principles and International Financial Reporting Standards. The amendments primarily change the wording used to describe many of the requirements in generally accepted

 

47


Table of Contents

ITEM 2.    MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND

RESULTS OF OPERATIONS (Continued)

 

Recently Issued Accounting Requirements (Continued)

 

accounting principles for measuring and disclosing information about fair value measurements. The guidance is effective for all interim and annual reporting periods beginning after December 15, 2011. The adoption of the guidance is not expected to have a material impact on the Company’s business, financial position, results of operations or liquidity.

In December 2010, the FASB issued authoritative guidance related to goodwill and other intangibles. The provisions of the guidance modify Step 1 of the goodwill impairment test for reporting units with zero or negative carrying amounts. For those reporting units, an entity is required to perform Step 2 of the goodwill impairment test if it is more likely than not that a goodwill impairment exists. In determining if it is more likely than not that a goodwill impairment exists, an entity should consider whether there are any adverse qualitative factors indicating that an impairment may exist. The guidance is effective for all interim and annual reporting periods beginning after December 15, 2010. The adoption of the guidance did not, and is not expected to, have a material impact on the Company’s business, financial position, results of operations or liquidity.

In December 2010, the FASB issued authoritative guidance related to business combinations. The provisions of the guidance specify that if a public entity presents comparative financial statements, the entity should disclose revenue and earnings of the combined entity as though the business combination(s) that occurred during a particular year had occurred as of the beginning of the comparable prior year annual reporting period. Supplemental pro forma disclosures also have been expanded to include a description of the nature and amount of material, non-recurring pro forma adjustments included in the pro forma financial statements. The guidance is effective prospectively for business combinations with an acquisition date on or after the beginning of the first annual reporting period beginning on or after December 15, 2010. The adoption of the guidance did not have a material impact on the Company’s business, financial position, results of operations or liquidity.

In August 2010, the FASB issued authoritative guidance related to the presentation of insurance claims and related insurance recoveries, which addresses the diversity in practice related to the accounting by healthcare entities for medical malpractice claims and similar liabilities and their related anticipated insurance recoveries. The provisions clarify that a healthcare entity should not net insurance recoveries against the related claim liability and the amount of the claim liability should be determined without consideration of insurance recoveries. The guidance is effective for all interim periods beginning after December 15, 2010. The adoption of the guidance did not have a material impact on the Company’s business, financial position, results of operations or liquidity.

In January 2010, the FASB issued authoritative guidance related to fair value measurements and disclosures. The provisions of the guidance require new disclosures related to transfers in and out of Levels 1 and 2 classifications (as described in Note 14). The provisions also require a reconciliation of the activity in Level 3 recurring fair value measurements (as described in Note 14). Existing disclosures also were expanded to include Level 2 fair value measurement valuation techniques and inputs. The guidance is effective for all interim and annual reporting periods beginning after December 15, 2009, except for the disclosures for Level 3 activity which is effective for fiscal years beginning after December 15, 2010. The adoption of the guidance did not, and is not expected to, have a material impact on the Company’s business, financial position, results of operations or liquidity.

Recent Regulatory Changes

On July 29, 2011, CMS issued the 2011 CMS Rules. Based upon the Company’s review of the 2011 CMS Rules, the Company believes that its nursing center Medicare rates could decline by as much as 15% in 2012. Management believes that these rules could reduce the Company’s annual revenues by approximately

 

48


Table of Contents

ITEM 2.    MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND

RESULTS OF OPERATIONS (Continued)

 

Recent Regulatory Changes (Continued)

 

$95 million to $105 million in its nursing center business and approximately $10 million to $15 million in its rehabilitation therapy business. In addition, management believes that other technical changes required under the 2011 CMS Rules may increase rehabilitation therapy costs by approximately $20 million to $25 million on an annual basis.

In addition, CMS also issued final rules that provided payment increases to inpatient rehabilitation facilities (“IRFs”) and LTAC hospitals. Among other things, CMS indicated that Medicare payment rates for IRFs are expected to increase at an annual rate of 2.2% and LTAC hospital payment rates are expected to rise 2.5%. Based upon its review of the final rules, management believes that the Medicare rate increase for the Company’s LTAC hospitals will likely approximate 0.7% in 2012.

Results of Operations—Continuing Operations

Hospital division

Revenues increased 47% in the third quarter of 2011 to $685 million compared to $465 million in the same period in 2010 and increased 25% to $1.8 billion for the nine months ended September 30, 2011 from $1.5 billion in the same period in 2010. Revenue growth in both periods was primarily attributable to the Merger, the Vista Acquisition, the development of new hospitals and higher reimbursement rates. Same-facility revenues were up 5% for the third quarter and 3% for the nine months ended September 30, 2011 compared to the same periods in 2010, while aggregate same-facility admissions increased 4% in the third quarter and 2% for the nine months ended September 30, 2011 compared to the respective prior year periods. Aggregate revenues associated with the Merger and the Vista Acquisition were $196 million and $324 million for the third quarter and nine months ended September 30, 2011, respectively.

Operating income for the third quarter and nine months ended September 30, 2011 included $3 million related to an impairment charge. Excluding the impairment charge, hospital operating margins improved to 18.4% in the third quarter of 2011 and 18.6% for the nine months ended September 30, 2011 compared to 16.3% and 17.9% for the respective periods in 2010. The increase in operating margins for both periods was primarily attributable to higher reimbursement rates and cost efficiencies associated with volume growth. Aggregate operating income associated with the Merger and the Vista Acquisition was $45 million and $74 million for the third quarter and nine months ended September 30, 2011, respectively.

Average hourly wage rates increased 1% in the third quarter and 2% for the nine months ended September 30, 2011 compared to the respective prior year periods. Employee benefit costs increased 51% in the third quarter of 2011 and 30% for the nine months ended September 30, 2011 compared to the respective prior year periods, primarily attributable to the Merger and the Vista Acquisition.

Professional liability costs were $8 million and $6 million in the third quarter of 2011 and 2010, respectively, and $25 million and $22 million for the nine months ended September 30, 2011 and 2010, respectively.

Nursing center division

Revenues increased 6% in the third quarter of 2011 to $571 million compared to $540 million in the same period of 2010 and increased 5% to $1.7 billion for the nine months ended September 30, 2011 from $1.6 billion in the same period in 2010. Revenue growth in both periods was primarily attributable to growth in admissions and reimbursement rate increases that reflected inflationary adjustments and higher average patient acuity.

 

49


Table of Contents

ITEM 2.    MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND

RESULTS OF OPERATIONS (Continued)

 

Results of Operations—Continuing Operations (Continued)

 

Nursing center division (Continued)

 

Aggregate same-facility admissions increased 5% in the third quarter and 6% for the nine months ended September 30, 2011 compared to the respective prior year periods. Aggregate same-facility patient days declined 2% in both the third quarter and nine months ended September 30, 2011 compared to the respective prior year periods, primarily as a result of declines in average length of stay.

Operating income for the third quarter and nine months ended September 30, 2011 included $24 million related to impairment charges. Excluding the impairment charges, nursing center operating margins improved to 15.7% in the third quarter of 2011 and 15.8% for the nine months ended September 30, 2011 compared to 12.8% and 13.4% for the respective periods in 2010. The increase in operating margins in both periods was primarily attributable to higher reimbursement rates, increases in Medicare and managed care payor mix, and operating efficiencies associated with the growth in admissions. Management expects that operating margins will be significantly reduced beginning in the fourth quarter of 2011 as a result of the 2011 CMS Rules.

Average hourly wage rates increased 2% in both the third quarter and nine months ended September 30, 2011 compared to the same periods in 2010, while employee benefit costs increased 3% and 4% in the respective periods compared to the same periods in 2010.

Professional liability costs were $8 million and $7 million in the third quarter of 2011 and 2010, respectively, and $25 million and $23 million for the nine months ended September 30, 2011 and 2010, respectively.

Rehabilitation division

Skilled nursing rehabilitation services

Revenues increased 158% in the third quarter of 2011 to $268 million compared to $104 million in the same period of 2010 and increased 85% to $563 million for the nine months ended September 30, 2011 from $304 million in the same period in 2010. Revenue growth in both periods was primarily attributable to the Merger, and to a lesser extent, growth in new customers and the volume of services provided to existing customers. Revenues associated with the Merger were $137 million and $183 million for the third quarter and nine months ended September 30, 2011, respectively. Revenues derived from unaffiliated customers aggregated $209 million and $47 million in the third quarter of 2011 and 2010, respectively, and $387 million and $134 million for the nine months ended September 30, 2011 and 2010, respectively.

Operating margins improved to 10.7% in the third quarter of 2011 and 9.5% for the nine months ended September 30, 2011 compared to 9.1% and 9.3% for the respective periods of 2010, primarily attributable to the Merger and increased operating efficiencies. Management expects that operating margins will be significantly reduced beginning in the fourth quarter of 2011 as a result of the 2011 CMS Rules. Operating income associated with the Merger was $16 million and $21 million for the third quarter and nine months ended September 30, 2011, respectively.

Hospital rehabilitation services

Revenues increased 242% in the third quarter of 2011 to $69 million compared to $20 million in the same period of 2010 and increased 109% to $130 million for the nine months ended September 30, 2011 from $62 million in the same period in 2010. Revenue growth in both periods was primarily attributable to the Merger, and to a lesser extent, growth in new customers and the volume of services provided to existing customers.

 

50


Table of Contents

ITEM 2.    MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND

RESULTS OF OPERATIONS (Continued)

 

Results of Operations—Continuing Operations (Continued)

 

Hospital rehabilitation services (Continued)

 

Revenues associated with the Merger were $47 million for the third quarter of 2011 and $63 million for the nine months ended September 30, 2011. Revenues derived from unaffiliated customers aggregated $49 million and $1 million in the third quarter of 2011 and 2010, respectively, and $68 million and $3 million for the nine months ended September 30, 2011 and 2010, respectively.

Operating margins declined to 22.4% in the third quarter of 2011 and 22.2% for the nine months ended September 30, 2011 compared to 23.1% and 23.5% for the respective periods of 2010, primarily attributable to start-up costs associated with new contracts. Operating income associated with the Merger was $11 million for the third quarter of 2011 and $15 million for the nine months ended September 30, 2011.

Corporate overhead

Operating income for the Company’s operating divisions excludes allocations of corporate overhead. These costs aggregated $49 million and $34 million in the third quarter of 2011 and 2010, respectively, and $131 million and $101 million for the nine months ended September 30, 2011 and 2010, respectively. The increase in both periods was primarily attributable to the Merger. As a percentage of consolidated revenues, corporate overhead totaled 3.2% and 3.3% in the third quarter of 2011 and 2010, respectively, and totaled 3.3% and 3.1% for the nine months ended September 30, 2011 and 2010, respectively. Operating results for the nine months ended September 30, 2010 included approximately $1 million related to retirement costs.

Transaction costs

Operating results for the third quarter and nine months ended September 30, 2011 included transaction costs totaling $5 million and $29 million, respectively, primarily related to the Merger. Operating results for the third quarter and nine months ended September 30, 2011 also included severance costs totaling $1 million and $16 million, respectively, related to the Merger. Operating results for the third quarter and nine months ended September 30, 2010 included transaction costs totaling $1 million and $3 million, respectively.

Capital costs

Rent expense increased 18% to $106 million in the third quarter of 2011 compared to $89 million in the same period of 2010 and increased 10% to $293 million for the nine months ended September 30, 2011 from $267 million in the same period in 2010. The increase in both periods resulted primarily from the Merger, the Vista Acquisition, contractual inflation and contingent rent increases.

Depreciation and amortization expense increased 61% to $46 million in the third quarter of 2011 compared to $29 million in the same period of 2010 and increased 30% to $117 million for the nine months ended September 30, 2011 from $90 million in the same period in 2010. The increase in both periods resulted from the Merger, the Company’s ongoing capital expenditure program and its hospital development projects.

Interest expense increased to $26 million in the third quarter of 2011 compared to $1 million in the same period of 2010 and increased to $55 million for the nine months ended September 30, 2011 from $4 million in the same period in 2010. The increase in the third quarter and nine months ended September 30, 2011 was attributable to increased borrowings necessary to finance the Merger and higher interest rates compared to the same periods in 2010. Interest expense for the nine months ended September 30, 2011 included $14 million of Merger related financing costs.

 

51


Table of Contents

ITEM 2.    MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND

RESULTS OF OPERATIONS (Continued)

 

Results of Operations—Continuing Operations (Continued)

 

Consolidated results

Losses from continuing operations before income taxes aggregated $2 million in the third quarter of 2011 compared to income from continuing operations before income taxes of $4 million in the same period in 2010. Income from continuing operations before income taxes aggregated $26 million for the nine months ended September 30, 2011 compared to $57 million in the same period in 2010. Income from continuing operations aggregated $1 million in the third quarter of 2011 compared to $5 million in the same period in 2010. Income from continuing operations aggregated $17 million for the nine months ended September 30, 2011 compared to $36 million in the same period in 2010. Impairment charges totaling $27 million ($16 million net of income taxes) negatively impacted the consolidated pretax operating results for the third quarter and nine months ended September 30, 2011. Transaction, severance and financing costs primarily related to the Merger also negatively impacted the consolidated pretax operating results by $6 million ($4 million net of income taxes) for the third quarter of 2011 and $59 million ($38 million net of income taxes) for the nine months ended September 30, 2011. Transaction, severance and retirement costs (unrelated to the Merger) negatively impacted the consolidated pretax operating results by $1 million for the third quarter of 2010 and $6 million ($4 million net of income taxes) for the nine months ended September 30, 2010.

Results of Operations—Discontinued Operations

Income from discontinued operations totaled $1.1 million in the third quarter of 2011 compared to a loss from discontinued operations of $0.2 million in the third quarter of 2010. Income from discontinued operations totaled $1.5 million for the nine months ended September 30, 2011 compared to a loss from discontinued operations of $0.3 million for the nine months ended September 30, 2010.

Liquidity

Operating cash flows

Cash flows provided by operations (including discontinued operations) aggregated $118 million for the nine months ended September 30, 2011 compared to $151 million for the same period in 2010. Operating cash flows for the nine months ended September 30, 2011 were negatively impacted by $99 million ($77 million net of income taxes) of transaction, severance and financing payments, primarily related to the Merger. Transaction, severance and retirement payments (unrelated to the Merger) for the nine months ended September 30, 2010 were $4 million ($2 million net of income taxes). Operating cash flows also were negatively impacted by lower accounts receivable collections for the nine months ended September 30, 2011 compared to the same period in 2010, primarily as a result of temporary billing delays caused by information systems conversions related to the Merger. Operating cash flows in both periods were favorably impacted by federal income tax refunds of $25 million and $10 million for the nine months ended September 30, 2011 and 2010, respectively. During the nine months ended September 30, 2011, the Company maintained sufficient liquidity to finance its routine capital expenditures, ongoing development programs, and acquisition (excluding the Merger) and strategic development activities.

The Company utilizes its ABL Facility to meet working capital needs and finance its acquisition and development activities. As a result, the Company typically carries minimal amounts of cash on its consolidated balance sheet. Based upon the Company’s expected operating cash flows and the availability of borrowings under the Company’s ABL Facility ($367 million at September 30, 2011), management believes that the Company has the necessary financial resources to satisfy its expected short-term and long-term liquidity needs.

 

52


Table of Contents

ITEM 2.    MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND

RESULTS OF OPERATIONS (Continued)

 

Liquidity (Continued)

 

53

New credit facilities and notes

In connection with the Merger, the Company entered into the ABL Facility, the Term Loan Facility and the Notes. The Company used proceeds from the ABL Facility, the Term Loan Facility and the Notes to pay the Merger Consideration, repay all amounts outstanding under Kindred’s and RehabCare’s previous credit facilities and to pay transaction costs. The amounts outstanding under Kindred’s and RehabCare’s former credit facilities that were repaid at the Merger closing were $390 million and $345 million, respectively. The ABL Facility and the Term Loan Facility have incremental facility capacity in an aggregate amount between the two facilities of $200 million, subject to meeting certain conditions, including a specified senior secured leverage ratio. In connection with these new credit arrangements, the Company paid $46 million of lender fees related to debt issuance that were capitalized as deferred financing costs and paid $13 million of other financing costs that were charged to interest expense.

All obligations under the ABL Facility and the Term Loan Facility are fully and unconditionally guaranteed, subject to certain exceptions, by substantially all of the Company’s existing and future direct and indirect domestic 100% owned subsidiaries, as well as certain non-100% owned domestic subsidiaries as the Company may determine from time to time in its sole discretion. The Notes are guaranteed by substantially all of the Company’s domestic 100% owned subsidiaries.

The agreements governing the ABL Facility, the Term Loan Facility and the Notes include a number of restrictive covenants that, among other things and subject to certain exceptions and baskets, impose operating and financial restrictions on the Company and certain of its subsidiaries. In addition, the Company is required to comply with a minimum fixed charge coverage ratio and a maximum total leverage ratio. These financing agreements also contain customary affirmative covenants and events of default. The Company was in compliance with the terms of the ABL Facility, the Term Loan Facility and the Notes at September 30, 2011.

ABL Facility

The ABL Facility has a five-year tenor and is secured by the First Priority ABL Collateral. The ABL Facility has a second priority lien on substantially all of the other assets and properties of the Company. As of September 30, 2011, the Company had $249 million outstanding under the ABL Facility. In addition, approximately $13 million of letters of credit were issued under the ABL Facility to backstop outstanding letters of credit previously issued by RehabCare under its terminated credit facility.

Borrowings under the ABL Facility bear interest at a rate per annum equal to the applicable margin plus, at the Company’s option, either (1) LIBOR determined by reference to the costs of funds for eurodollar deposits for the interest period relevant to such borrowing adjusted for certain additional costs, or (2) a base rate determined by reference to the highest of (a) the prime rate of JPMorgan Chase Bank, N.A., (b) the federal funds effective rate plus one-half of 1.00% and (c) LIBOR as described in subclause (1) plus 1.00%. The initial applicable margin for borrowings under the ABL Facility was 2.75% with respect to LIBOR borrowings and 1.75% with respect to base rate borrowings. The applicable margin is subject to adjustment each fiscal quarter, based upon average historical excess availability during the preceding quarter.

Term Loan Facility

The Term Loan Facility has a tenor of seven years and is secured by a first priority lien on substantially all of the Company’s assets and properties other than the First Priority ABL Collateral and a second priority lien on the First Priority ABL Collateral. The Term Loan Facility net proceeds totaled $693 million, net of a $7 million original issue discount that will be amortized over the tenor of the Term Loan Facility.

Borrowings under the Term Loan Facility bear interest at a rate per annum equal to an applicable margin plus, at the Company’s option, either (1) LIBOR determined by reference to the costs of funds for eurodollar


Table of Contents

ITEM 2.    MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND

RESULTS OF OPERATIONS (Continued)

 

Liquidity (Continued)

 

Term Loan Facility (Continued)

 

deposits for the interest period relevant to such borrowing adjusted for certain additional costs, or (2) a base rate determined by reference to the highest of (a) the prime rate of JPMorgan Chase Bank, N.A., (b) the federal funds effective rate plus one-half of 1.00% and (c) LIBOR described in subclause (1) plus 1.00%. LIBOR is subject to an interest rate floor of 1.50%. The initial applicable margin for borrowings under the Term Loan Facility was 3.75% with respect to LIBOR borrowings and 2.75% with respect to base rate borrowings.

Notes

In connection with the Merger, the Company completed a private placement of the Notes. The Notes bear interest at an annual rate equal to 8.25% and are senior unsecured obligations of the Company and the subsidiary guarantors, ranking pari passu with all of their respective existing and future senior unsubordinated indebtedness. Pursuant to a registration rights agreement, the Company filed with the SEC a registration statement related to an offer to exchange the Notes for an issue of SEC-registered notes with substantially identical terms. The exchange offer commenced on October 13, 2011 and is currently scheduled to expire on November 10, 2011.

Other financing activities

As a result of improved professional liability underwriting results of the Company’s limited purpose insurance subsidiary, the Company received distributions of $3 million and $22 million during the nine months ended September 30, 2011 and 2010, respectively, from its limited purpose insurance subsidiary in accordance with applicable regulations. These distributions had no impact on earnings and the proceeds were used primarily to repay borrowings under the Company’s revolving credit facility.

Capital Resources

Excluding the Merger and acquisitions, routine capital expenditures (expenditures necessary to maintain existing facilities that generally do not increase capacity or add services) totaled $95 million for the nine months ended September 30, 2011 compared to $69 million for the same period in 2010. Hospital development capital expenditures (primarily new facility construction) totaled $54 million for the nine months ended September 30, 2011 compared to $29 million for the same period in 2010. Nursing and rehabilitation center development capital expenditures (primarily the addition of transitional care services for higher acuity patients and new facility construction) totaled $15 million for the nine months ended September 30, 2011 compared to $11 million for the same period in 2010. The Company anticipates that routine capital spending for 2011 should approximate $135 million to $140 million, hospital development capital spending should approximate $65 million to $70 million and nursing and rehabilitation center development capital spending should approximate $20 million to $25 million. Management expects that substantially all of these expenditures will be financed through internal sources.

Management believes that its capital expenditure program is adequate to improve and equip existing facilities. The Company’s capital expenditure program is financed generally through the use of internally generated funds. At September 30, 2011, the estimated cost to complete and equip construction in progress approximated $42 million.

The Merger purchase price totaled $963 million and was comprised of $662 million in cash and $301 million of Kindred common stock.

Excluding the Merger, the Company financed certain other acquisitions with either operating cash flows or revolving credit facility borrowings. These expenditures totaled $69 million for the nine months ended September 30, 2011 compared to $88 million for the same period in 2010.

 

54


Table of Contents

ITEM 2.    MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND

RESULTS OF OPERATIONS (Continued)

 

Other Information

Effects of inflation and changing prices

The Company derives a substantial portion of its revenues from the Medicare and Medicaid programs. Congress and certain state legislatures have enacted or may enact additional significant cost containment measures limiting the Company’s ability to recover its cost increases through increased pricing of its healthcare services. Medicare revenues in LTAC hospitals and nursing centers are subject to fixed payments under the Medicare prospective payment systems.

Medicaid reimbursement rates in many states in which the Company operates nursing and rehabilitation centers also are based upon fixed payment systems. Generally, these rates are adjusted annually for inflation. However, these adjustments may not reflect the actual increase in the costs of providing healthcare services.

Various healthcare reform provisions became law when the Patient Protection and Affordable Care Act was enacted on March 23, 2010 and the Healthcare Education and Reconciliation Act was enacted on March 30, 2010 (collectively, the Affordable Care Act (the “ACA”)). The reforms contained in the ACA will impact each of the Company’s businesses in some manner. Several of the reforms are very significant and could ultimately change the nature of the Company’s services, the methods of payment for the Company’s services and the underlying regulatory environment. The reforms include possible modifications to the conditions of qualification for payment, bundling payments to cover both acute and post-acute care and the imposition of enrollment limitations on new providers. In addition, a primary goal of healthcare reform is to reduce costs, which includes reductions in the reimbursement paid to the Company and other healthcare providers. Moreover, healthcare reform could negatively impact insurance companies, other third party payors, the Company’s customers, as well as other healthcare providers, which may in turn negatively impact the Company’s business. As such, these healthcare reforms or other similar healthcare reforms could have a material adverse effect on the Company’s business, financial position, results of operations and liquidity.

The ACA enacted a series of reductions to the annual market basket payment updates for LTAC hospitals. In addition to specific market basket reductions, Congress has mandated that the annual market basket payment update for a variety of providers, including both LTAC hospitals and nursing centers, be reduced for a “productivity adjustment” determined by CMS. These productivity adjustments may vary and will be determined annually by CMS. The productivity adjustments for LTAC hospitals and nursing centers were implemented on October 1, 2011.

The Budget Control Act of 2011, enacted on August 2, 2011, increased the United States debt ceiling in connection with deficit reductions over the next ten years. The Budget Control Act of 2011 also establishes a 12 member joint committee of Congress known as the Joint Select Committee on Deficit Reduction. The goal of the Joint Select Committee on Deficit Reduction is to propose legislation to reduce the United States federal deficit by $1.5 trillion for fiscal years 2012 to 2021. Reductions in Medicare and Medicaid spending could be included as part of these deficit reduction measures. Moreover, if such legislation is not enacted by December 23, 2011, approximately $1.2 trillion in domestic and defense spending reductions will automatically begin January 1, 2013, split evenly between domestic and defense spending. Payments to Medicare providers would be subject to these automatic spending reductions, subject to a 2% cap. At this time it is unclear how this automatic reduction may be applied to various Medicare healthcare programs. Reductions to Medicare and Medicaid reimbursement from the Budget Control Act of 2011 could have a material adverse effect on the Company’s business, financial position, results of operations or liquidity.

The Long-Term Acute Care Prospective Payment System (“LTAC PPS”) maintains LTAC hospitals as a distinct provider type, separate from short-term acute care hospitals. Only providers certified as LTAC hospitals may be paid under this system. To maintain certification under LTAC PPS, the average length of stay of fee for service Medicare patients must be at least 25 days.

 

55


Table of Contents

ITEM 2.    MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND

RESULTS OF OPERATIONS (Continued)

 

Other Information (Continued)

 

Effects of inflation and changing prices (Continued)

 

CMS is currently evaluating various certification criteria for designating a hospital as a LTAC hospital. If such certification criteria were developed and enacted into legislation, the Company’s hospitals may not be able to maintain their status as LTAC hospitals or may need to adjust their operations.

The SCHIP Extension Act became law on December 29, 2007. This legislation provides for, among other things:

 

  (1) a mandated study by the Secretary of Health and Human Services on the establishment of LTAC hospital certification criteria;

 

  (2) enhanced medical necessity review of LTAC hospital cases;

 

  (3) a three-year moratorium on the establishment of a LTAC hospital or satellite facility, subject to exceptions for facilities under development;

 

  (4) a three-year moratorium on an increase in the number of licensed beds at a LTAC hospital or satellite facility, subject to exceptions for states where there is only one other LTAC hospital and upon request following the closure or decrease in the number of licensed beds at a LTAC hospital within the state;

 

  (5) a three-year moratorium on the application of a one-time budget neutrality adjustment to payment rates to LTAC hospitals under LTAC PPS;

 

  (6) a three-year moratorium on very short-stay outlier payment reductions to LTAC hospitals initially implemented on May 1, 2007;

 

  (7) a three-year moratorium on the application of the policy known as the “25 Percent Rule” (described below) to freestanding LTAC hospitals;

 

  (8) a three-year period during which LTAC hospitals that are co-located with another hospital may admit up to 50% of their patients from their co-located hospital and still be paid according to LTAC PPS;

 

  (9) a three-year period during which LTAC hospitals that are co-located with an urban single hospital or a hospital that generates more than 25% of the Medicare discharges in a metropolitan statistical area (“MSA Dominant hospital”) may admit up to 75% of their patients from such urban single hospital or MSA Dominant hospital and still be paid according to LTAC PPS; and

 

  (10) the elimination of the July 1, 2007 market basket increase in the standard federal payment rate of 0.71%, effective for discharges occurring on or after April 1, 2008.

The ACA revised certain provisions of the SCHIP Extension Act. The moratoriums on the establishment of new LTAC hospitals or satellites and bed increases at LTAC hospitals or satellites, the application of a one-time budget neutrality adjustment to rates, the payment reductions due to the very short-stay outlier provisions and application of the “25 Percent Rule” to freestanding hospitals have been extended from three years to five years. In addition, the periods during which LTAC hospitals may admit up to 50% of their patients from co-located hospitals and during which LTAC hospitals may admit up to 75% of their patients from a MSA Dominant hospital have been extended from three years to five years as well.

CMS has regulations governing payments to LTAC hospitals that are co-located with another hospital (a “HIH”). The rules generally limit Medicare payments to the HIH if the Medicare admissions to the HIH from its co-located hospital exceed 25% of the total Medicare discharges for the HIH’s cost reporting period, the “25 Percent Rule.” There are limited exceptions for admissions from rural, urban single and MSA Dominant

 

56


Table of Contents

ITEM 2.    MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND

RESULTS OF OPERATIONS (Continued)

 

Other Information (Continued)

 

Effects of inflation and changing prices (Continued)

 

hospitals. Admissions that exceed this “25 Percent Rule” are paid using the short-term acute care inpatient payment system (“IPPS”). Patients transferred after they have reached the short-term acute care outlier payment status are not counted toward the admission threshold. Patients admitted prior to meeting the admission threshold, as well as Medicare patients admitted from a non co-located hospital, are eligible for the full payment under LTAC PPS. If the HIH’s admissions from the co-located hospital exceed the limit in a cost reporting period, Medicare will pay the lesser of (1) the amount payable under LTAC PPS or (2) the amount payable under IPPS. At September 30, 2011, the Company operated 29 HIHs with 1,148 licensed beds.

On May 1, 2007, CMS issued regulatory changes regarding Medicare reimbursement for LTAC hospitals (the “2007 Final Rule”). In the 2007 Final Rule, the “25 Percent Rule” was expanded to all LTAC hospitals, regardless of whether they are co-located with another hospital. Under the 2007 Final Rule, all LTAC hospitals were to be paid LTAC PPS rates for admissions from a single referral source up to 25% of aggregate Medicare admissions. Patients reaching high cost outlier status in the short-term hospital were not to be counted when computing the 25% limit. Admissions beyond the 25% threshold were to be paid at a lower amount based upon IPPS. However, as set forth above, the SCHIP Extension Act initially placed a three-year moratorium on the expansion of the “25 Percent Rule” to freestanding hospitals. That moratorium was extended to five years by the ACA. In addition, the SCHIP Extension Act initially provided for a three-year period during which (1) LTAC hospitals may admit up to 50% of their patients from their co-located hospitals and still be paid according to LTAC PPS; and (2) LTAC hospitals that are co-located with an urban single hospital or a MSA Dominant hospital may admit up to 75% of their patients from such urban single or MSA Dominant hospital and still be paid according to LTAC PPS. Those periods also were extended to five years under the ACA. The five-year moratorium of the “25 Percent Rule” threshold payment adjustment for freestanding hospitals and grandfathered HIHs will expire for cost reporting periods beginning on or after July 1, 2012. The expansion of the admission limit to 50% for non-grandfathered LTAC hospitals from their co-located hospital will expire for cost reports beginning on or after October 1, 2012, the same time at which the 75% limit for MSA Dominant hospitals will expire.

On July 31, 2009, CMS issued final regulations regarding Medicare reimbursement for LTAC hospitals for the fiscal year beginning October 1, 2009. Included in those final regulations is (1) a market basket increase to the standard federal payment rate of 2.5%; (2) an offset of 0.5% applied to the standard federal payment rate to account for the effect of documentation and coding changes; (3) adjustments to area wage indexes; and (4) a decrease in the high cost outlier threshold per discharge to $18,425. These final regulations also include a recalibration of the diagnostic categories called Medicare Severity Diagnosis Related Groups or more specifically, for LTAC hospitals, “MS-LTC-DRGs,” payment weights. CMS indicated that all of these changes will result in a 3.3% increase to average Medicare payments to LTAC hospitals. The 2.7% annualized reduction that resulted from a recalibration of MS-LTC-DRG payment weights on June 3, 2009 is incorporated into the final October 1, 2009 payment weights. On April 1, 2010, CMS reduced the October 1, 2009 standard federal payment rate by 0.25% as mandated by the ACA. In addition to specific market basket reductions, Congress has mandated that the annual market basket payment update for a variety of providers, including LTAC hospitals, be reduced for a “productivity adjustment” determined by CMS. These productivity adjustments may vary and will be determined annually by CMS. The productivity adjustments for LTAC hospitals were implemented on October 1, 2011.

On July 30, 2010, CMS issued final regulations regarding Medicare reimbursement for LTAC hospitals for the fiscal year beginning October 1, 2010. Included in those final regulations is (1) a market basket increase to the standard federal payment rate of 2.5%; (2) an offset of 2.5% applied to the standard federal payment rate to

 

57


Table of Contents

ITEM 2.    MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND

RESULTS OF OPERATIONS (Continued)

 

Other Information (Continued)

 

Effects of inflation and changing prices (Continued)

 

account for the effect of documentation and coding changes; (3) an offset of 0.5% applied to the standard federal payment rate as mandated by the ACA; (4) adjustments to area wage indexes; and (5) an increase in the high cost outlier threshold per discharge to $18,785. CMS indicated that all of these changes will result in a 0.5% increase to average Medicare payments to LTAC hospitals.

On August 1, 2011, CMS issued final regulations regarding Medicare reimbursement for LTAC hospitals for the fiscal year beginning October 1, 2011. Included in the final regulations is (1) a market basket increase to the standard federal payment rate of 2.9%; (2) offsets to the standard federal payment rate mandated by the ACA of: (a) 1.0% to account for the effect of a productivity adjustment, and (b) 0.1% as required by statute; (3) a wage level budget neutrality factor of 0.99775 applied to the adjusted standard federal payment rate; (4) adjustments to area wage indexes; and (5) a decrease in the high cost outlier threshold per discharge to $17,931. CMS has projected the impact of these proposed changes will result in a 2.5% increase to average Medicare payments to LTAC hospitals. Management believes that the impact of these proposed changes to LTAC PPS would result in an approximate 0.7% increase in payments to the Company’s LTAC hospitals.

On August 2, 2011, the Long-Term Care Hospital Improvement Act of 2011 was introduced into the United States Senate (the “LTAC Legislation”). If enacted, the LTAC Legislation would implement new patient and facility criteria for LTAC hospitals and alleviate the negative impact of various scheduled Medicare reimbursement adjustments. The LTAC Legislation provides for patient criteria to ensure that LTAC hospital patients are physician screened prior to admission and throughout their stay for the appropriateness of their stay in a LTAC hospital. In addition, facility criteria would establish common requirements for the programmatic, personnel and clinical operations of a LTAC hospital. The LTAC Legislation further provides that at least 70% of patients must be medically complex in order for a hospital to maintain its Medicare certification as a LTAC hospital. The LTAC Legislation also would repeal the “25 Percent Rule” for all LTAC hospitals, the scheduled very short-stay outlier payment reductions and the one-time budget neutrality adjustment requirement. There can be no assurances that the LTAC Legislation will be enacted in its current form or at all.

The Company cannot predict the ultimate long-term impact of LTAC PPS. This payment system is subject to significant change. Slight variations in patient acuity or length of stay could significantly change Medicare revenues generated under LTAC PPS. In addition, the Company’s hospitals may not be able to appropriately adjust their operating costs to changes in patient acuity and length of stay or to changes in reimbursement rates. In addition, there can be no assurance that LTAC PPS will not have a material adverse effect on revenues from commercial third party payors. Various factors, including a reduction in average length of stay, have negatively impacted revenues from commercial third party payors in recent years.

On July 29, 2011, CMS issued final regulations regarding Medicare reimbursement for IRFs for the fiscal year beginning October 1, 2011. Included in those proposed regulations is (1) a market basket increase to the standard payment conversion factor of 2.9%; (2) offsets to the standard payment conversion factor mandated by the ACA of: (a) 1.0% to account for the effect of a productivity adjustment, and (b) 0.1% as required by statute; (3) a wage level budget neutrality factor of 0.9988 applied to the standard payment conversion factor; (4) a case mix group budget neutrality factor of 0.9988 applied to the standard payment conversion factor; (5) adjustments to area wage indexes; and (6) a decrease in the high cost outlier threshold per discharge to $10,660. CMS has projected the impact of these proposed changes will result in a 2.2% increase to average Medicare payments to IRFs.

On July 31, 2009, CMS issued final regulations regarding Medicare reimbursement for nursing centers for the fiscal year beginning October 1, 2009. Included in these regulations are (1) a market basket increase to the

 

58


Table of Contents

ITEM 2.    MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND

RESULTS OF OPERATIONS (Continued)

 

Other Information (Continued)

 

Effects of inflation and changing prices (Continued)

 

federal payment rates of 2.2%; (2) updates to the wage indexes which adjust the federal payment; and (3) a reduction in the resource utilization groups (“RUG”) indexes attributed to a CMS forecast error in a prior year, resulting in a 3.3% reduction in payments. CMS estimated that these changes will result in a net decrease in Medicare payments to nursing and rehabilitation centers of 1.1%. In addition to specific market basket reductions, Congress has mandated that the annual market basket payment update for a variety of providers, including nursing centers, be reduced for a “productivity adjustment” determined by CMS. These productivity adjustments may vary and will be determined annually by CMS. The productivity adjustments for nursing centers were implemented on October 1, 2011.

On July 16, 2010, CMS issued a notice that updates the payment rates for nursing centers for the fiscal year beginning October 1, 2010. That notice provided for an increase in rates of 1.7%, which is comprised of a market basket increase of 2.3% less a forecast error adjustment of 0.6%.

In addition, for the fiscal year beginning October 1, 2010, CMS finalized provisions that increase the number of RUG categories for nursing centers from 53 to 66 (i.e., RUGs IV) and amend the criteria, including the provision of therapy services, used to classify patients into these categories. CMS has indicated that these changes will be enacted in a budget neutral manner.

The therapy requirements to qualify for rehabilitation RUG categories are unchanged under RUGs IV, however, the regulatory changes altered how minutes were allocated to calculate the RUGs scores using the most recent clinical assessment tool of the minimum data set (“MDS 3.0”). Rather than count all therapy time that a nursing center patient receives, rehabilitation providers must now allocate therapy minutes between the patients being served during concurrent therapy sessions. In addition, the number of patients that a therapist/assistant may treat concurrently is limited to two patients. Additional tracking provisions also require therapists to track and report different delivery modes of therapy (individual, concurrent and group therapy) on MDS 3.0. The Company’s rehabilitation division has hired additional therapists to facilitate the provision of additional individual minutes as clinically appropriate. Effective October 1, 2010, CMS began paying claims using the RUGs IV system.

CMS issued the 2011 CMS Rules on July 29, 2011 updating Medicare payment rates for skilled nursing centers effective October 1, 2011. The 2011 CMS Rules impose (1) a negative adjustment to RUGs IV therapy rates, and (2) a net market basket increase of 1.7% consisting of (a) a 2.7% market basket inflation increase, less (b) a 1.0% adjustment to account for the effect of a productivity adjustment, beginning on October 1, 2011. CMS has projected the impact of these changes will result in an 11.1% decrease in payments to skilled nursing centers. Based upon the Company’s review of the 2011 CMS Rules, the Company believes that its nursing center Medicare rates could decline by as much as 15% in 2012. In addition to these rate changes, the 2011 CMS Rules introduced additional changes to RUG calculations along with adding additional assessments. Under the 2011 CMS Rules, group therapy is defined as therapy sessions with four patients who are performing similar therapy activities. In addition, for purposes of assigning patients to RUGs IV payment categories, the minutes of group therapy are divided by four with 25% of the minutes being allocated to each patient, consistent with the rules for concurrent therapy that have been in place since October 1, 2010. The 2011 CMS Rules also clarify the circumstances for reporting breaks in care of three or more days of therapy and also implement a new change of therapy assessment that is designed to allocate the patient to the RUG level that represents the treatment provided in the last seven days. Both changes are likely to produce alterations in the RUG scores billed for the patient along with generating additional assessments. Management believes that the 2011 CMS Rules could reduce the Company’s annual revenues by approximately $95 million to $105 million in its nursing center

 

59


Table of Contents

ITEM 2.    MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND

RESULTS OF OPERATIONS (Continued)

 

Other Information (Continued)

 

Effects of inflation and changing prices (Continued)

 

business and approximately $10 million to $15 million in its rehabilitation therapy business. In addition, management believes that other technical changes required under the 2011 CMS Rules may increase rehabilitation therapy costs by approximately $20 million to $25 million on an annual basis.

On November 2, 2010, CMS issued a final rule related to rate changes to Medicare Part B therapy services included in the Medicare Physician Fee Schedule (“MPFS”) rule. The rule became effective January 1, 2011. The rule provides for a rate reduction for reimbursement of therapy expenses for secondary procedures when multiple therapy services are provided on the same day. CMS projects that the rule will result in an approximate 7% rate reduction for Medicare Part B therapy services in calendar year 2011. Based upon the Company’s historical Medicare Part B therapy services data, the Company estimates that this rule will reduce its Medicare revenues related to Part B therapy services by approximately $7 million per year beginning in 2011.

Medicare Part B provides reimbursement for certain physician services, limited drug coverage and other outpatient services, such as therapy and other services, outside of a Medicare Part A covered patient stay. Payment for these services is determined according to MPFS. Annually since 1997, the MPFS has been subject to a sustainable growth rate adjustment (“SGR”) intended to keep spending growth in line with allowable spending. Each year since the SGR was enacted, this adjustment produced a scheduled negative update to payment for physicians, therapists and other healthcare providers paid under the MPFS. Annually, since 2002, Congress has stepped in with so-called “doc fix” legislation to stop payment cuts to physicians. In December 2010, Congress passed the Medicare and Medicaid Extenders Act of 2010 (“MMEA”) which again suspended the payment cut for 2011.

Since 2006, federal legislation has provided for an annual Medicare Part B outpatient therapy cap. In succeeding years, CMS subsequently increased the amount of the therapy cap. Legislation also was passed that required CMS to implement a broad process for reviewing medically necessary therapy claims, creating an exception to the cap. Legislation has annually extended the Medicare Part B outpatient therapy cap exception process. The Medicare Improvements for Patients and Providers Act of 2008, enacted on July 15, 2008, extended the therapy cap exception process from July 1, 2008 to December 31, 2009. The ACA provided that the exception process remain in effect from January 1, 2010 through December 31, 2010. MMEA extended the therapy cap exception process through December 31, 2011.

The Company believes that its operating margins will continue to be under pressure as the growth in operating expenses, particularly professional liability, labor and employee benefits costs, exceeds payment increases from third party payors. In addition, as a result of competitive pressures, the Company’s ability to maintain operating margins through price increases to private patients is limited.

 

60


Table of Contents

ITEM 2.    MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND

RESULTS OF OPERATIONS (Continued)

 

Condensed Consolidated Statement of Operations

(Unaudited)

(In thousands, except per share amounts)

 

     2010 Quarters     2011 Quarters  
     First     Second     Third     Fourth     First     Second     Third  

Revenues

   $ 1,089,837      $ 1,081,364      $ 1,053,012      $ 1,135,484      $ 1,192,421      $ 1,292,592      $ 1,514,062   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Salaries, wages and benefits

     627,175        612,205        613,607        652,703        678,695        765,133        900,570   

Supplies

     85,886        85,455        83,753        87,103        90,022        96,718        107,514   

Rent

     88,319        88,981        89,295        90,777        91,453        95,677        105,511   

Other operating expenses

     234,204        238,687        234,968        240,750        259,369        287,132        332,017   

Other income

     (3,084     (2,857     (2,794     (2,687     (2,785     (2,880     (2,815

Depreciation and amortization

     31,121        29,852        29,167        31,412        32,549        37,871        46,947   

Interest expense

     1,307        1,298        1,642        2,843        5,728        23,157        25,790   

Investment (income) loss

     (877     377        (403     (342     (495     (257     (37
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
     1,064,051        1,053,998        1,049,235        1,102,559        1,154,536        1,302,551        1,515,497   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Income (loss) from continuing operations before income taxes

     25,786        27,366        3,777        32,925        37,885        (9,959     (1,435

Provision (benefit) for income taxes

     10,631        11,230        (1,323     13,170        15,609        (3,419     (2,342
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Income (loss) from continuing operations

     15,155        16,136        5,100        19,755        22,276        (6,540     907   

Discontinued operations, net of income taxes:

              

Income (loss) from operations

     (154     87        (260     1,125        (179     587        1,119   

Gain (loss) on divestiture of operations

     (137     54        86        (456     —          —          —     
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Income (loss) from discontinued operations

     (291     141        (174     669        (179     587        1,119   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net income (loss)

     14,864        16,277        4,926        20,424        22,097        (5,953     2,026   

(Earnings) loss attributable to noncontrolling interest

     —          —          —          —          —          421        (241
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Income (loss) attributable to Kindred

   $ 14,864      $ 16,277      $ 4,926      $ 20,424      $ 22,097      $ (5,532   $ 1,785   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Amounts attributable to Kindred stockholders:

              

Income (loss) from continuing operations

   $ 15,155      $ 16,136      $ 5,100      $ 19,755      $ 22,276      $ (6,119   $ 666   

Income (loss) from discontinued operations

     (291     141        (174     669        (179     587        1,119   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Income (loss) attributable to Kindred

   $ 14,864      $ 16,277      $ 4,926      $ 20,424      $ 22,097      $ (5,532   $ 1,785   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Earnings (loss) per common share:

              

Basic:

              

Income (loss) from continuing operations

   $ 0.38      $ 0.41      $ 0.13      $ 0.50      $ 0.56      $ (0.14   $ 0.01   

Discontinued operations:

              

Income (loss) from operations

     —          —          (0.01     0.03        —          0.01        0.02   

Gain (loss) on divestiture of operations

     —          —          —          (0.01     —          —          —     
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net income (loss)

   $ 0.38      $ 0.41      $ 0.12      $ 0.52      $ 0.56      $ (0.13   $ 0.03   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Diluted:

              

Income (loss) from continuing operations

   $ 0.38      $ 0.41      $ 0.13      $ 0.50      $ 0.55      $ (0.14   $ 0.01   

Discontinued operations:

              

Income (loss) from operations

     —          —          (0.01     0.03        —          0.01        0.02   

Gain (loss) on divestiture of operations

     —          —          —          (0.01     —          —          —     
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net income (loss)

   $ 0.38      $ 0.41      $ 0.12      $ 0.52      $ 0.55      $ (0.13   $ 0.03   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Shares used in computing earnings (loss) per common share:

              

Basic

     38,626        38,756        38,778        38,790        39,035        43,231        51,329   

Diluted

     38,859        38,914        38,838        39,089        39,543        43,231        51,406   

 

61


Table of Contents

ITEM 2.    MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND

RESULTS OF OPERATIONS (Continued)

 

Operating Data

(Unaudited)

(In thousands)

 

     2010 Quarters     2011 Quarters  
     First     Second     Third     Fourth     First     Second     Third  

Revenues:

              

Hospital division

   $ 507,062      $ 493,401      $ 465,198      $ 507,660      $ 558,974      $ 593,425      $ 684,781   

Nursing center division

     539,321        542,215        539,914        566,435        567,472        568,199        571,226   

Rehabilitation division:

              

Skilled nursing rehabilitation services

     98,997        101,148        103,807        117,325        122,656        172,074        267,993   

Hospital rehabilitation services

     21,147        20,913        20,436        21,182        22,490        38,291        69,811   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
     120,144        122,061        124,243        138,507        145,146        210,365        337,804   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
     1,166,527        1,157,677        1,129,355        1,212,602        1,271,592        1,371,989        1,593,811   

Eliminations:

              

Skilled nursing rehabilitation services

     (56,464     (56,279     (56,841     (57,084     (57,946     (58,691     (59,221

Hospital rehabilitation services

     (20,226     (20,034     (19,502     (20,034     (21,225     (20,706     (20,528
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
     (76,690     (76,313     (76,343     (77,118     (79,171     (79,397     (79,749
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
   $ 1,089,837      $ 1,081,364      $ 1,053,012      $ 1,135,484      $ 1,192,421      $ 1,292,592      $ 1,514,062   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Income (loss) from continuing operations:

              

Operating income (loss):

              

Hospital division

   $ 95,440      $ 91,790      $ 75,784      $ 97,343      $ 108,385      $ 108,465      $ 122,599 (a) 

Nursing center division

     70,614        76,529        69,363        86,912        87,350        93,532        65,982 (a) 

Rehabilitation division:

              

Skilled nursing rehabilitation services

     9,537        9,307        9,486        5,307        9,149        15,531        28,682   

Hospital rehabilitation services

     5,146        4,793        4,728        4,302        5,332        8,033        15,606   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
     14,683        14,100        14,214        9,609        14,481        23,564        44,288   

Corporate:

              

Overhead

     (33,831     (32,799     (34,329     (33,002     (38,315     (43,801     (48,806

Insurance subsidiary

     (480     (791     (783     (1,099     (602     (420     (750
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
     (34,311     (33,590     (35,112     (34,101     (38,917     (44,221     (49,556

Transaction costs (b)

     (770     (955     (771     (2,148     (4,179     (34,851     (6,537
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Operating income

     145,656        147,874        123,478        157,615        167,120        146,489        176,776   

Rent

     (88,319     (88,981     (89,295     (90,777     (91,453     (95,677     (105,511

Depreciation and amortization

     (31,121     (29,852     (29,167     (31,412     (32,549     (37,871     (46,947

Interest, net

     (430     (1,675     (1,239     (2,501     (5,233     (22,900     (25,753
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Income (loss) from continuing operations before income taxes

     25,786        27,366        3,777        32,925        37,885        (9,959     (1,435

Provision (benefit) for income taxes

     10,631        11,230        (1,323     13,170        15,609        (3,419     (2,342
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
   $ 15,155      $ 16,136      $ 5,100      $ 19,755      $ 22,276      $ (6,540   $ 907   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

 

(a) Includes impairment charges of $3.1 million for the hospital division and $23.6 million for the nursing center division.
(b) Transaction-related charges for the 2010 periods have been reclassified to conform with the current period presentation.

 

62


Table of Contents

ITEM 2.    MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND

RESULTS OF OPERATIONS (Continued)

 

Operating Data (Continued)

(Unaudited)

(In thousands)

 

     2010 Quarters      2011 Quarters  
     First      Second      Third      Fourth      First      Second      Third  

Rent:

                    

Hospital division

   $ 37,415       $ 38,043       $ 38,122       $ 39,406       $ 40,299       $ 43,997       $ 52,737   

Nursing center division

     49,392         49,439         49,627         49,647         49,384         49,562         49,862   

Rehabilitation division:

                    

Skilled nursing rehabilitation services

     1,449         1,445         1,474         1,662         1,698         1,791         2,169   

Hospital rehabilitation services

     26         25         28         27         28         33         95   
  

 

 

    

 

 

    

 

 

    

 

 

    

 

 

    

 

 

    

 

 

 
     1,475         1,470         1,502         1,689         1,726         1,824         2,264   

Corporate

     37         29         44         35         44         294         648   
  

 

 

    

 

 

    

 

 

    

 

 

    

 

 

    

 

 

    

 

 

 
   $ 88,319       $ 88,981       $ 89,295       $ 90,777       $ 91,453       $ 95,677       $ 105,511   
  

 

 

    

 

 

    

 

 

    

 

 

    

 

 

    

 

 

    

 

 

 

Depreciation and amortization:

                    

Hospital division

   $ 13,014       $ 12,549       $ 12,655       $ 13,421       $ 14,278       $ 16,572       $ 21,612   

Nursing center division

     12,113         11,185         10,527         11,646         11,793         13,038         12,655   

Rehabilitation division:

                    

Skilled nursing rehabilitation services

     523         558         591         731         759         1,339         3,023   

Hospital rehabilitation services

     62         68         77         99         97         819         2,372   
  

 

 

    

 

 

    

 

 

    

 

 

    

 

 

    

 

 

    

 

 

 
     585         626         668         830         856         2,158         5,395   

Corporate

     5,409         5,492         5,317         5,515         5,622         6,103         7,285   
  

 

 

    

 

 

    

 

 

    

 

 

    

 

 

    

 

 

    

 

 

 
   $ 31,121       $ 29,852       $ 29,167       $ 31,412       $ 32,549       $ 37,871       $ 46,947   
  

 

 

    

 

 

    

 

 

    

 

 

    

 

 

    

 

 

    

 

 

 

Capital expenditures, excluding acquisitions (including discontinued operations):

                    

Hospital division:

                    

Routine

   $ 6,065       $ 7,954       $ 9,113       $ 13,835       $ 12,144       $ 11,809       $ 12,919   

Development

     5,774         10,209         12,900         12,257         7,777         6,423         39,964   
  

 

 

    

 

 

    

 

 

    

 

 

    

 

 

    

 

 

    

 

 

 
     11,839         18,163         22,013         26,092         19,921         18,232         52,883   

Nursing center division:

                    

Routine

     4,049         9,135         11,548         12,292         8,155         8,000         10,572   

Development

     1,793         2,079         7,464         15,365         3,322         7,705         4,113   
  

 

 

    

 

 

    

 

 

    

 

 

    

 

 

    

 

 

    

 

 

 
     5,842         11,214         19,012         27,657         11,477         15,705         14,685   

Rehabilitation division:

                    

Skilled nursing rehabilitation services:

                    

Routine

     228         258         328         1,608         255         217         296   

Development

     —           —           —           —           10         181         75   
  

 

 

    

 

 

    

 

 

    

 

 

    

 

 

    

 

 

    

 

 

 
     228         258         328         1,608         265         398         371   

Hospital rehabilitation services:

                    

Routine

     39         23         23         208         25         72         81   

Development

     —           —           —           —           —           —           —     
  

 

 

    

 

 

    

 

 

    

 

 

    

 

 

    

 

 

    

 

 

 
     39         23         23         208         25         72         81   

Corporate:

                    

Information systems

     4,146         7,853         6,625         11,162         3,932         13,641         11,516   

Other

     288         447         986         683         207         211         1,211   
  

 

 

    

 

 

    

 

 

    

 

 

    

 

 

    

 

 

    

 

 

 
   $ 22,382       $ 37,958       $ 48,987       $ 67,410       $ 35,827       $ 48,259       $ 80,747   
  

 

 

    

 

 

    

 

 

    

 

 

    

 

 

    

 

 

    

 

 

 

 

63


Table of Contents

ITEM 2.    MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND

RESULTS OF OPERATIONS (Continued)

 

Condensed Consolidating Statement of Operations

(Unaudited)

(In thousands)

 

    Three months ended September 30, 2011  
                Rehabilitation division                          
    Hospital
division  (a)
    Nursing
center
division (a)
    Skilled
nursing
services
    Hospital
services
    Total     Corporate     Transaction
costs
    Eliminations     Consolidated  

Revenues

  $ 684,781      $ 571,226      $ 267,993      $ 69,811      $ 337,804      $ —        $ —        $ (79,749   $ 1,514,062   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Salaries, wages and benefits

    316,507        272,505        227,577        49,262        276,839        33,482        1,256        (19     900,570   

Supplies

    77,045        28,650        1,506        62        1,568        251        —          —          107,514   

Rent

    52,737        49,862        2,169        95        2,264        648        —          —          105,511   

Other operating expenses

    168,630        204,089        10,228        4,881        15,109        18,638        5,281        (79,730     332,017   

Other income

    —          —          —          —          —          (2,815     —          —          (2,815

Depreciation and amortization

    21,612        12,655        3,023        2,372        5,395        7,285        —          —          46,947   

Interest expense

    206        25        —          —          —          25,559        —          —          25,790   

Investment income

    (1     (18     (1     (1     (2     (16     —          —          (37
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
    636,736        567,768        244,502        56,671        301,173        83,032        6,537        (79,749     1,515,497   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Income (loss) from continuing operations before income taxes

  $ 48,045      $ 3,458      $ 23,491      $ 13,140      $ 36,631      $ (83,032   $ (6,537   $ —          (1,435
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

Income tax benefit

                    (2,342
                 

 

 

 

Income from continuing operations

                  $ 907   
                 

 

 

 

 

    Three months ended September 30, 2010  
                Rehabilitation division                          
    Hospital
division
    Nursing
center
division
    Skilled
nursing
services
    Hospital
services
    Total     Corporate     Transaction
costs
    Eliminations     Consolidated  

Revenues

  $ 465,198      $ 539,914      $ 103,807      $ 20,436      $ 124,243      $ —        $ —        $ (76,343   $ 1,053,012   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Salaries, wages and benefits

    215,590        267,665        89,923        15,040        104,963        25,403        —          (14     613,607   

Supplies

    55,189        27,559        836        24        860        145        —          —          83,753   

Rent

    38,122        49,627        1,474        28        1,502        44        —          —          89,295   

Other operating expenses

    118,635        175,327        3,562        644        4,206        12,358        771        (76,329     234,968   

Other income

    —          —          —          —          —          (2,794     —          —          (2,794

Depreciation and amortization

    12,655        10,527        591        77        668        5,317        —          —          29,167   

Interest expense

    —          36        —          —          —          1,606        —          —          1,642   

Investment income

    —          (21     —          —          —          (382     —          —          (403
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
    440,191        530,720        96,386        15,813        112,199        41,697        771        (76,343     1,049,235   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Income from continuing operations before income taxes

  $ 25,007      $ 9,194      $ 7,421      $ 4,623      $ 12,044      $ (41,697   $ (771   $ —          3,777   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

Income tax benefit

                    (1,323
                 

 

 

 

Income from continuing operations

                  $ 5,100   
                 

 

 

 

 

(a) Includes $26.7 million in aggregate of impairment charges in other operating expenses (hospital division — $3.1 million and nursing center division — $23.6 million).

 

64


Table of Contents

ITEM 2.    MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND

RESULTS OF OPERATIONS (Continued)

 

Condensed Consolidating Statement of Operations (Continued)

(Unaudited)

(In thousands)

 

    Nine months ended September 30, 2011  
                Rehabilitation division                          
    Hospital
division
    Nursing
center
division
    Skilled
nursing
services
    Hospital
services
    Total     Corporate     Transaction
costs
    Eliminations     Consolidated  

Revenues

  $ 1,837,180      $ 1,706,897      $ 562,723      $ 130,592      $ 693,315      $ —        $ —        $ (238,317   $ 3,999,075   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Salaries, wages and benefits

    842,829        816,022        483,996        93,996        577,992        91,502        16,122        (69     2,344,398   

Supplies

    206,504        83,645        3,396        122        3,518        587        —          —          294,254   

Rent

    137,033        148,808        5,658        156        5,814        986        —          —          292,641   

Other operating expenses

    448,398        560,366        21,969        7,503        29,472        49,085        29,445        (238,248     878,518   

Other income

    —          —          —          —          —          (8,480     —          —          (8,480

Depreciation and amortization

    52,462        37,486        5,121        3,288        8,409        19,010        —          —          117,367   

Interest expense

    272        76        —          —          —          40,525        13,802        —          54,675   

Investment income

    (4     (58     (3     (1     (4     (723     —          —          (789
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
    1,687,494        1,646,345        520,137        105,064        625,201        192,492        59,369        (238,317     3,972,584   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Income from continuing operations before income taxes

  $ 149,686      $ 60,552      $ 42,586      $ 25,528      $ 68,114      $ (192,492   $ (59,369   $ —          26,491   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

Provision for income taxes

                    9,848   
                 

 

 

 

Income from continuing operations

                  $ 16,643   
                 

 

 

 

 

    Nine months ended September 30, 2010  
                Rehabilitation division                          
    Hospital
division(a)
    Nursing
center
division(a)
    Skilled
nursing
services
    Hospital
services
    Total     Corporate(a)     Transaction
costs
    Eliminations     Consolidated  

Revenues

  $ 1,465,661      $ 1,621,450      $ 303,952      $ 62,496      $ 366,448      $ —        $ —        $ (229,346   $ 3,224,213   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Salaries, wages and benefits

    664,317        805,560        261,497        45,960        307,457        75,667        —          (14     1,852,987   

Supplies

    170,273        82,135        2,206        67        2,273        413        —          —          255,094   

Rent

    113,580        148,458        4,368        79        4,447        110        —          —          266,595   

Other operating expenses

    368,057        517,249        11,919        1,802        13,721        35,668        2,496        (229,332     707,859   

Other income

    —          —          —          —          —          (8,735     —          —          (8,735

Depreciation and amortization

    38,218        33,825        1,672        207        1,879        16,218        —          —          90,140   

Interest expense

    3        96        —          —          —          4,148        —          —          4,247   

Investment income

    (1     (56     (3     (1     (4     (842     —          —          (903
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
    1,354,447        1,587,267        281,659        48,114        329,773        122,647        2,496        (229,346     3,167,284   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Income from continuing operations before income taxes

  $ 111,214      $ 34,183      $ 22,293      $ 14,382      $ 36,675      $ (122,647   $ (2,496   $ —          56,929   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

Provision for income taxes

                    20,538   
                 

 

 

 

Income from continuing operations

                  $ 36,391   
                 

 

 

 

 

(a) Includes $2.9 million in aggregate of severance and retirement costs in salaries, wages and benefits (hospital division — $1.1 million, nursing center division — $0.5 million and corporate — $1.3 million).

 

65


Table of Contents

ITEM 2.    MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND

RESULTS OF OPERATIONS (Continued)

 

Operating Data

(Unaudited)

 

     2010 Quarters      2011 Quarters  
     First      Second      Third      Fourth      First      Second      Third  

Hospital data:

                    

End of period data:

                    

Number of hospitals:

                    

Long-term acute care

     83         83         83         89         89         120         120   

Inpatient rehabilitation

     —           —           —           —           —           5         5   
  

 

 

    

 

 

    

 

 

    

 

 

    

 

 

    

 

 

    

 

 

 
     83         83         83         89         89         125         125   
  

 

 

    

 

 

    

 

 

    

 

 

    

 

 

    

 

 

    

 

 

 

Number of licensed beds:

                    

Long-term acute care

     6,580         6,576         6,563         6,887         6,889         8,609         8,597   

Inpatient rehabilitation

     —           —           —           —           —           183         183   
  

 

 

    

 

 

    

 

 

    

 

 

    

 

 

    

 

 

    

 

 

 
     6,580         6,576         6,563         6,887         6,889         8,792         8,780   
  

 

 

    

 

 

    

 

 

    

 

 

    

 

 

    

 

 

    

 

 

 

Revenue mix %:

                    

Medicare

     56         56         55         58         60         60         60   

Medicaid

     9         9         9         9         8         8         8   

Medicare Advantage

     10         10         10         9         10         10         10   

Commercial insurance and other

     25         25         26         24         22         22         22   

Admissions:

                    

Medicare

     7,432         7,125         6,769         7,640         8,504         8,913         11,002   

Medicaid

     997         990         1,022         1,034         1,085         1,163         1,236   

Medicare Advantage

     1,129         1,106         936         1,071         1,172         1,348         1,609   

Commercial insurance and other

     2,262         2,048         1,978         2,020         2,282         2,290         2,669   
  

 

 

    

 

 

    

 

 

    

 

 

    

 

 

    

 

 

    

 

 

 
     11,820         11,269         10,705         11,765         13,043         13,714         16,516   
  

 

 

    

 

 

    

 

 

    

 

 

    

 

 

    

 

 

    

 

 

 

Admissions mix %:

                    

Medicare

     63         63         63         65         65         65         67   

Medicaid

     8         9         10         9         8         8         7   

Medicare Advantage

     10         10         9         9         9         10         10   

Commercial insurance and other

     19         18         18         17         18         17         16   

Patient days:

                    

Medicare

     202,882         195,964         179,324         198,129         219,213         237,257         275,561   

Medicaid

     47,813         45,952         48,514         46,596         45,650         45,746         48,911   

Medicare Advantage

     34,524         36,000         31,186         32,868         35,639         39,503         47,819   

Commercial insurance and other

     75,483         70,651         70,198         69,585         70,522         72,759         83,375   
  

 

 

    

 

 

    

 

 

    

 

 

    

 

 

    

 

 

    

 

 

 
     360,702         348,567         329,222         347,178         371,024         395,265         455,666   
  

 

 

    

 

 

    

 

 

    

 

 

    

 

 

    

 

 

    

 

 

 

Average length of stay:

                    

Medicare

     27.3         27.5         26.5         25.9         25.8         26.6         25.0   

Medicaid

     48.0         46.4         47.5         45.1         42.1         39.3         39.6   

Medicare Advantage

     30.6         32.5         33.3         30.7         30.4         29.3         29.7   

Commercial insurance and other

     33.4         34.5         35.5         34.4         30.9         31.8         31.2   

Weighted average

     30.5         30.9         30.8         29.5         28.4         28.8         27.6   

Revenues per admission:

                    

Medicare

   $ 38,078       $ 38,938       $ 37,675       $ 38,368       $ 39,439       $ 40,089       $ 37,408   

Medicaid

     45,738         42,774         42,910         41,704         42,432         41,576         40,720   

Medicare Advantage

     45,187         46,169         48,122         44,744         46,217         42,708         43,616   

Commercial insurance and other

     56,344         59,842         61,314         61,131         54,065         56,850         57,216   

Weighted average

     42,899         43,784         43,456         43,150         42,856         43,271         41,462   

Revenues per patient day:

                    

Medicare

   $ 1,395       $ 1,416       $ 1,422       $ 1,479       $ 1,530       $ 1,506       $ 1,494   

Medicaid

     954         922         904         925         1,009         1,057         1,029   

Medicare Advantage

     1,478         1,418         1,444         1,458         1,520         1,457         1,468   

Commercial insurance and other

     1,688         1,735         1,728         1,775         1,749         1,789         1,832   

Weighted average

     1,406         1,416         1,413         1,462         1,507         1,501         1,503   

Medicare case mix index (discharged patients only)

     1.21         1.21         1.19         1.17         1.21         1.22         1.17   

Average daily census

     4,008         3,830         3,579         3,774         4,122         4,344         4,953   

Occupancy %

     68.2         66.1         62.0         64.0         68.7         65.5         62.6   

Annualized employee turnover %

     21.8         22.6         22.3         22.0         21.2         22.1         21.4   

 

66


Table of Contents

ITEM 2.    MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND

RESULTS OF OPERATIONS (Continued)

 

Operating Data (Continued)

(Unaudited)

 

    2010 Quarters     2011 Quarters  
    First     Second     Third     Fourth     First     Second     Third  

Nursing and rehabilitation center data:

             

End of period data:

             

Number of facilities:

             

Nursing and rehabilitation centers:

             

Owned or leased

    218        219        222        222        220        220        220   

Managed

    4        4        4        4        4        4        4   

Assisted living facilities

    6        7        7        7        6        6        6   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
    228        230        233        233        230        230        230   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Number of licensed beds:

             

Nursing and rehabilitation centers:

             

Owned or leased

    26,711        26,760        27,030        26,957        26,767        26,687        26,687   

Managed

    485        485        485        485        485        485        485   

Assisted living facilities

    327        463        463        463        413        413        413   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
    27,523        27,708        27,978        27,905        27,665        27,585        27,585   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Revenue mix %:

             

Medicare

    35        34        33        36        38        37        36   

Medicaid

    41        41        41        39        37        38        38   

Medicare Advantage

    6        7        7        7        7        7        7   

Private and other

    18        18        19        18        18        18        19   

Patient days (excludes managed facilities):

             

Medicare

    369,102        363,149        346,837        344,018        370,395        358,760        345,362   

Medicaid

    1,312,517        1,292,246        1,289,643        1,287,739        1,232,620        1,229,517        1,255,418   

Medicare Advantage

    87,692        92,051        91,643        94,336        97,460        94,483        95,751   

Private and other

    397,550        415,921        437,413        453,357        425,414        435,667        436,074   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
    2,166,861        2,163,367        2,165,536        2,179,450        2,125,889        2,118,427        2,132,605   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Patient day mix %:

             

Medicare

    17        17        16        16        17        17        16   

Medicaid

    61        60        60        59        58        58        59   

Medicare Advantage

    4        4        4        4        5        4        5   

Private and other

    18        19        20        21        20        21        20   

Revenues per patient day:

             

Medicare Part A

  $ 470      $ 469      $ 468      $ 534      $ 537      $ 544      $ 550   

Total Medicare (including Part B)

    513        515        519        587        579        589        599   

Medicaid

    168        171        171        171        172        173        174   

Medicare Advantage

    398        400        405        432        416        420        421   

Private and other

    238        234        232        228        235        240        243   

Weighted average

    249        250        249        260        267        268        268   

Average daily census

    24,076        23,773        23,538        23,690        23,621        23,279        23,180   

Admissions (excludes managed facilities)

    19,026        18,924        19,383        19,118        20,619        20,143        20,118   

Occupancy %

    89.0        87.3        86.8        86.4        86.9        85.9        85.5   

Medicare average length of stay

    33.7        35.2        34.3        33.0        32.9        33.4        33.0   

Annualized employee turnover %

    36.7        38.8        39.8        39.6        37.8        39.8        40.2   

 

67


Table of Contents

ITEM 2.    MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND

RESULTS OF OPERATIONS (Continued)

 

Operating Data (Continued)

(Unaudited)

 

    2010 Quarters     2011 Quarters  
    First     Second     Third     Fourth     First     Second     Third  

Rehabilitation data:

             

Skilled nursing rehabilitation services:

             

Revenue mix %:

             

Company-operated

    57        56        55        49        47        34        22   

Non-affiliated

    43        44        45        51        53        66        78   

Sites of service (at end of period)

    554        568        595        635        641        1,848        1,835   

Revenue per site

  $ 172,498      $ 171,254      $ 167,832      $ 174,896      $ 178,812      $ 137,316      $ 137,643   

Therapist productivity %

    83.8        84.2        82.1        78.6        80.6        81.6        80.5   

Home health and hospice revenues

  $ 3,434      $ 3,875      $ 3,947      $ 6,266      $ 8,038      $ 10,828      $ 15,419   

Hospital rehabilitation services:

             

Revenue mix %:

             

Company-operated

    96        96        95        95        94        54        29   

Non-affiliated

    4        4        5        5        6        46        71   

Sites of service (at end of period):

             

Inpatient rehabilitation units

    —          —          —          1        1        104        102   

LTAC hospitals

    85        85        85        91        93        97        99   

Sub-acute units

    7        7        7        7        8        22        23   

Outpatient units

    10        11        11        12        12        119        114   

Other

    2        2        4        4        5        8        7   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
    104        105        107        115        119        350        345   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Revenue per site

  $ 203,337      $ 199,174      $ 190,986      $ 184,193      $ 188,989      $ 199,661      $ 202,352   

Annualized employee turnover %

    12.6        14.2        15.4        14.4        14.5        17.1        16.5   

 

68


Table of Contents

ITEM 3.    QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

The following discussion of the Company’s exposure to market risk contains “forward-looking statements” that involve risks and uncertainties. Given the unpredictability of interest rates as well as other factors, actual results could differ materially from those projected in such forward-looking information.

The Company’s exposure to market risk relates to changes in the prime rate, federal funds rate and LIBOR which affect the interest paid on certain borrowings.

The following table provides information about the Company’s financial instruments that are sensitive to changes in interest rates. The table presents principal cash flows and related weighted average interest rates by expected maturity date.

Interest Rate Sensitivity

Principal Amount by Expected Maturity

Average Interest Rate

(Dollars in thousands)

 

     Expected maturities      Fair
value
9/30/11
 
     2011     2012     2013     2014     2015     Thereafter     Total     

Liabilities:

                 

Long-term debt, including amounts due within one year:

                 

Fixed rate:

                 

Notes

   $ —        $ —        $ —        $ —        $ —        $ 550,000      $ 550,000       $ 420,062   

Other

     24        96        102        109        116        133        580         550 (a) 
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

    

 

 

 
   $ 24      $ 96      $ 102      $ 109      $ 116      $ 550,133      $ 550,580       $ 420,612   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

    

 

 

 

Average interest rate

     6.0     6.0     6.0     6.0     6.0     8.2     

Variable rate:

                 

ABL Facility (b)

   $ —        $ —        $ —        $ —        $ —        $ 248,500      $ 248,500       $ 248,500   

Term Loan Facility (c)

     1,750        7,000        7,000        7,000        7,000        668,500        698,250         647,627   

Other (d)

     58        232        233        233        3,720        —          4,476         4,476   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

    

 

 

 
   $ 1,808      $ 7,232      $ 7,233      $ 7,233      $ 10,720      $ 917,000      $ 951,226       $ 900,603   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

    

 

 

 

 

(a) Calculated based upon the net present value of future principal and interest payments using a discount rate of 6%.
(b) Interest on borrowings under the Company’s ABL Facility is payable, at the Company’s option, at a rate per annum equal to the applicable margin plus, at the Company’s option, either (1) LIBOR determined by reference to the costs of funds for eurodollar deposits for the interest period relevant to such borrowing adjusted for certain additional costs, or (2) a base rate determined by reference to the highest of (a) the prime rate of JPMorgan Chase Bank, N.A., (b) the federal funds effective rate plus one-half of 1.00% and (c) LIBOR as described in subclause (1) plus 1.00%. The initial applicable margin for borrowings under the ABL Facility was 2.75% with respect to LIBOR borrowings and 1.75% with respect to base rate borrowings. The applicable margin is subject to adjustment each fiscal quarter, based upon average historical excess availability during the preceding quarter.
(c) Interest on borrowings under the Company’s Term Loan Facility is payable, at the Company’s option, at a rate per annum equal to an applicable margin plus, at the Company’s option, either (1) LIBOR determined by reference to the costs of funds for eurodollar deposits for the interest period relevant to such borrowing adjusted for certain additional costs, or (2) a base rate determined by reference to the highest of (a) the prime rate of JPMorgan Chase Bank, N.A., (b) the federal funds effective rate plus one-half of 1.00% and (c) LIBOR described in subclause (1) plus 1.00%. LIBOR is subject to an interest rate floor of 1.50%. The initial applicable margin for borrowings under the Term Loan Facility was 3.75% with respect to LIBOR borrowings and 2.75% with respect to base rate borrowings. The expected maturities for the Term Loan Facility exclude the original issue discount of approximately $7 million.
(d) Interest based upon LIBOR plus 4%.

 

69


Table of Contents

ITEM 4.    CONTROLS AND PROCEDURES

Evaluation of Disclosure Controls and Procedures and Changes in Internal Control Over Financial Reporting

The Company has carried out an evaluation under the supervision and with the participation of management, including the Company’s Chief Executive Officer and Chief Financial Officer, of the effectiveness of the design and operation of the Company’s disclosure controls and procedures. There are inherent limitations to the effectiveness of any system of disclosure controls and procedures, including the possibility of human error and the circumvention or overriding of the controls and procedures. Accordingly, even effective disclosure controls and procedures can only provide reasonable assurance of achieving their control objectives. Based upon this evaluation, the Chief Executive Officer and Chief Financial Officer have concluded that, as of September 30, 2011, the Company’s disclosure controls and procedures are effective to provide reasonable assurance that information required to be disclosed in the reports that the Company files and submits under the Exchange Act is recorded, processed, summarized and reported as and when required.

Except as described below with respect to the status of the integration of RehabCare, there has been no change in the Company’s internal control over financial reporting during the Company’s quarter ended September 30, 2011, that has materially affected, or is reasonably likely to materially affect, the Company’s internal control over financial reporting.

On June 1, 2011, the Company completed the RehabCare acquisition. The Company is in the process of integrating RehabCare into the Company’s existing internal control environment. The Company expects to exclude RehabCare from the assessment of internal control over financial reporting as of December 31, 2011.

 

70


Table of Contents

PART II. OTHER INFORMATION

 

Item 1. Legal Proceedings

The Company is a party to various legal actions (some of which are not insured), and regulatory and other government investigations in the ordinary course of business. The Company is unable to predict the ultimate outcome of pending litigation and regulatory and other government investigations. These legal actions and investigations could potentially subject the Company to sanctions, damages, recoupments, fines and other penalties. The DOJ, CMS or other federal and state enforcement and regulatory agencies may conduct additional investigations related to the Company’s businesses in the future which may, either individually or in the aggregate, have a material adverse effect on the Company’s business, financial position, results of operations and liquidity.

On February 10, 2011, Arthur I. Murphy, Jr., a purported stockholder of RehabCare, filed a purported class action lawsuit in the Circuit Court of St. Louis County, Missouri (which we refer to as the “Circuit Court”) against RehabCare, RehabCare’s directors and Kindred (which we refer to as the “Murphy litigation”); and on March 2, 2011, Alfred T. Kowalewski, a purported stockholder of RehabCare, filed a purported class action lawsuit in the Circuit Court, Missouri against RehabCare, RehabCare’s directors and Kindred (which we refer to as the “Kowalewski litigation” and, together with the Murphy litigation, the “Missouri litigation”). On February 15, 2011, the Norfolk County Retirement System, a purported stockholder of RehabCare, filed a purported class action lawsuit in the Court of Chancery against RehabCare, RehabCare’s directors and Kindred (which we refer to as the “Norfolk County litigation”); on February 28, 2011, City of Pontiac General Employees’ Retirement System, a purported stockholder of RehabCare, filed a purported class action lawsuit in the Court of Chancery against RehabCare, RehabCare’s directors and Kindred (which we refer to as the “City of Pontiac litigation”); and on March 4, 2011, Plumbers & Pipefitters National Pension Fund, a purported stockholder of RehabCare, filed a purported class action lawsuit in the Court of Chancery against RehabCare, RehabCare’s directors and Kindred (which we refer to as the “Plumbers & Pipefitters litigation” and, together with the Norfolk County litigation and the City of Pontiac litigation, the “Delaware litigation”).

The complaints in the Missouri litigation and Delaware litigation contain similar allegations, including among other things, that RehabCare’s directors breached their fiduciary duties to the RehabCare stockholders, including their duties of loyalty, due care, independence, good faith and fair dealing, by entering into a merger agreement which provides for inadequate consideration to RehabCare stockholders, and that RehabCare and Kindred aided and abetted RehabCare’s directors alleged breaches of their fiduciary duties. The plaintiffs seek injunctive relief preventing the defendants from consummating the transactions contemplated by the merger agreement, or in the event the defendants consummate the transactions contemplated by the merger agreement, rescission of such transactions and attorneys’ fees and expenses.

On March 8, 2011, the plaintiffs in the Kowalewski litigation filed a motion with the Circuit Court to consolidate the Missouri litigation and to appoint lead counsel. On March 31, 2011, the plaintiffs in the Kowalewski litigation filed an amended complaint and a motion for expedited discovery and on April 11, 2011, the plaintiffs in the Murphy litigation filed an amended complaint and a motion for expedited discovery. This April 11, 2011 amended complaint in the Murphy litigation also added Citigroup Global Markets Inc. as a named defendant in the litigation. On April 7, 2011, the defendants filed a motion to dismiss and/or stay the Missouri litigation. After holding hearings on April 8 and April 22, 2011, the Circuit Court stayed the Missouri litigation by Order dated April 25, 2011.

On March 9, 2011, the Court of Chancery consolidated the Delaware litigation under the caption “In Re RehabCare Group, Inc. Shareholders Litigation” and plaintiffs filed a verified consolidated class action complaint on April 5, 2011.

 

71


Table of Contents

PART II. OTHER INFORMATION (Continued)

 

Item 1. Legal Proceedings (Continued)

 

On May 12, 2011, the defendants entered into a memorandum of understanding with the plaintiffs in the Delaware litigation regarding the settlement of the Delaware litigation. In connection with the settlement contemplated by the memorandum of understanding, (i) Kindred and RehabCare agreed to make certain additional disclosures related to the proposed merger, which were contained in a Form 8-K filed with the SEC on May 12, 2011, (ii) RehabCare agreed to make the payment, at and subject to the closing of the merger between Kindred and RehabCare, of $2.5 million in cash into a settlement pool for the benefit of the plaintiff class in In re RehabCare Group, Inc. Shareholders Litigation, to be distributed after final approval of the settlement of the Delaware Litigation and (iii) Kindred, Kindred Healthcare Development, Inc. and RehabCare agreed to enter into an amendment, dated May 12, 2011, to the merger agreement, dated as of February 7, 2011, among Kindred, Kindred Healthcare Development, Inc. and RehabCare, the material terms of which are as follows:

 

   

inclusion of an acknowledgement by Kindred and RehabCare of the waiver of any existing standstill undertakings for the benefit of RehabCare;

 

   

change of the definition of “Company Termination Fee” to mean an amount equal to $13 million; and

 

   

modification of the agreement to eliminate the requirement for a three-business day period during which Kindred has the right to match a superior proposal.

A copy of the Amendment to Agreement and Plan of Merger was filed as Exhibit 2.1 to the Form 8-K filed with the SEC on May 12, 2011. The foregoing description of such Amendment to Agreement and Plan of Merger is qualified by this exhibit which is incorporated herein by reference.

On June 29, 2011, the parties submitted to the Court of Chancery a proposed Stipulation of Settlement and Dismissal, which the Court granted on July 1, 2011. The Court of Chancery held a formal settlement hearing on September 8, 2011, at which the Court approved the agreed-upon Stipulation of Settlement and Dismissal as fair and reasonable, and awarded plaintiffs’ attorneys’ fees in the amount of $1.7 million plus expenses incurred. The Stipulation of Settlement and Dismissal became final on October 11, 2011 after the time to file an appeal of the Court’s order approving the settlement expired.

 

Item 6. Exhibits

 

4.1   Second Supplemental Indenture, dated as of September 28, 2011, among Kindred Healthcare, Inc., the Subsidiary Guarantors party thereto and Wells Fargo Bank, National Association, as Trustee. Exhibit 4.1 to the Company’s Current Report on Form 8-K dated September 28, 2011 (Comm. File No. 001-14057) is hereby incorporated by reference.
4.2   Second Joinder Agreement to the Registration Rights Agreement, dated as of September 28, 2011, among the Subsidiary Guarantors party thereto. Exhibit 4.2 to the Company’s Current Report on Form 8-K dated September 28, 2011 (Comm. File No. 001-14057) is hereby incorporated by reference.
31   Rule 13a-14(a)/15d-14(a) Certifications.
32   Section 1350 Certifications.
101.XML   XBRL Instance Document. *
101.XSD   XBRL Taxonomy Extension Schema Document. *
101.CAL   XBRL Taxonomy Extension Calculation Linkbase Document. *
101.DEF   XBRL Taxonomy Extension Definition Linkbase Document.*
101.LAB   XBRL Taxonomy Extension Label Linkbase Document. *
101.PRE   XBRL Taxonomy Extension Presentation Linkbase Document. *

 

* In accordance with Regulation S-T, the XBRL-related information in Exhibit 101 to this Quarterly Report on Form 10-Q shall be deemed to be “furnished” and not “filed.”

 

72


Table of Contents

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

   KINDRED HEALTHCARE, INC.

Date: November 9, 2011

  

/s/    PAUL J. DIAZ        

   Paul J. Diaz
  

President and

Chief Executive Officer

Date: November 9, 2011

  

/s/    RICHARD A. LECHLEITER        

   Richard A. Lechleiter
  

Executive Vice President and

Chief Financial Officer

 

73